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ABSTRACT
Many halogenated xenobiotics such as the environmental contaminant trichloroethylene 
are detoxified by conjugation to glutathione. Subsequent metabolic processing yields 
the cysteine conjugate of the original compound which may then serve as a substrate for 
cysteine conjugate B-lyase (glutamine transaminase K, GTK). In rats bioactivation of 
certain cysteine conjugates by 6-lyase results in toxicity specific to the P3 segment of 
the renal proximal tubule whereeis in humans, the nephrotoxicity is less acute, however, 
excessive exposure to halogenated alkenes can result in specific neurotoxicity and 
neurodegeneration.
As an approach to studying the species difference toxicity we have isolated and 
transiently expressed in COS-1 cells, full length cDNAs encoding rat and human 
cysteine conjugate 6-lyase (Perry et ah, 1993 & 1995). In this thesis I examine the 
differences in enzyme activity observed with the transiently expressed rat and human 6- 
lyase cDNAs. Rat 6-lyase expressed in COS-1 cells showed lower activity than the 
human enzyme, it also possessed a 5’ non-coding region containing an inverted repeat, 
the removal of which did not increase the activity of the expressed truncated rat cDNA. 
This would suggest that the inverted repeat was not interfering with mRNA translation 
and that differences in activity between rat and human 6-lyase were due to some other 
reason.
In order to assess the structure-activity relationships of rat and human cysteine 
conjugate 6-lyase, their full length cDNAs in the expression vector pUSlOOO were 
stably incorporated into the pig kidney epithelial cell line, LLC-PKl. Confirmation of 
the stable retention of the transfected cDNAs and the continuing high level expression 
was obtained using Southern blot analysis and enzyme activity assays. The cell lines 
stably expressing rat and human cysteine conjugate 6-lyase were then used to assess the 
in vitro toxicity of sixteen different cysteine conjugates using a tétrazolium salt (XTT - 
sodium 3 ' - [1 -(phenylamino-carbonyl) -3,4-tetrazolium] -bis (4-methoxy-6-nitro)
benzene sulphonic acid hydrate) method to assess mitochondrial integrity. The kinetics 
of the metabolism of several cysteine conjugates by cytosolic extracts from the stable 
cell lines expressing rat and human cysteine conjugate 6-lyase were examined.
It would appear that those cysteine conjugates which are good substrates for cytosolic 
cysteine conjugate 6-lyase are not necessarily the most toxic. Again, those haloalkenes 
containing fluorine groups appear to be better substrates for cysteine conjugate 6-lyase 
than those containing chlorine groups. The cysteine conjugates DCVC and PCBC 
would appear to be preferentially metabolised by a mitochondrial enzyme, since they 
exhibit greater cytotoxicity in the wild type LLC-PKl cells than in the cell lines stably 
transfected with rat and human cytosolic cysteine conjugate 6-lyase. This data would 
suggest that the cytosolic 6-lyase in the stable cell lines is preventing some of the 
DCVC and PCBC from getting to its mitochondrial target. Those conjugates which are 
metabolised within the mitochondria have a far greater toxic effect than those which do 
not. These data suggest that the site of metabolism of the cysteine conjugate determines 
the degree of cytotoxicity observed.
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MS Mass spectrometry
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CHAPTER 1 
INTRODUCTION
1.1 GENERAL INTRODUCTION
Everyday, living organisms come into contact with foreign compounds such as 
xenobiotics (e.g. drugs, environmental pollutants, pesticides and herbicides) and as a 
result have developed an extremely efficient mechanism for disposal of such 
compounds. In general this is done by firstly converting such compounds into polar 
metabolites which are water soluble and hence more readily excreted by the kidney. 
Compounds which are ionic can be efficiently metabolised and excreted, however 
lipophilic compounds i.e. those compounds which are lipid soluble, prove to be 
problematical as they can be reabsorbed by the kidney repeatedly. Since the majority of 
foreign compounds, in particular pharmaceuticals, are lipid soluble, without an 
alternative method of metabolism these compounds would remain in the body 
indefinitely.
Drug metabolism has sparked much interest over the past 35 years, and research has led 
us to believe that there are many different ways in which the body converts lipophilic 
compounds into more water soluble polar metabolites. Metabolism may essentially be 
divided into two main processes known as P H A S E  I  (functionalisation) and P H A S E  I I  
(conjugation) metabolism.
Phase I metabolism involves the modification of a xenobiotic by the introduction of a 
functional group, for example the incorporation of a hydroxyl group. The prime 
objective of phase I metabolism is not to polarise the compounds, but to prepare the 
compounds for subsequent conjugation with highly polar moieties during phase II, thus 
making the compounds more readily excreted in urine or bile. If, however, the 
xenobiotic already possesses a polar group, this step is not necessary (Gibson & Skett,
1
1994; Timbrell, 1991). Phase II metabolism involves the conjugation of the phase I 
product with a polar endogenous group resulting in the formation of a polar conjugate 
of the parent xenobiotic which is readily excretable. Examples of polar groups usually 
used in conjugation are glucuronic acid, amino acids, glutathione and sulphate. 
Reviews of phase I and II metabolism may be found in Gibson and Skett (1994) and 
Timbrell (1991).
Further to phase I and II metabolism, a third phase of metabolism has been proposed, 
whereby the conjugate formed in phase II is metabolised by gut microflora after having 
been excreted in bile. The conjugate is subsequently re-absorbed and metabolised. This 
occurrence has been observed with glutathione conjugates, which were further 
metabolised into cysteine conjugates and mercapturic acids (Gibson and Skett, 1994; 
Figure 1.1).
Research has shown however, that in the majority of cases, it is not the actual parent 
compound which gives rise to toxicity, but the reactive intermediates produced by its 
subsequent metabolism (Anders, 1985). The most important organ involved with the 
absorption of biotransformed drugs is considered to be the liver, which contains very 
high levels of drug metabolising enzymes, has a relatively high blood flow and is the 
first organ to which blood (carrying orally absorbed xenobiotics) are transported.
Extra-hepatic tissue contains the majority of enzymes involved in drug metabolism and 
is believed to have a toxicological significance, even though they may only contribute 
to a small percentage of the overall metabolism of compounds. It is believed that 
reactive intermediates formed as a result of bioactivation, such as activated oxygen 
species, electrophiles and radicals, may either be produced in the target organs / tissues 
or produced in the liver and subsequently transported to the target site. Alternatively, 
some compounds may be activated in multiple step reactions resulting in the production
of a stable proximate toxic metabolite which may then be transported to and 
bioactivated at the target organ. An example of this is the halogenated alkenes such as 
hexachloro-1,3-butadiene (HCBD), which has been implicated in nephrotoxicity and 
carcinogenicity observed in rodents. An enzyme of particular interest in this thesis is 
kidney cytosolic cysteine conjugate 6-lyase, which is involved in the bioactivation of 
halo-alkenes such as HCBD. This enzyme is toxicologically important since its activity 
gives rise to metabolites which are selectively toxic to the P3 segment of the proximal 
tubule in the kidney (Lock & Ishmael, 1985).
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Figure 1.1 - Mercapturic acid synthesis (Adapted from Chasseud, 1976).
1.2  MERCAPTURIC ACID SYNTHESIS
The endogenous peptide glutathione or y -L-glutamyl-L-cysteine, is present in all 
mammalian cells and plays an important role in protection against toxic species formed 
during drug and chemical detoxification. Biosynthesis of glutathione-S-conjugates 
(Figure 1.1, step I) provides a cellular defence against strong electrophiles such as 
haloalkanes, epoxides, alkenes, nitroalkenes and aromatic nitro- and halo- compounds. 
Electrophilic compounds which are formed during phase I metabolism react with the 
nucleophilic sulphur atom present in the cysteine moiety of glutathione generally giving 
rise to non-toxic conjugate products. The resultant glutathione-conjugate can be further 
metabolised to form an N-acetyl-L-cysteine conjugate or mercapturic acid, which in turn 
can be excreted in the urine or bile. This metabolic pathway is also referred to as the 
mercapturic acid pathway.
1.2.1 Glutathione Conjugation
Glutathione conjugation can occur both enzymatically or spontaneously (highly 
electrophilic substrates). The enzymatic reaction is catalysed by the family of enzymes 
known as the glutathione-S-transferases (GST; EC 2.5.1.18) which are found in both 
the cytosolic and microsomal fractions of most mammalian tissues (Chasseaud, 1979; 
Jacoby, 1990).
Cytosolic glutathione-S-transferases are a family of homo and heterodimeric proteins 
(subunit molecular weight, 25,000 - 29,000) of which at least 12 different subunits 
have been identified. They possess broad and overlapping substrate specificities 
(Mannervik and Danielson, 1988) and catalyse the reaction of the thiolate form of 
glutathione with various electronegative atoms (Dekant et a l, 1989). Microsomal 
glutathione-S-transferases are membrane bound and differ from cytosolic transferases 
in molecular weight and immunological activity (Morgenstem et al, 1985). The most
important site in the body for glutathione conjugation quantitatively speaking is the 
liver, here the microsomal GSTs are more effective than the cytosolic enzymes at 
catalysing glutathione conjugation with haloalkenes (Elfarra, 1993).
1.2.2 Hydrolysis o f the Glutathione y-glutamyl Group
The initial step in the formation of mercapturic acids via glutathione conjugation 
involves the hydrolytic transfer of the y -glutamyl group of the conjugate onto an 
appropriate acceptor (Figure 1.1, step II). This step is catalysed by the enzyme, y- 
glutamyl transpeptidase (y-gt; Meister and Tate, 1976) and dipeptidases, with the 
formation of either the corresponding cysteinyl-glycine-S-conjugate or cysteinyl 
glycine dipeptide.
y-G t, is found in serum and all mammalian cells with the exception of muscle, the 
majority being membrane bound, although some y -gt activity has been detected in 
cytosol. The active site of the membrane bound y -gt is found on the luminal side of the 
renal tubule cells (Horiuchi et al. , 1978).
The highest y -gt activity is found in the kidney, followed by the pancreas which has 
approximately 20% of the renal activity (Goldbarg et ai, 1960). All other tissues 
possess y-gt activity which is less than 1% of that found in the kidney. The activity of 
y -gt is found in specific localised sites of the proximal convoluted tubule in the kidney, 
notably the brush border and basolateral membranes in the P3 region. The remainder of 
the proximal tubule has a much lower y-gt activity (Spater et al., 1982). The brush 
border membrane of the villus cells present in the small intestine also possess y-gt 
activity (Curthoys and Shapiro, 1975), so too does the biliary tree, where gut flora are 
believed to carry out the transferase reaction (Ballattori et ai, 1988).
1.2.3 Removal o f Glycine by Peptidases
Only two of the enzymes which catalyse the removal of glycine from cysteinylglycine- 
S-conjugates have been purified, namely cysteinylglycine dipeptidase (CGD, EC 
3.4.13.6) and aminopeptidase M (APM, EC 3.4.11.2) (Kozak and Tate, 1982). CGD 
is the more active of the two enzymes, but both exhibit their greatest activity in the 
kidney, followed by the liver (Hinchman and Ballattori, 1990). Lower activities of 
these enzymes may be found in the small intestine (Grafstrom et a l, 1979) and 
pancreatic sections of the bile (Hirata and Takahashi, 1981). In the kidney, CGD and 
APM are found in the luminal (Hughey et a l , 1978) and basolateral membranes of the 
cells bordering the proximal tubule (Sochor et a l , 1980; Dass et a l , 1981). In the liver 
APM is located in the canilicular membrane of hepatocytes and in the luminal membrane 
of the biliary epithelium (Inoue et a l , 1983).
1.2.4 N-acetylation of Cysteine-S-Conjugates to 
Mercapturic Acids
Mercapturic acids are N-acetyl conjugates and are end products of a pathway which 
involves the detoxification of potentially harmful electrophilic compounds (Duffel and 
Jacoby, 1982). The final step in the conversion of glutathione conjugates to mercapturic 
acids is known as N-acetylation and is catalysed by the enzyme cysteine conjugate N- 
acetyltransferase (NAT, EC 2.3.1.8) (Green and Elce, 1975). NATs exhibit their 
greatest activity in the liver and kidney, although they may be found with lower 
activities in other tissues such as the intestinal epithelium. In both the liver and kidney, 
NATs are found in the endoplasmic reticulum with their active sites facing the 
cytoplasm (Okajima et a l , 1984) and require acetyl coenzyme A (AcCoA) as a cofactor. 
Total NAT activity is higher in the mammalian liver (Inoue et al, 1987) however, 
specific NAT activity is greater in the kidney, being primarily located in the cells of the 
straight proximal tubule (Hughey et al, 1978). N-acetylation is a reversible reaction.
the reverse reaction being catalysed by renal acylases (Nash et al., 1984) leading to the 
reformation of cysteine S-conjugates (Suzuki and Tateishi, 1981).
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1.3 BIOACTIVATION AND NEPHROTOXICITY - THE ROLE
OF GLUTATHIONE
It was previously believed that glutathione conjugation was a protective mechanism 
leading to mercapturic acid synthesis, however research has shown that this is not 
strictly true. Glutathione conjugation has been the focus of much attention since its role 
in the bioactivation of some xenobiotics to toxic metabolites became apparent (van 
Bladeren, 1988). Toxic glutathione conjugates may be separated into three groups :
•  Reactive, direct acting glutathione conjugates,
•  Glutathione conjugates in which glutathione reversibly binds to and serves 
as a transporter molecule,
•  Glutathione conjugates which require further bioactivation.
Examples of these three groups are found in figure 1.2.
1.3.1 Direct acting glutathione S-conjugates
Dihaloalkanes such as 1,2-dichloroethane and 1,2-dibromoethane conjugate with 
glutathione forming the glutathione conjugates, 2-chloro and 2-bromoethyl glutathione 
respectively (Hill et al. , 1978; van Bladeren et a l , 1979). These glutathione conjugates 
are also known as sulphur half-mustards which in turn may undergo internal 
displacement of the second halogen atom, giving rise to the formation of extremely 
reactive electrophilic episulfonium ions (Vermeulen et a l, 1989). It is believed that 
these strong eleetrophiles may be involved in the formation of DNA-adducts and hence 
play an important role in the mutagenicity and nephrotoxicity of 1,2-dihaloalkanes (Hill 
eta l, 1978).
Br ^SG
Br^ ^  ^  Br
1,2-dibromoethane 2-bromoethylglutathione
1). Direct acting glutathione S-conjugates
S
II
R— N =  C = S  + GSH ^  R— NH C— SG
Benzyl/allyl
isothiocyanate
2). Reversible glutathione conjugate formation may serve as a transport mechanism 
for cytotoxic chemicals.
Cl^ /S G  C l^  / S -
/ C — C ------- ►  c = C  c  =  C
H Cl a  H ^Cl
1,2,2-trichloroethene 1,2-dichloroethyl- unstable enethiol
(glutathione)
3). Glutathione S-conjugates requiring further metabolism for bioactivation
Figure 1 . 2 -  Three forms of reactive glutathione conjugate
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The haloalkane, dichloromethane is metabolised by glutathione S-transferase to from S- 
(ehloromethyl)glutathione, a reactive eleetrophile which in turn rapidly hydrolyses to 
S-(hydroxymethyl)glutathione. This compound finally decomposes to the products 
formaldehyde and glutathione. Both S-(chloromethyl)glutathione and formaldehyde are 
reactive intermediates and may be responsible for the dichloromethane-induced 
tumorigenesis in sensitive species (Andersen et al. , 1987; Reitz et al. , 1989).
1.3 .2  Glutathione as a Transporter o f Eleetrophiles
Some glutathione conjugates may induce toxicity by transferring eleetrophiles to distant 
nucleophilic centres of essential biomaeromolecules. Bruggeman et a l, (1986) 
investigated the reaction between equimolar amounts of glutathione and allyl 
isothiocyanates and demonstrated that at equilibrium, 15-20% of the isothiocyanate 
remained unconjugated. Furthermore, they noted that by changing the concentration of 
the reactants and adjusting the pH, the position of equilibrium could be altered. These 
findings would suggest that after initial in vivo detoxification, the isothiocyanates may 
be released at different sites according to glutathione concentrations and pH. Dunnick et 
al, (1982) discovered that allyl isothiocyanate gives rise to bladder carcinoma in rats, 
the acidic environment favouring release of the isothiocyanate in the bladder.
1.3.3 Glutathione S-Conjugates Requiring Further 
Metabolism
Glutathione conjugates are not usually excreted without further metabolism, instead
they are metabolised to cysteine conjugates which are finally N-acetylated and excreted
as mercapturates in the urine. Thioethers of cysteine however, also serve as substrates
for the enzyme cysteine conjugate B-lyase present in the proximal tubule of the kidney.
These compounds contain electronegative and/or unsaturated substituents and are
enzymatically cleaved to form pyruvate, ammonia and reactive sulphur containing
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fragments which are selectively toxic to the P3 segment of the kidney proximal tubule 
(Lock and Ishmael, 1979).
Glutathione conjugates of hydroquinones such as benzoquinone, menadione and 
ehloroquinone, and aminophenol are nephrotoxic in rat and cytotoxic to kidney cells. It 
is believed that B-lyase does not play a role in the toxicity of these compounds since 
their toxicity is dependent on the enzyme y-gt (Monks and Lau, 1990; Klos et al., 
1992). Glutathione conjugates of hydroquinones and quinones appear to be targeted to 
renal proximal tubule cells by brush border y -gt. The enzyme y -gt then catalyses the 
hydrolysis of sueh conjugates, resulting in the formation of the corresponding 
hydroquinone cysteine S-conjugate, which can be more readily oxidised to a toxic 
quinone metabolite than the parent compound (Monks and Lau, 1990).
It is now acknowledged that glutathione conjugation and the mercapturic acid pathway 
are not solely detoxification pathways for xenobiotics, but that xenobiotics may form 
biologically active glutathione derived adducts which may be further metabolised to 
sulphur containing products which may be potential mutagens / alkylating agents.
The major factors which determine the toxic potential of haloalkyl derived glutathione 
conjugates of halogenated alkenes are firstly their suitability as substrates for B-lyases 
and secondly the reactivity of the thiols which they produce.
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1.4  INTER-ORGAN TRANSPORT OF GLUTATHIONE
CONJUGATES AND THEIR METABOLITES
Mercapturic acid synthesis involves many enzyme catalysed reactions which may occur 
at several sites within the body, most notably the liver, kidney and gut. Figure 1.3 
illustrates the proposed routes for transport of glutathione conjugates and their 
metabolites. It is generally accepted that glutathione conjugation occurs in the liver, 
most of the resulting conjugates passing across the canalicular membrane into the bile. 
Once the bile is saturated, the remaining conjugates pass into the plasma via the hepatic 
sinusoidal membrane (Chasseaud, 1976). The glutathione conjugates released into the 
bile are then degraded to their appropriate cysteine S-conjugates by enzymes such as y- 
gt and peptidases whieh are present in the luminal membrane of the biliary epithelium 
and the bile canalieular membranes of hepatocytes (Inoue et al, 1983; Ballatori et a l ,
1986). It is proposed that a transport system exists in the canalicular membranes which 
may function in the biliary secretion of glutathione S-conjugates (Inoue et al, 1984). 
Alternatively, those glutathione conjugates which arrive in the small intestine intact, 
will subsequently be metabolised to their respective cysteine S-conjugates by y -gt and 
CGD/APM.
From the small intestine or bile duct, cysteine S-conjugates are absorbed into the blood 
and transported to the liver via the hepatie portal vein. Once in the liver, some cysteine 
conjugates are converted to mercapturic acids by N-acetyl transferase (Green and Elce, 
1975). The mercapturic acids together with the remaining cysteine conjugates and the 
glutathione conjugates whieh passed directly from the liver into the plasma are 
transported via the blood to the kidney, the kidney being the primary organ for the 
handling of plasma glutathione and cysteine conjugates.
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Once in the kidney, the above metabolites are either filtered into the tubular lumen or 
pass into the peritubular circulation. The glutathione conjugates may be biotransformed 
to cysteine S-conjugates by y -gt and CGD present in the renal brush border (Hughey et 
al, 1978; Kozac and Tate, 1982; Elfarra and Anders, 1984), after which they are 
transported across the brush border membrane (Sochor et a l , 1980; Dass et a l , 1981). 
Glutathione conjugates present in the peritubular circulation may also be metabolised by 
y -gt and peptidases present in the peritubular vaseulature (Sochor et a l , 1980; Dass et 
al., 1981) or basolateral membrane (Spater et al, 1982). It is also possible that intact 
glutathione conjugates may pass from the peritubular circulation into the proximal 
tubular epithelial cells via the basolateral membrane (Rankin and Curthoys, 1982; Lash 
and Jones, 1984; Rankin etal, 1985). Lash and Jones (1984) suggested that the renal 
elearance of glutathione conjugates included transport from blood through epithelial 
cells into the lumen by a sodium-dependent organic anion transport mechanism which 
was inhibited by probenecid but not by cysteine conjugates. From the renal epithelial 
eells, the glutathione conjugates may pass into the tubular lumen by use of a membrane 
potential sensitive transport system present in the brush border membrane, where the 
glutathione conjugates are metabolised by y-gt and CGD / APM (Griffith, 1981; Inoue 
and Morino, 1985).
From the peritubular circulation or tubular lumen, the cysteine S-conjugates pass into 
the tubular cells where they undergo one of five possible fates. Firstly, they may be 
secreted into the plasma and transported to the liver via the renal hepatic circulation, 
where they may be subsequently N-acetylated to mercapturic acids and excreted in 
urine. Alternatively, the eysteine conjugates may be N-acetylated by N-acetyl 
transferase in the tubular lumen cells giving rise to their corresponding mercapturic 
acids (Duffel and Jacoby, 1982). The majority of the mercapturic acids then pass into 
the urine via a specific renal active transport system (Smith and Francis, 1983; Lock 
and Ishmael, 1985).
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The two pathways outlined above, result in the detoxification and elimination of 
potentially toxic species, however, the mercapturic acid pathway does not always lead 
to detoxifieation. Studies have implicated that the formation of glutathione S-conjugates 
is the initial step in the bioactivation of nephrotoxic haloalkenes, whereby cysteine S- 
conjugates undergo a third possible fate. Here, the cysteine conjugate may undergo 
bioaetivation by the kidney enzyme cysteine conjugate B-lyase.
Another possible pathway for cysteine conjugate metabolism is their regeneration from 
mercapturic acids by the enzyme deacetylase (Suzuki and Tateishi, 1981). Alternatively, 
some eysteine S-eonjugates are direct acting nephrotoxins, which can form 
episulphonium ions, non-enzymatically, from sulphur mustards and therefore do not 
require further metabolism.
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Figure 1 .3  - Inter-organ transport of halogenated alkenes (Adapted from
Commandeur er fl/., 1991)
R-SG = glutathione S-conjugate; R-CYS = cysteine S-conjugate; MA = mercapturic add; GST = 
glutathione S-transferase; y -gt =y -glutamyl transpeptidase; CGD = cysteinylglydne dipeptidase; APM 
= aminopeptidase M; NAT = N-acteyl transferase; DA = deacetylase.
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1.5  THE THIOMETHYL SHUNT
In 1988, Van Bladeren discovered that glutathione conjugation played an important role 
in the bioactivation of xenobiotics, since then much research has focused on this area. 
Cysteine S-conjugates are N-acetylated into mercapturic acids in preparation for 
excretion, however, the mercapturic acids and cysteine conjugates may be shunted 
away from the direction of detoxification by the enzymes, deacetylase (Suzuki and 
Tateishi, 1981) and cysteine conjugate B-lyase (Figure 1.4), with the formation of toxic 
thiols. The microsomal enzyme, thiol S-methyl transferase further metabolises the 
newly generated thiol by converting it to a methylthiol group which is less water soluble 
(Weisiger and Jacoby, 1979). This alternative pathway has become known as the 
thiomethyl shunt (Jacoby et al. , 1989).
It would appear that the activity of deacetylases is a crucial factor in the observed 
nephrotoxicity of a number of mercapturic acids both in vivo (Commandeur et al. , 
1988) and in vitro (Boogaard et al., 1989). The cofactor involved in N-acetylation is 
acetyl coenzyme A whose often limited availability is believed to direct the 
biotransformation of halogenated alkenes towards the bioactivation step (Commandeur 
eta l, 1989).
Mercapturic acid synthesis, a pathway originally thought to be responsible for 
detoxification, produces a toxic thiol containing compound which after méthylation is 
less excretable due to its hydrophobicity. However, although thiomethyl metabolites are 
less excretable, they are less toxic than the thiol metabolites produced by cysteine 
conjugate B-lyase metabolism. The role of thiol-S-methyl transferase is thought to be in 
the detoxification of thiols to thiomethyl derivatives, which may subsequently be 
metabolised by cytochrome P450 or flavin monooxygenases to excretable products.
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1.6  TOXICITY OF HALOGENATED ALKENES
There are numerous halogenated alkenes which have been shown to produce 
nephrotoxic effects in experimental animals such as rats and mice, but with minimal or 
no liver damage. The metabolism of such compounds is known to occur predominantly 
via glutathione conjugation. Of particular interest is the chlorinated hydrocarbon - 
hexachlorobutadiene (HCBD) since its toxicity is almost exclusive to the kidney 
(Gradiski et al, 1975; Kociba et al, 1977). HCBD is a widely used solvent, a by­
product from the manufacture of trichloroethylene and tetrachloroethylene which are 
metal degreasing agents and dry cleaning solvents. The manufacture of carbon 
tetrachloride also results in the formation of HCBD. Furthermore, HCBD is used in 
small quantities as a vineyard fumigant and in the removal of chlorine gas during the 
manufacture of HCl. More specifically, it has been found that changes in renal function 
occur after HCBD administration to male rats. A dose of 200 mg/kg of HCBD was seen 
to result in a decrease in urine concentrating abilities, glucosuria and proteinuria,
together with an increase in urinary excretion of alkaline phosphatase and N-acetyl-a-
D-glucosamidase. The renal clearance of insulin, urea, p-aminohippuiic acid (PAH) and 
tetraethyl ammonium bromide (TEA) was seen to be significantly reduced with a 
concurrent rise in plasma urea (Lock and Ishmael, 1979).
Intraperitoneal administration of HCBD to rats gave rise to kidney necrosis 24hrs post 
administration. The necrosis observed was confined to the pars recta (S3 or P3 
segment) of the proximal renal tubule which resulted in a distinct band of damage in the 
outer stripe of the outer medulla ( Lock and Ishmael, 1979; Ishmael et a l, 1982). 
Furthermore, high concentrations of the commonly used solvents, tetrachloroethylene 
and trichloroethylene administered to rats, induced carcinomas of the proximal tubules 
(NCI, 1986a,b). Trichloroethylene fed to calves has also been seen to result in renal 
injury and fatal aplastic anaemia (Lock et a l , 1996).
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Huoroalkenes are also implicated in halogenated alkene toxicity. 
Chlorotrifluoroethylene or CTFE (Dohn et al, 1985) is used in the production of 
polytetrafluoroethylene (PTFE) and fluoropolymers which are commercially important 
monomers produced in large quantities since the 1960s. Both CTFE and TEE induce 
renal injury specific to the S3 segment of the proximal tubule in rat. Hexafluoropropene 
(HFP) on the other hand has been seen to produce more widespread injury which also 
involves the SI and S2 segments of the proximal tubule (Potter et a l , 1981).
Halogenated hydrocarbons are potentially toxic to man due to occupational and 
environmental exposure. Mutti et al, (1992) report that exposure to perchloroethylene 
resulted in early renal changes, indicating the need for solvent exposed subjects to be 
monitored for the development of chronic renal diseases. Henschler et al, (1995) 
investigated the effects of occupational exposure to high doses of trichloroethylene, and 
discovered that there was an increased incidence of renal cell tumors amongst these 
subjects. As concern increases about the potential of halogenated hydrocarbons, so too 
has research to evaluate their toxicological effects and further understand the underlying 
mechanisms of these effects. The following pages report the experimental evidence for 
the metabolism of these compounds in rodents following glutathione conjugation and 
mercapturic acid synthesis. Also reported is the increasing evidence of toxic effects 
present in man.
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1.6.1 Toxicity of Halogenated Alkene Glutathione 
Conjugates
Glutathione conjugation has many important biological functions such as protection 
against oxidative stress, storage of cysteine and enzyme regulation . Glutathione also 
plays a role in the maintenance of the cellular redox state and transport phenomena. 
However, when glutathione conjugation involves haloalkenes the results may be 
detrimental to the organism. Renal proximal tubular cells are the targets for the toxic 
effects of haloalkenes bioactivated by glutathione S-conjugation. Therefore, although 
glutathione is an important biomolecule, it can also participate in reactions which result 
in the bioactivation of foreign substances and ultimately in tissue damage (Meister, 
1989 & 1992).
1 .6 .1 .1  Evidence for Glutathione Conjugation 
Fluorinated alkenes
Huoroalkenes are generally metabolised by glutathione transferases to their 
corresponding S-(fluoroalkyl)-glutathiones (Figure 1.5). For example the fluoroalkene, 
tetrafluoroethene (TFE) is metabolised by glutathione-S-transferase to S -(l,1,2,2- 
tetrafluoroethyl)glutathione in vitro (Odum and Green, 1984). When rats were exposed 
to the compound TFE (Odum and Green, 1984), glutathione conjugation was 
confirmed by the presence of the cysteine conjugate of TFE (S-(1,1,2,2-
tetrafluoroethyl)-cysteine or TFEC) in the bile. Exposure of experimental animals to 
chemically synthesised S-(2-chloro-1,1,2-tiifiuoroethyl)glutathione, the glutathione 
conjugate of chloro-tiifiuoroethylene (CTFE), gave rise to toxic effects similar to those 
observed for the parent compound TFE (Dohn et a l , 1985). Both TFE and CTFE form 
glutathione conjugates when the addition of glutathione across their double bonds is 
catalysed by rat hepatic glutathione S-transferases (Dohn and Anders, 1982; Odum and 
Green, 1984 : Figure 1.5).
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Glutathione
yF S-transferase F^  yF
y C = C ^  + GSH -------------------- H— C C — SG
F F F F
TFE TFEG
Figure 1 . 5 -  Conjugation of tetrafluoroethene and glutathione (GSH) resulting in 
the formation of S-(l,l,2,2-tetrafluoroethyl)glutathione (TFEG)
Glutathione
yCl S-transferase H yCl
C = C ^  + GSH ------------------► C = C
Cl Cl Cl^  ^SG
Trichloroethene DCVG
Figure 1 . 6 -  Conjugation of trichloroethene and glutathione (GSH) resulting in the 
formation of S-( 1,2-dichloroethyl)glutathione (DCVG)
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Chlorinated alkenes
The metabolism of the chlorinated alkene, HCBD is probably one of the most well 
documented. In 1981, Lock and Ishmael discovered that administration of HCBD to 
rats lead to a depletion of hepatic glutathione levels. They also noted that in female rats 
there was not only depletion of the glutathione pool in the liver, as in male rats, but 
there was also a noticeable depletion in kidney glutathione levels. This was confirmed 
by Hook et a l, in 1983 and further research by Lock and Ishmael (1986), led to the 
finding that female rats were approximately four times more susceptible to the toxic 
effects of HCBD and its metabolites than male rats. It is believed that HCBD forms a 
conjugate with glutathione, mediated primarily by the microsomal glutathione S- 
transferases which leads to glutathione depletion (Wolf et a l , 1984). Since the levels of 
cytosolic and microsomal glutathione transferases in the kidney are significantly lower 
than in the liver (Wolf et a l , 1984), it is thought that the conjugates formed in the liver 
may initially be responsible for the extra-hepatic effects (Elfarra and Anders, 1984).
When rats were treated with radiolabelled HCBD (^ '‘C-HCBD) a number of 
radiolabelled metabolites were detected in the bile, the major metabolites being S- 
(1,2,3,4,4-pentachloro-1,3-butadienyl)glutathione (PCBDG) and S-( 1,2,3,4,4- 
pentachloro-1,3-butadienyl)cysteinyl glycine (Nash eta l, 1984). In 1985, Jones et a l , 
confirmed these studies, and identified the mono- and di-substituted glutathione 
conjugates as well as several unidentified metabolites. In 1988, Dekant et a l , found that 
in the presence of glutathione, cytosol and microsomes from the liver could transform 
HCBD into PCBDG. From these and other similar experiments, it was proposed that 
the formation of glutathione conjugates in the liver and their subsequent metabolism to 
cysteine-S-conjugates lead to the formation of reactive intermediates in the kidney 
which may be the cause of HCBD induced nephrotoxicity and carcinogenicity.
23
Another chlorinated alkene is the dry cleaning fluid tetrachloroethylene, which when 
administered to rats was found to result in the presence of S-( 1,2,2- 
trichlorovinyl)glutathione (TCVG) in the bile, together with the detection of its further 
metabolite S-(l,2,2-trichlorovinyl)N-acetylcysteine in the urine (Odum and Green,
1987). Chemically synthesised haloalkene glutathione conjugates were administered to 
experimental animals (PCBDG, Ishmael and Lock, 1986; DCVG, Lash and Anders,
1986), resulting in toxicity similar to that induced by exposure to the parent compound. 
Since chlorinated alkenes produce S-chloroalkenyl glutathione conjugates, it is believed 
that an addition -elimination mechanism is involved. An example of the conjugation 
reaction of a haloalkene with glutathione may be found in figure 1.6.
The urine of humans and rats exposed to varying concentrations of trichloroethene for 
6h was found to contain dose-dependent increases of trichloroacetic acid, 
trichloroethanol and N-acetyl-S-(dichlorovinyl)L-cysteine. Over a period of 48hr, 
0.45 mu mol mercapturic acid was excreted by humans exposed to 160 ppm 
tricholroethene which suggested that reactive metabolites existed in humans after 
bioactivation of trichloroethene by glutathione (Bemauer et al. , 1996).
More recently, Otieno and Anders (1997 b), stably incorporated the gene encoding 
human microsomal glutathione transferase into the genome of the cell line, LLC-PKl. 
They observed increased expression of glutathione transferase in both the microsomal 
fraction and more interestingly, the cytosolic fraction. Furthermore, on administration 
of the haloalkenes HCBD and l-chloro-2,4-dinitrobenzene (CDNB), they detected 
increased levels of their respective glutathione conjugates , accompanied by an increase 
in cytotoxicity associated with HCBD.
ToFigueras et al. , (1997) evaluated the metabolism of hexachlorobenzene in humans by 
sampling the plasma and urine of 100 subjects who came into regular contact with
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airborne hexachlorobenzene (HCB). In all plasma samples tested, there were detectable 
levels of HCB. In the urine, the major detectable metabolites were pentachlorophenol 
(PCB) and to a greater extent, a sulphur derivative which following hydrolysis, 
produced pentachlorobenzenethiol (PCBT). They found a strong association between 
the levels of HCB present in the plasma and the levels of PCBT present in the urine, 
with the association being stronger in males than females. From this work it may be 
concluded that the formation of cysteine conjugates is quantitatively a more important 
metabolic pathway in humans than the formation of PCP and would suggest that PCBT 
is a good urinary marker for HCB internal dose and glutathione-mediated metabolism 
(T oFigueras eta l, 1997).
1.6.2 Experimental Evidence Supporting Further
Metabolism of Glutathione Conjugates
Several studies have confirmed that the glutathione conjugate of HCBD produces a 
toxic effect when administered to rat renal cells (Earl et ah, 1984; Jones et al, 1986). 
When the y -glutamyl transferase inhibitor, anthglutin was administered (Minato, 1979) 
complete protection against toxicity was observed, suggesting that for toxicity to occur, 
the glutathione conjugate must be further metabolised. Renal tubule suspensions treated 
with CTFE show a decrease in CTFE concentrations together with the appearance of S- 
(1,1,2-trifluoro-2-chloroethyl)glutathione (CTFG) in the suspension medium (Hassall 
et al, 1984). The toxicity observed with CTFG and indeed DCVG, was seen to be 
reduced with the presence of the y-glutamyl transferase inhibitor, AT-125 (L-(aS,5s) 
a-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid; Dohn et a l , 1985; Hassall et 
al, 1984). Furthermore, Lash and Anders (1986), have demonstrated that the toxicity 
observed on the treatment of isolated rat renal proximal tubular cells with DCVG was 
protected by the administration of AT-125, again suggesting that further metabolism of 
DCVG is necessary in order for a toxic effect to be observed. Davis (1988), however 
discovered that AT-125 did not incur protection against the toxicity observed with the
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administration of HCBD, which suggests that some glutathione conjugates may 
undergo non-enzymatic hydrolysis. The addition of a y -glutamyl acceptor, such as 
glycylglycine, potentiates the toxicity observed on treatment of isolated rat renal 
proximal tubular cells with DCVG (Lash and Anders, 1986). It has also been reported 
that the fitting of a billiary cannula to HCBD-treated rats provided protection from 
nephrotoxicity, whereas naive rats treated with lyophilised bile collected from HCBD- 
treated rats exhibited renal necrosis analogous to that observed with rats administered 
HCBD (Nash era/., 1984).
Further to experimentation on animals many cell lines have also been used in order to 
assess the potential toxicity of halogenated alkenes and their conjugates. One such cell 
line is the pig renal epithelial cell line, LLC-PKl, which is sensitive to DCVG, 
however, the toxic effects may be prevented by the use of y-glutamyl inhibitors 
(Stevens e ta l ,  1986a). Certain inhibitors of cysteinylglycine dipeptidase such as 
phenylalanyl glycine, have also been shown to reduce the nephrotoxic effect of 
halogenated alkenes (Lash and Anders, 1986). Such evidence would suggest that the 
metabolism of glutathione conjugates leading to the production of their corresponding 
cysteine conjugates as an essential requirement for renal toxicity.
The administration of DCVG to isolated kidney cells has led to the discovery that 
transport of the glutathione conjugate into the cells occurs via a sodium-coupled 
transport system located on the basolateral membrane (Lash and Jones, 1985). It is 
believed that this transport system plays an important role in determining the selective 
nephrotoxicity observed with the glutathione conjugates of halogenated alkenes.
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1.6.3 Nephrotoxicity o f Haloalkene Cysteine Conjugates
There are several cysteine conjugates of haloalkenes which have been studied both 'in 
vitro' and 'in vivo' over the years, such as CTFEC (Hassall et a l, 1984; Dohn et a l ,
1985), DCVC (Hassall e ta l, 1984), PCBDC (Jaffe e ta l, 1983; Schnellmann et a l ,
1987) and TFEC (Odum and Green, 1984), which exhibit pathological legions 
identical to those observed with the parent compounds. In 1984, it was suggested that 
the nephrotoxicity observed with exposure to HCBD was due the production of a toxic 
thiol as a result of cleavage of the cysteine conjugate of HCBD by a renal cytosolic B- 
lyase enzyme (Nash etal, 1984), which was consistent with the presence of a urinary 
sulphenic acid metabolite of HCBD. Isolated rabbit renal tubule cells treated with the 
cysteine conjugate DCVC were seen to exhibit decreased active transport of PAH and 
TEA, which it is believed may be a result of an active intermediate binding covalently 
to membrane associated nucleophilic groups (Hassall et al, 1983). Aminooxyaceüc 
acid (AQAA) is an inhibitor of pyridoxal phosphate dependent enzymes such as 
cysteine conjugate B-lyase, and research has shown that a reduction in renal cell 
toxicity induced by a homocysteine analogue of DCVC , S-( 1,2-dichlorovinyl-)-L- 
homocysteine (DCVHC; see Figure 1.7) occurs in the presence of AQAA (Lash and 
Anders, 1989). DCVCH is a more potent nephrotoxin in rats than DCVC (Elfarra et 
al, 1986), it has also been shown to be more toxic than DCVC in isolated renal 
proximal tubular cells. These finding would suggest that the difference in 'in vivo' 
nephrotoxicity between DCVHC and DCVC is due to intrarenal differences in the 
metabolism of the two compounds rather than factors outside the kidney (Elfarra et a l ,
1986).
Both Elfarra et a l , (1986) and Lash et a l , (1986a) suggest that the enzyme responsible 
for cysteine-S-conjugate induced nephrotoxicity is cysteine conjugate B-lyase. They 
have studied the nephrotoxicity of cysteine conjugates using a-methyl analogues of 
DCVC , DCVHC and CTFC, which allowed them to assess the requirement for
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metabolism by B-lyase in nephrotoxicity. In the B-lyase catalysed elimination reaction, 
removal of the cysteine conjugate a-proton is facilitated after the formation of the 
Schiffs base. This results in the cleavage of the carbon-sulphur bond, whereas when 
the a-proton is substituted with a methyl group, the conjugate cannot be metabolised 
by B-lyase. The a-methyl analogues are therefore non-toxic to isolated renal cells. 
Treatment of rats with DL-propargylglycine, an inhibitor of several PLP-dependent 
enzymes was also seen to block DCVHC induced nephrotoxicity (Elfarra et a l , 1986). 
Blockage of DCVHC toxicity by inhibitors of PLP-dependent enzymes, together with 
the fact that a-methyl analogues of DCVHC are non-toxic, suggest that PLP-dependent 
enzymes are responsible for the bioactivation of cysteine conjugates.
In 1987, Elfarra et a l , discovered that both renal cytosolic and mitochondrial B-lyase 
activity could be enhanced by a-keto acids such as a-keto-y -methiol butyrate and a- 
ketobutyrate. Since a-keto acids are known to re-convert the pyridoxamine phosphate 
form of an enzyme back to the active pyridoxal phosphate form, this provides further 
evidence to support the involvement of PLP-dependent enzyme in cysteine conjugate 
nephrotoxicity.
Anders e ta l , (1987) studied the effects of DCVC and DCVHC on the maintenance of 
cellular glutathione and ATP concentrations together with their effects on cellular 
calcium homeostasis. They found that both DCVC and DCVHC inhibited several 
mitochondrial processes in intact cells, DCVHC also inhibited processes which were 
not linked to mitochondrial function, indicating that it also has extramitochondrial 
targets which may also account for its greater toxicity. N-acetylation of DCVC was seen 
to be four times faster than with DCVHC (Elfarra et al, 1986) which may be a 
contributing factor to the greater nephrotoxicity of DCVHC.
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Figure 1 . 7 -  Chemical structures of several cysteine conjugates
DCVC = S-( 1,2-dichlorovinyl) -L-cysteine;
DCVHC = S-( 1,2-dichlorovinyl)-L-homocysteine;
DCVMeC = S-(l,2-dichlorovinyl)-DL-a-methylcysteine 
DCVMeHC = S-(l,2-dichlorovinyl)-DL-a-methylhomocysteine.
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Para-aminohippurate (PAH), is an organic anion secreted by the S2 segment of 
mammalian proximal tubular cells which can be transported into tubule cells via an 
electrochemical gradient. Dantzler et al, (1995), investigated the relevance of this 
organic anion transporter system to cysteine conjugate mediated nephrotoxicity. They 
studied the kinetics of interactions of PAH, probenecid and N-acetyl cysteine 
conjugates with the basolateral organic anion transporter isolated in rabbit renal 
proximal tubules, and found that cysteine conjugates and their N-acetyl derivatives not 
only interacted competitively with the PAH transporter, but they were also transported 
by it.
More recently, Bouthillier er a/., (1996) investigated the effects of anethol dithiolthione 
(ADT) on HCBD induced nephrotoxicity. ADT is known to protect rodents against 
carbon tetrachloride induced nephrotoxicity (Ansher et al, 1983) together with 
increasing the activity of phase II enzymes such as glutathione S-transferase (Ansher et 
al, 1986; Kenschler era/., 1987). Since many chemicals are deactivated by glutathione 
conjugation, it was proposed that modulation of glutathione conjugation by 
dithiolthiones would afford some protection against nephrotoxicity. Rats treated with 
ADT prior to administration of HCBD were seen to be protected against nephrotoxicity, 
but still possessed S-( 1,2,3,4,4-pentachloro-1,3-butadienyl)-glutathione in their urine 
(Bouthillier et a l , 1996). Furthermore, rat cortical slices incubated with ADT prior to 
incubation with the glutathione conjugate (PCBG) and the cysteine conjugate (PCBC) 
of HCBD, showed little or no modulation of renal cysteine conjugate B-lyase activity. It 
was therefore concluded that ADT protected rats against HCBD induced nephrotoxicity, 
however, this did not involve modulation of liver glutathione conjugation or B-lyase 
activity.
The enzyme cysteine conjugate B-lyase is present in many animals, work performed by 
Lock etal, (1996), showed that intravenous administration of 4mg/kg DCVC to calves
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produced severe renal tubule injury after 24hr, and administered for 10 days produced 
aplastic anaemia. Administration of the alpha-methyl analogue of DCVC produced no 
toxic effects even at doses five times that of the administered DCVC. Intravenous 
administration of the N-acetyl cysteine conjugate of DCVC produced renal toxicity but 
no bone marrow injury. These findings indicate that calves have the ability to 
deacetylate mercapturic acids, and that B-lyase metabolism of DCVC is necessary for 
bone marrow and renal injury to ocurr. Intravenous administration of TFEC lead to 
severe renal tubular damage, howevr, it did not affect the bone marrow. The cysteine 
conjugates of perchloroethylene and HCBD, produced neither renal tubular damage nor 
bone marrow injury at molar concentrations equivalent or greater than DCVC (Lock et 
al, 1996).
In 1996, Andreadou a/.,(1996a) synthesised a selection of novel selenium substituted 
cysteine conjugates as potential kidney selective prodrugs which could be activated by 
cysteine conjugate B-lyase to selenium-containing chemoprotectants or antitumor 
agents. Conjugates were incubated with rat renal cytosol and the kinetics of B- 
elimination assessed. It appeared that all of the selenium-substituted cysteine 
conjugates made better substrates for rat renal cysteine conjugate B-lyase than L- 
cysteine S-conjugates and would therefore be more promising prodrugs (Andreadou et 
al, 1996a). However, since several selenium compounds are known to be toxic, 
further cytotoxicity studies were performed by the same group (Andreadou et a l , 
1996b). Isolated rat renal proximal tubular cells were incubated for varying periods of 
time with several different selenium-substituted cysteine conjugates. Mitochondrial 
function remained unaffected by cytotoxicity induced by these compounds, AOAA also 
provided protection against cytotoxicity induced by certain but not all of the Se- 
substituted conjugates, suggesting the involvement of cystiene conjugate B-lyase. This 
data would suggest that the cytotoxicity of selenocysteine Se-conjugates was
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dependent on the nature of the Se-bound substituent, although certain of the compounds 
were non-toxic,
1 .6 .3 .1  Cellular transport o f cysteine conjugates
Cellular transport is an important factor in cysteine conjugate induced nephrotoxicity. 
DCVC -induced nephrotoxicity ‘in vivo ' is blocked by probenecid, an inhibitor of the 
basolateral membrane anion transport system. Lash and Jones (1985) discovered that 
probenecid inhibits glutathione S-conjugate transport in rat renal basolateral membrane 
vesicles. It is also capable of preventing HCBD induced toxicity in rat renal proximal 
tubular cells (Lock and Ishmael, 1985) and inhibits nephrotoxicity due to the direct 
acting nephrotoxin, S-2-chloroethyl-DL-cysteine (Elfarra et ai, 1985). The sodium 
dependent, probenecid-sensitive organic anion transport system and the sodium 
independent L-amino acid transport system have also been shown to be involved in the 
renal tubular uptake of DCVC and DCVHC (Lash and Anders, 1989). Schaeffer and 
Stevens (1987), studied the L-amino acid transport system in a pig renal epithelial cell 
line (LLC-PKl) and found that saturable uptake of DCVC in these cells was sodium 
independent. Lock et al. , (1986) found that mercapturates were also transported via the 
probenecid sensitive transport system and that once in the tubule cell, were subject to 
further metabolism into their corresponding cysteine S-conjugates. Cysteine conjugate 
toxicity is blocked effectively by inhibitors of the organic anion transport system, it may 
therefore be concluded that in order for nephrotoxicity to occur, the cysteine conjugates 
must be transported into the renal tubular cells where they are subsequently metabolised 
by cysteine conjugate B-lyase.
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1.7  THE ROLE OF S-OXIDASE IN NEPHROTOXICITY
One of the metabolites of DCVC is DCVC sulphoxide (DCVCO), which in rats has 
been shown to produce greater nephrotoxicity than DCVC when administered in 
equimolar doses (Lash et ai, 1994). Renal microsomes possess flavin containing 
monooxygenases which are required for sulphoxidation of cysteine conjugates (Sausen 
et al, 1993), however, DCVCO has not been detected in incubations containing 
microsomes and DCVC (Sausen and Elfarra, 1990).
DCVC is thought to be metabolised to DCVCO via the S-oxidase pathway (Lash et al. , 
1994). DCVCO can react directly as a Michael acceptor with cellular nucleophiles 
(Sausen and Elfarra, 1991) forming covalent adducts, or it may be further metabolised 
by 6-lyase to form pyruvate, ammonia and 1,2-dichlorovinyl sulphenic add 
(Bhattachyra and Schultze, 1967). AOAA, the inhibitor of PLP-dependent enzymes 
provides a certain degree of protection against DCVC toxicity (Lash and Anders, 1986), 
however it does not affect S-oxidase activity and cannot provide protection for rats 
against DCVCO-induced nephrotoxicity (Lash er a/., 1994).
There is substantial evidence to support the role of S-oxidase metabolism in DC VC- 
induced toxicity. DCVC is more cytotoxic than DCVCO in proximal tubular cells, 
however, DCVCO shows greater cytotoxicity than DCVC in distal tubular cells. In 
proximal tubular cells the 6-lyase activity is much greater than in distal tubular cells 
(Jones et al., 1988; MacFarlane et al. , 1989; Lash et al. , 1994) which correlates with 
the greater degree of DC VC-induced toxicity observed in proximal tubular cells 
compared to distal tubular cells, together with the fact that AOAA affords protection to 
proximal tubular cells but not to distal tubular cells. Distal tubular cells possess 6-lyase 
activity which is inhibited by AOAA, however AOAA does not protect these cells from 
DC VC-induced toxicity which suggests that cytotoxicity in these cells is not dependent
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on bioactivation by B-lyase and supports the role of S-oxidase in the bioactivation and 
nephrotoxicity of DCVC (Lash et a l , 1994). This evidence, together with the findings 
that DCVCO reacts with glutathione (Sausen and Elfarra, 1991), and that hepatic and 
renal non-protein thiol concentrations are significantly reduced following Hn vivo’ 
treatment of rats with DCVCO, suggests that DCVCO may be involved in DC VC- 
induced toxicity.
In 1995, it was found that male rats which had been administered '^‘C-HCBD had (e)- 
N-acetyl-S -( 1,2,3,4,4-pentachlorobuta-1,3 -dienyl) -L-cysteine sulphoxide in their 
urine, whereas female rats showed no traces of sulphoxides (Wemer et al, 1995). 
Werner et al, went on to investigate the formation of (e)-N-acetyl-S-( 1,2,3,4,4- 
pentachlorobuta-l,3-dienyl)-L-cysteine sulphoxide in 13 individual human liver 
microsomes of both sexes and demonstrated that the mercapturic acid of HCBC (N-Ac- 
PCBC) was the substrate for this monooxygenase activity in both sexes. The 
glutathione (PCBG) and cysteine (PCBC) conjugates are not, however, substrates for 
this monooxygenase activity. It was soon discovered with the use of selective inhibitors 
of P-450 and flavin-containing monooxygenases (FMO), that only the cytochrome P- 
450 family could participate in oxidation of mercapturic acids and that more specifically 
only members of the CYP3A family were involved. The CYP3A family is a major 
section of cytochrome P-450s present in human liver, it would therefore be expected 
that exposure of humans to HCBD would give rise to chlorovinyl sulphoxides which 
are Michael-acceptors and may bind to macromolecules giving rise to toxic effects 
(Wemer et al, 1995).
More recently, experiments using rabbit liver microsomes have been shown to catalyse 
NADPH- and time-dependent S-oxidation of several cysteine conjugates to their 
respective sulfoxides (Ripp et al, 1997). The flavin containing mono-oxygenase 
(FMO) substrate, methimazole, was seen to inhibit S-oxidation of all cysteine
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conjugates assessed. The P450 inhibitor, 1-benzylimidazole was seen only to inhibit S- 
oxidation of the cysteine conjugate TCVC. The group went on to use cDNAs 
expressing isoforms of rabbit FMOs, to show that FMOs can catalyse cysteine 
conjugate S-oxidation, however the particular isoform involved is dependent on the 
structure of the cysteine conjugate (Ripp et al, 1997). Furthermore the sulfoxides of 
TCVC and DCVC were active towards glutathione whereas the other sulfoxides tested 
were not.
1.7.1 Detoxication o f Sulphenic Acids via the
Formation o f Thiol Metabolites
It has been proposed that an alternative pathway for the detoxication of sulphenic acids 
exists, whereby cysteine conjugate sulphoxides are metabolised to their corresponding 
thiols and cysteine conjugates (Tomisawa et a l , 1993). They found that the sulphoxide 
initially undergoes cleavage of the C-S bond forming a putative sulphenic acid, 
followed by non-enzymatic conversion to the thiol and subsequent transformation of the 
thiol to the cysteine conjugate by the reverse reaction of cysteine conjugate 6-lyase 
(Figure 1.8).
1.7.2 Cis-Platin Nephrotoxicity
In 1994, it was discovered that after subcutaneous administration of cis -platin to mice, 
renal proximal tubular damage was seen (Ban et al, 1994). Pre-treatment with 
inhibitors of 6-lyase and S-oxidase reduced the amount of tubular damage by 
approximately 40 and 75% respectively. It was therefore believed that 6-lyase activity 
gives rise to a gradual and continual release of platinum which then attacks subcellular 
organelles producing toxicity. The work of Ban et a l, (1994) suggests that the 
nephrotoxicity of cw-platin is dependent on a probenecid-sensitive transport 
mechanism together with intracellular bioactivation by renal 6-lyase and 6-oxidase.
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Figure 1 .8  - The formation of a cysteine conjugate from a cysteine conjugate
sulphoxide, taken from Tomisawa et al. , (1993)
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1 . 8  MECHANISMS OF TOXICITY
The pathway from halogenated alkene to toxicity involves many different stages of 
metabolism, firstly a glutathione conjugate is formed in the liver which is translocated to 
the kidney where cysteine S-conjugates are formed and subsequently metabolised by 
the renal enzyme, 6-lyase. Cysteine S-conjugates are both potent and selective 
nephrotoxins which can induce toxicity either by enzyme dependent activation 
producing unstable thiols or by a spontaneous non-enzymatic route whereby 
electrophilic episulphonium ions are formed from sulphur mustards (direct acting 
nephrotoxins; Schasteen and Reed, 1983).
1.8.1 Formation o f Reactive Thiols
As with many enzymatic reactions, the exact chemical nature of the toxic product of 6-
lyase cleavage of cysteine conjugates is not known in all cases. 6-Lyase metabolism of
S-haloalkyl conjugates e.g. CTFEC (S-(2-chloro-l,l,2-trifluoroethyl)-L-cysteine ) and 
S-haloalkenyl conjugates e.g. DCVC, produces unstable thiols which further rearrange 
chemically producing reactive intermediates which can bind to macromolecules resulting 
in the nephrotoxicity observed with such cysteine conjugates.
In 1987, Dekantera/., studied the ‘in vitro’ bioactivation of CTFEC, and found that 
initially an unstable nucleophilic thiol (2-chloro-1,1,2-trifluoroethane thiol (thiolate)) 
was formed which then lost hydrogen fluoride giving rise to an acylating intermediate, 
chlorofluorothionoacetyl fluoride. Subsequent hydrolysis of this intermediate produced 
the final metabolites chlorofluoroacetic acid, inorganic fluoride and hydrogen sulphide 
(Figure 1.9). Both the inorganic fluoride and the chlorofluoroacetic acid are cytotoxic to 
rat renal proximal tubular cells (Dekant et al, 1987) which would suggest that both 
these metabolites and the reactive intermediate chlorofluorothionoacetyl fluoride may be 
responsible for CTFEC-induced cytotoxicity. The bioactivation of TFEC by 6-lyase has
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also been examined (Commandeur et a l, 1989) and it has been suggested that 
difluorothionoacyl fluoride, a potent acylating agent is the main reactive intermediate 
(Figure 1.10).
It would appear that fluoroalkyl cysteine S-conjugates are transformed to reactive 
thionoacyl fluorides. Thioketenes (haloalkenyl S-conjugates) are formed from the 
enethiols produced by 6-lyase mediated cleavage of halovinyl cysteine S-conjugates 
(Dekant et al, 1991). The halovinyl cysteine conjugate DCVC is metabolised to a 
chlorothioketene (Figure 1.11). Thionoacyl fluorides and thioketenes are both potent 
acylating agents which are believed to cause cytotoxicity due to non-selective acylation 
of cellular macromolecules such as proteins, lipids and as a result may cause functional 
inactivation of these macromolecules. Thioketenes are known to interact with DNA 
which may explain the potent, 6-lyase dependent mutagenicity of halovinyl cysteine 6- 
conjugsites in Salmonella typhimurium (Dekant, 1994).
Commandeur et al, (1996), investigated the bioactivation of S-(2,2-dihalo-l,l- 
difluoroethyl)-L-cysteines and S-(trihalovinyl)-L-cysteines by cysteine conjugate 6- 
lyase. Beta-elimination reactions were performed with rat renal cytosol and a 6-lyase 
model system, consisting of pyridoxal-phosphate and copper (II) ions. F-19-nuclear 
magnetic resonance (F-19-NMR) and CC-MS (CC-mass spectrometry), allowed the 
analysis of the 6-elimination products from 6-lyase bioactivation of several cysteine 
conjugates. The cysteine conjugate TFEC was mainly converted into 
difluorothionoacetyl fluoride derived products, CTFEC and DCDFEC on the other hand 
preferred the thiirane pathway (Commandeur et a l , 1996).
In 1997, Shim and Richard, conducted experiments to evaluate two plausible routes of 
cysteine conjugate bioactivation, the thiirane and the thionoacyl fluoride pathway. They 
used computational methods to investigate the pathway preference of six fluorine-,
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chlorine- and bromine-substituted 2,2-dihalo-1,1 -difluoroethane-1 -thiolates. They 
found that 2,2-difluoro-1,1-difluoroethane-1 -thiolate followed a thionoacyl fluoride 
pathway, whereas the bromine-substituted thiolates preferred a thiirane pathway, the 
chlorine-substituted thiolates were difficult to predict pathways for. These results are 
supported by work from Finkelstein et al. , (1996) who also found that brominated 2,2- 
dihalo- 1,1 -difluoroethane-1 -thiolates preferred the thiirane pathway.
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Figure 1 .9  - The bioactivation of S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine 
(CTFEC) (Dekant et a l , 1987)
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(DCVC) and the formation of its proposed reactive metabolite, chlorothioketene 
(Adapted from Commandeur et al. , 1991).
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1.8.2 Reactive Intermediates o f Bromine Containing
Cysteine S-Conjugates
Another member of the halogens is bromine, those flnoroalkene derived cysteine 
conjugates which do not contain bromine are toxic both ‘m vivo’ and ‘in vitro’ 
however, they are not mutagenic in the Ames test. Those fluoroalkene derived cysteine 
conjugates which do contain bromine on the other hand, are both toxic and mutagenic 
(Finkelstein et al, 1994a). Dekant et al, (1987), used rat kidney homogenates to 
demonstrate that 6-lyase mediated metabolism of bromine containing, fluoroalkene 
derived cysteine conjugates resulted in the formation of inorganic fluoride but no 
organofluorine compounds in the reaction mixture. Later, Stijntjes et a l, (1992), 
demonstrated by HPLC analysis that formation of glyoxylate occurred, which is not 
seen with bromine lacking cysteine conjugates. In all cases bromofluoroacetic acid was 
not detected.
In 1994, Finkelstein et al, (1994b), suggested a bioactivation pathway via which the 
formation of glyoxylate during the metabolism of bromine containing fluoroalkene 
derived cysteine conjugates could occur (Figure 1.12). The formation of glyoxylate is 
supported by the formation of inorganic fluoride and the mercaptoacetate from S-(2- 
bromo-1,1 -difluoroethyl)cysteine metabolism, together with the formation of 
mercaptoacetate when bromothioacetic acid is incubated in phosphate buffer (pH 7.4).
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Figure 1 .1 3 -  Glutathione conjugation of 1,2-dibromoethane and the formation of its 
electrophilic sulphonium ion
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1 .8 .2 .1  a-thiolactones: a possible role in mutagenicity
The properties of a-thiolactones still remain uncharacterised, however the analogue B- 
propiolactone is both mutagenic and carcinogenic (Fukuda et a/., 1970). Finkelstein et 
al, (1994b) suggest that a-thiolactones may play a role in the mutagenicity seen with 
bromine containing cysteine conjugates .
1.8.3 Formation o f Direct Acting Nephrotoxins
Certain haloalkanes have the ability to form direct acting nephrotoxins, these 
compounds are transformed by glutathione S-transferase into mutagenic and 
nephrotoxic S-(2-haloethyl)glutathione S-conjugates which in turn form electrophilic 
episulphonium ions or sulphur half-mustards (Figure 1.13). Examples of such 
haloalkanes are 1,2-dibromoethane, 1,2-dichloroethane and l-bromo-2-chloroethane 
which are both toxic and carcinogenic (Spencer et a i , 1951, Weisburger, 1977).
The formation of sulphur half-mustards is glutathione dependent, and results in the 
formation of 1,2-dibromoethane metabolites which bind to DNA and dibromoethane 
induce mutagenicity (van Bladeren et al, 1980). Glutathione conjugation of 1,2- 
dibromoethane results in the formation of S-[2-(N^-guanyl)ethyl]-L-glutathione which 
is a major DNA adduct 'in vivo ’ (Ozawa and Guengerich, 1983) and is a mutagen 
responsible for inducing base substitutions (Dekant and Vamvakas, 1993).
S-2-Chloroethyl-DL-cysteine (CEC) is the cysteine conjugate of 1,2-dichloroethane,
and it is believed that the formation of direct acting nephrotoxins play an important role
in CEC induced nephrotoxicity. Elfarra et al, (1985) administered CEC to rats and
discovered that doses greater than 50mg/kg resulted in renal dysfunction accompanied
by histopathological changes in the kidney. CEC does not appear to be a substrate for
cysteine conjugate B-lyase and analogues of CEC in which the chlorine atom has been
substituted with a hydrogen atom or a hydroxyl group are not toxic (Elfarra et a l ,
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1985, Webb et a l, 1987). It would therefore appear that the toxicity of CEC is 
dependent on the internal displacement of the chlorine atom by the sulphur atom 
forming electrophilic episulphonium ions. Organic anion transport inhibitors such as 
probenecid, provide protection against both nephrotoxicity and cytotoxicity induced by 
CEC, which would suggest that transport mechanisms are important in determining the 
target organ selectivity (Elfarra et al, 1985). Rat hepatocytes treated with CEC 
demonstrated rapid depletion of intracellular glutathione concentrations which it was 
concluded, was partially due to the intracellular reaction between the episulphonium ion 
and glutathione resulting in the formation of S-[(2-DL-cysteinyl)ethyl]glutathione 
(Webb era/., 1987).
Rannug etal, (1978) reported that 'in vitro' , CEC was a direct acting mutagen which 
is associated with a depletion of glutathione, inhibition of Ca^  ^ATPase and initiation of 
lipid peroxidation. Target organ selectivity of CEC would suggest that it may be 
accumulated in toxic concentrations in renal tissue as a result of renal tubular cell active 
transport (Elfarra er a/., 1985).
46
1.9  MUTAGENICITY AND CYTOTOXICITY OF
HALOALKENE-S-CONJUGATES
As previously discussed, both glutathione and cysteine conjugates of haloalkene are 
toxic to renal proximal tubular cells. Those cysteine conjugates which are derived from 
chlorinated alkenes however, are also mutagenic, whereas conjugates from fluoiinated 
alkenes are not ( Green and Odum, 1985). Some cysteine conjugates such as PCBC, 
DCVC and TCVC induce genotoxic effects in mammalian cells whereas CTFEC does 
not (Vamvakas et a l, 1989). Similarly, Vamvakas et a l, (1988a), found that CTFEC 
was not genotoxic in bacteria.
Vamvakas et al, (1989), suggested that the differences in genotoxicity between 
chloroalkenyl and fluoroalkenyl cysteine conjugates were due to differences in the 
stability of their reactive intermediates, since both compounds produced reactive, 
acylating intermediates. The reactive intermediate formed as a result of B-lyase 
bioactivation of fluoroalkyl cysteine S-conjugates such as CTFEC, is a thionoacyl 
fluoride, whereas bioactivation of halovinyl cysteine S-conjugates such as DCVC, 
PCBC and TCVC results in the formation of thioketenes (Dekant et a l , 1991). Carbon- 
fluoiine bonds in thionoacetyl fluorides have low bond energies, hence it would be 
expected that they have a short half life and may therefore be unable to react with DNA 
(Vamvakas 1989).
1.9 .1  Mutagenicity
Green and Odum (1985), demonstrated that both the glutathione and cysteine 
conjugates of HCBD are mutagens. Administration of HCBD to rats, resulted in an 
increased incidence of renal tumors, adenomas and adenocarcinomas (Kociba et a l , 
1977). Another mutagen is DCVC, Batlacharya and Shultze (1972 & 1973), of which 
B-lyase cleavage results in a reactive intermediate which binds to DNA resulting in
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structural modifications and possibly as a consequence, alterations in gene expression. 
It has been demonstrated that the mutagenicity of chloroalkenes is dependent on both 13- 
lyase and Y -glutamyl transpeptidase (Vamvakas et a l , 1988b). Glutathione conjugates 
of chloroalkenes have been found to induce unscheduled DNA synthesis in LLC-PKl 
cells, however this occurs at concentrations which do not give rise to cytotoxicity 
(Vamvakas et al, 1989). Certain mercapturic acids have been found to be mutagenic 
but only as a result of their subsequent metabolism by deacetylase followed by 6-lyase 
cleavage (Vamvakas et al, 1987). The chloroalkene-derived cysteine conjugate 
PCBDC also exhibits genotoxicty by forming DNA-DNA cross-links (Jaffe et a l ,
1983). Schrenk and Dekant (1989), suggested that the DNA adducts formed were a 
consequence of 6-lyase metabolism of PCBDC. Experiments involving HCBD have 
shown that following 'in vivo’ metabolism, binding of metabolites to DNA was more 
common in the kidney than the liver and was almost exclusive to mitochondrial DNA , 
however, the exact structure formed between the DNA and the HCBD metabolites 
remains undetermined.
Studies using the renal cell line, LLC-PKl show that halovinyl-deiived cysteine 
conjugates induce 6-lyase dependent DNA repair (Vamvakas et a l , 1989), however the 
genotoxicity observed is minimal and the concentration range over which DNA repair 
occurs in the absence of cytotoxicty and cell death is small. Vamvakas et a l, (1989) 
also showed that unlike DCVC, PCBC or TCVC, CTFEC did not induce any 
unscheduled DNA synthesis despite the 6-lyase dependent cytotoxicty. Again, CTFEC 
was found not to be a genotoxin or a mutagen in bacteria (Vamvakas et a l , 1988a).
6-Lyase metabolism of DCVC produces reactive intermediates which have been shown 
to interact directly with DNA, DCVC is also a mutagen in Salmonella typhimurium 
(Dekant et a l , 1986). In LLC-PKl cells, DCVC has been shown to induce DNA repair 
(Vamvakas et a l , 1989) and 'in vivo ’ produces single strand breaks in rat kidney DNA
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(Jaffe et al, 1985). More recently Vamvakas et a l, (1993) have shown that DCVC 
forms adducts with the nucleotides adenine, guanine and cytosine.
1.9.2 Cytotoxicty
Further to their mutagenic effects, chloroalkyl-derived cysteine conjugates also induce 
cytotoxicity. PCBDC and DCVC have both been shown to markedly reduce cellular 
respiration and ATP levels in freshly isolated proximal tubular cells. DCVC and 
DCVHC inhibit oxygen consumption in isolated kidney cells (Anders et al, 1987). 
Since oxygen consumption in proximal tubular cells is mainly due to mitochondrial 
respiration, it is believed that both compounds target the mitochondria. The PLP- 
dependent enzyme inhbitor, AOAA, affords protection against inhibition of respiration 
due to DCVC and propargylglycine affords protection against inhibition of respiration 
by DCVHC. The a-methyl analogue of DCVC, DCVMeHC however, has no effect on 
cellular oxygen consumption. DCVHC would appear to have extra mitochondrial 
targets, since it also inhibits processes which are not linked to mitochondrial function. 
The differences in toxicity between DCVC and DCVHC may partly be explained by the 
competing detoxication reactions, such as N-acetylation, which occurs 4 times more 
rapidly with DCVC than with DCVHC (Elfarra et a l , 1986).
Elfarra eta l, (1984 & 1985), administered DCVC, DCVMeC and CEC, a direct acting 
nephrotoxin and hepatotoxin, to mitochondria and mitoplasts. They found that DCVC 
was a potent inhibitor of state 3 respiration in intact mitochondria and that AOAA 
provided protection against this. DCVMeC, on the other hand was non-toxic. CEC was 
also found to inhibit respiration in intact mitochondria, which would suggest that direct 
acting cysteine conjugates also inhibit mitochondrial function. DCVC has also been 
associated with the inhibition of mitochondrial membrane potential (Lash and Anders ,
1987), together with the inhibition of succinate-linked state 3 respiration (ADP- 
dependent) and the alteration of the concentration of several citric acid cycle
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intermediates. The cysteine conjugate PCBDC, has been linked with the uncoupling of 
oxidative phosphorylation (Schnellmann et ai, 1989; Hayden and Stevens, 1990). It 
would therefore appear that the primary subcellular target of cysteine conjugate induced 
toxicity is the mitochondria, resulting in the disruption of energy (ATP) requiring 
processes.
Binding studies using labelled CTFEC,DCVC, HFPC, PCBC and TFEC have 
confirmed thqt cysteine conjugates bind to mitochondrial macromolecules (Hayden and 
Stevens, 1990). Mitochondrial toxicity , however, was found not to correlate with the 
extent of metabolism and binding of ^^S-containing metabolites. The link between S- 
conjugate induced cell death, mitochondrial binding and mitochondrial toxicity still 
remains unclear. It is unlikely that the mitochondrial dysfunction outlined above 
contributes to cell death, a more likely explanation is that the alteration in intracellular 
Ca^  ^homeostasis is responsible.
1 .9 .2 .1  Intracellular Calcium Homeostasis
In 1986, Jones et al. , discovered that both PCBDG and DCVC selectively depleted 
mitochondrial calcium levels, at the same time increasing cytosolic calcium levels. They 
therefore suggested that alterations in compartmentalisation of intracellular calcium 
levels played an important role in cysteine conjugate induced cell death. Earlier studies 
(Jones et al., 1986) had shown that shortly after treatment with PCBDG, plasma 
membrane blebs occurred, which were associated with disturbances of intracellular 
calcium homeostasis and subsequent cytoskeletal alterations. Calcium 
compartmentalisation was studied using LLC-PKl cells, and it was found that rapid 
changes occufTed after administration of DCVC (Vamvakas et al., 1990). Koob et al., 
(1990) discovered that freshly isolated rat kidney cells treated with toxic concentrations 
of DCVC were protected against alterations in calcium levels by the use of calcium 
chelators.
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Intracellular calcium homeostasis is controlled by transport systems present on the 
plasma membrane, mitochondria and endoplasmic reticulum, which control transient 
increases in intracellular calcium concentrations for processes such as muscle 
contraction, secretion of neurotransmitters and extracellular signal transduction. 
Uncontrolled or sustained increases of intracellular calcium levels may occur via 
enhanced influx of extracellular calcium or by impairment of intracellular buffering 
systems or both. Alterations in calcium levels such as these are thought to disrupt 
membrane integrity and hence the cytoskeleton leading to cell death. It is possible that 
this toxicity may occur via activation of calcium dependent phospholipases and 
proteases.
Proximal tubular cells treated with DCVC show increased calcium flux into the 
mitochondrial matrix (van der Water et al, 1994), this then induces hydroperoxide 
formation which potentiates dissipation of the mitochondrial membrane leading to cell 
death. AOAA which inhibits metabolism of DCVC by 6-lyase, completely prevents the 
decrease in membrane potential. DNA structure and function may also be disturbed by 
increased intracellular calcium concentrations, since this activates endonucleases which 
may catalyse the formation of DNA strand breaks followed by the induction of 
poly(ADP-ribosyl)ation of nuclear proteins.
Chen et al, (1994) investigated the effects of DCVC bioactivation on the signal- 
response relationships among increased intracellular calcium, thiol depletion, lipid 
peroxidation and cell death in LLC-PKl cells. They found that 1 hr after DCVC 
treatment, there was an increase in intracellular free calcium levels which occurred 
some time before the release of lactate dehydrogenase (LDH). The increase in 
intracellular free calcium and cytotoxicity could be prevented by administration of 
AOAA. Pretreatment of the cells with ionomycin increased the level of free calcium and 
potentiated DC VC-induced LDH release. DPPD, an antioxidant which blocks lipid
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peroxidation and toxicity, had no effect on the levels of intracellular free calcium. Chen 
et al, (1994) hypothesised that the covalent binding of the reactive intermediate from 
DCVC metabolism lead to downregulation of intracellular calcium homeostasis and 
elevation of intracellular free calcium. Increased intracellular free calcium may in turn be 
coupled to mitochondrial damage and the accumulation of endogenous oxidants which 
cause lipid peroxidation and cell death.
The cysteine conjugate S-(l,2,3,4,4-pentachlorobutadienyl)-L-cysteine (PCBC) was 
found to cause a collapse of the mitochondrial membrane potential, calcium independent 
oxidation of pyridine nucleotides and release of accumulated calcium (three indicators 
of a permeability transition) in isolated rat kidney mitochondria (Brown et al, 1996). 
The effects could be blocked by cyclosporine A and EGTA, in fact EGTA could reverse 
the collapse of membrane potential, indicating that PCBC induces an inner membrane 
permeability transition. AOAA, an inhibitor of PLP-dependent enzymes did not prevent 
the permeability transition , suggesting that although cysteine conjugate 6-lyase is 
necessary for PCBC induced nephrotoxicity, it is not a requirement for the permeability 
transition.
1 .9 .2 .2  Poly (ADP-ribosyl)ation
An important factor in the initiation of DNA repair, modulation of gene expression and 
DNA replication is chromatin structure. Changes in chromatin structure regulate the 
access and binding of proteins to DNA. In general, changes in chromatin structure may 
be brought about by poly(ADP-ribosyl)ation of histone proteins. It is thought that 
poIy(ADP-ribosyl) conjugates open up higher order chromatin structure or remove core 
histone octamers from DNA, increasing the accessibility of enzymes to DNA (Boulikas, 
1992). Potent inducers of poly(ADP-ribosyl)ation are double strand DNA breaks.
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DCVC induces DNA repair in LLC-PKl cells (Vamvakas et al, 1989) and reduces the 
ability of mitochondria to sequester calcium, resulting in an increase in intracellular 
calcium concentrations. It is also believed that DCVC may cause selective depletion of 
mitochondrial calcium levels by modifying mitochondrial membrane proteins by ADP- 
ribose moieties formed subsequent to hydrolysis of the oxidised pyridine nucleotides 
(Vamvakas et ai, 1992). Activation of calcium dependent endonucleases gives rise to 
increased formation of DNA double strand breaks followed by increased poly(ADP- 
ribosyl)ation of nuclear proteins (Vamvakas and Anders, 1990; Vamvakas et al., 1992). 
McLaren et a l, (1994), administered DCVC to male Wistar rats and found that there 
was an induction of DNA double strand breaks and poly(ADP-ribosyl)ation in the 
renal cortex. They went on to suggest that this post-translational modification of nuclear 
proteins may play a role in the formation of renal cell tumors following administration 
of DCVC. Further evidence to support this comes from Brown et a l , (1990) who saw 
a reduction of PCBG mediated renal toxicity following treatment with a poly(ADP- 
ribosyl)polymerase inhibitor, 3-aminobenzamide.
It is generally believed that large increases in the formation of nuclear poly(ADP- 
ribosyl)conjugates may lead to depletion of cellular NAD^ levels, NAD^ being the 
substrate for poly(ADP-iibosyl) transferase. In turn, this will lead to a depletion of the 
ATP pool resulting in cell death. The degree of nuclear protein poly(ADP-iibosyl)ation 
may also be non-lethal, however it may change the structure and function of proteins 
involved in regulation of gene expression. An alteration in the regulation of gene 
expression, in particular those genes involved in cell proliferation and differentiation, 
may lead to malignant transformation and tumor formation.
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1 .9 .2 .3  Expression of c-ntyc and c-fos  in Normal and Malignant 
Renal Growth
Regulation of cell proliferation involves several important factors, two of which are the 
protooncogenes c-myc and c-fos, which are involved in the transduction of 
extracellular growth signals to the genetic level. These protooncogenes are short lived 
phosphoproteins which bind to DNA, altering the expression of several inducible 
genes. In non-transformed cells c-myc expression is very strictly regulated, however, 
when cells become transformed often their regulatory mechanisms are impaired leading 
to permanently enhanced transcription which is independent of external stimulii 
(Campisi etal., 1984). Enhanced expression of c-fos and c-myc may induce malignant 
transformation (Littlewood & Evan, 1990; Angel & Karin, 1991).
In 1993, Vamvakas and Koster incubated the renal cell line LLC-PKl with SOOjaM 
DCVC for periods of between 0.5 to 5 hr. They discovered that DCVC induced a time 
dependent increase of expression of c-myc and c-fos, and that this induction did not 
persist after removal of DCVC. If however, induction of gene expression is a result of 
the formation of DNA-adducts which are converted into heritable mutations (Vamvakas 
and Koster, 1993), then it would be expected that these effects would continue even 
after removal of DCVC. It would therefore appear that persistent DNA mutations are 
not as important as the increased formation of DNA double strand breaks, increased 
poly(ADP-ribosyl)ation of nuclear proteins by perturbation of intracellular calcium 
homeostasis and the induced expression of c-myc and c-fos.
It still remains unclear as to whether or not the direct interactions of DCVC derived 
electfophiles with DNA and the calcium induced DNA double strand breaks modulate 
gene expression. In order to determine the mechanism of cysteine conjugate induced 
cell death and carcinogenicity however, it is clear that a greater understanding of both 
cytotoxicity and genotoxicity is needed.
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1 .9 .2 .4  Induction of stress response genes
All cells possess a battery of stress response genes, which are activated when the cells 
are exposed to any kind of stress, such as extremes of heat, oxidative stress, toxins and 
infection. The nephrotoxicity of cysteine conjugates such as TFEC has been associated 
with difluorothioamidyl-L-lysine (DFTAL) formation on critical mitochondrial target 
proteins. Bruschi etal, (1993), performed dose response studies on Fischer rats using 
TFEC, and found that TFEC adducted five proteins predominantly ‘in vivo’. Sequence 
analysis of these DFTAL proteins indicated that P66 was identical over 14 NH2- 
residues to mitochondrial PI protein or HSP60, whereas P84 was identical over 14 
residues to a member of the HSP70 family, mortalin. This data suggests the 
involvement of fundamental house keeping functions in cysteine conjugate induced 
nephrotoxicity.
LLC-PKl cells exposed to SOOpiM DCVC, CTFEC and TFEC for 5hr were found to 
have increased mRNA levels of the 70-kD heat shock protein, HSP70 (Chen et al. , 
1992). This induction was inhibited by the PLP-dependent enzyme inhibitor, AOAA 
and the thiol reducing reagent, dithiothreitol. These data suggests that alkylation and/or 
perturbation of thiols play a role in positive regulation of HSP70 gene transcription 
through a direct effect on protein conformation (Chen et al. , 1992).
Furthermore, van de Water etal. , (1996), provide evidence that bioactivation of DCVC 
gives rise to alkylation-induced oxidative cell injury in renal proximal tubular cells. 
They suggest that the reactive metabolites of 6-lyase bioactivation of DCVC bind to 
glutathione reductase (Grd) and glutathione peroxidase (Gpx) which are two enzymes 
involved in the glutathione redox cycle, thus impairing the cellular antioxidant system 
which is related to DC VC-induced oxidative cell injury (van de Water et al. , 1996).
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Nuclear transcription factor-kappa B (NF-kappa B) is a pro-inflammatory transcription 
factor which responds to many stimulii including oxidative stress (Schreck et al. , 
1992). Normally, NF-kappa B is held in the cytoplasm in an inactive, non-DNA 
binding form by labile I kappa B inhibitor proteins, when the cell is activated by stress 
for example, proteolytic degradation of I kappa B allows the active NF-kappa B to 
translocate to the nucleus and activate transcription of responsive genes (Matthews and 
Hay, 1995). In the cell line LLC-PKl, DCVC has been shown to induce the binding of 
nuclear proteins to the immunoglobulin K-light chain enhancer region of NF-kappa B 
(Otieno and Anders, 1997a). Transient transfection studies revealed that DCVC 
activated NF-kappa B was transcriptionally active, and that the pyridoxal phosphate 
dependent enzyme inhibitor, AOAA, inhibited this transactivation. Furthermore, they 
found that the antioxidants N,N’-diphenyl-p-phenlenediamine and N-acetyl-L-cysteine, 
together with the protein kinase inhibitor, staurosporine, also inhibited NF-kappa B 
transactivation (Otieno and Anders, 1997b). Two other cysteine conjugates, namely 
CTFEC and S-(2-bromo-2-chloro-l,l-difluoroethyl)-L-cysteine (BCDFEC) also 
transcriptionally activated NF-kappa B in LLC-PKl cells. It would therefore appear 
that cysteine conjugates can transcriptionally activate NF-kappa B, and that protein 
kinases and oxidative stress also appear to play a role in the NF-kappa B pathway.
Two other stress response genes are grp 78 and gadd 153, whose mRNA levels in 
LLC-PKl cells may be inceased by treatment with thiols. Grp 78 is a molecular 
chaperone expressed in the endoplasmic reticulum, it is a glucose-regulated protein 
which is induced by stress responses which deplete glucose or intracistemal calcium or 
otherwise disrupt glycoprotein trafficking (Hsieh et ai, 1996). Gadd 153 is a stress 
response gene inducible by growth arrest and DNA damage alternatively known as 
chop(Jeong eta l, 1997). Halleck et al, (1997a) proposed that both grp 78 and gadd 
153 are members of a gene battery which is responsive to reductive stress and that 
thiols produced as a result of cysteine conjugate 6-lyase metabolism could well induce
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these genes. In fact, treatment of LLC-PKl cells with trans-4,4-dihydroxy-l,2- 
dithiane, the intramolecular disulfide form of dithiothreitol (DTT), afforded some 
protection against TFEC (Halleck et al. , 1997b).
57
1.10 CYSTEINE CONJUGATE B-LYASE
The term cysteine conjugate 6-lyase or C-S lyase (EC 4.4.1.13) describes a group of 
enzymes which are capable of catalysing the cleavage of cysteine S-conjugates by 6- 
elimination (Figure 1.14a) (Elfarra and Anders, 1984) and is a subsidiary activity of 
some of the transaminases. The products of 6-elimination are thiol compounds and an 
acrylic compound, dihydroalanine, which is then rapidly hydrolysed to ammonia and 
pyruvate. The thiol products may subsequently be methylated by S-methyltransferases 
producing stable and non-toxic methylthio-deiivatives (Jakoby et a l, 1984). The 
cysteine conjugate DC VC however, when metabolised by 6-lyase produces an 
extremely reactive intermediate which contains the sulphur and vinyl carbon atoms of 
DCVC and reacts with proteins including the enzyme 6-lyase as well as binding to 
nucleic acids (Stevens and Jakoby, 1983). Such enzymes have been found in several 
mammalian tissues, with the greatest specific activity found in the kidney followed by 
the liver, but they have also been detected in the heart, muscle, brain, testes, pancreas, 
lung and intestinal microflora (Tateishi et a l , 1978; Bowsher and Henry, 1985; Larsen, 
1985; Stevens et a l , 1986b; Jones et a l , 1988; Cooper et a l , 1993).
Administration of DCVC to rats leads to selective and potent toxic effects in the kidney, 
the likes of which has not been observed in the liver , indicating that it is renal 6-lyase 
and not the enzymes present in the liver or intestinal microflora for example which is 
responsible for the bioactivation of DCVC to nephrotoxic metabolites.
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1.10.1 Bacterial 15-Lyase
Bacterial 6-lyases have been isolated in three species of gastrointestinal bacteria, namely 
Fusobacterium necrophorum (Larsen and Larsen, 1983); Fusobacterium varium 
(Tomisawa et al., 1984) and Eubacterium limosum (Larsen and Stevens, 1986).
The 6-lyase from Fusobacterium necrophorum has a molecular weight of 
approximately 228kDa and is a pyridoxal phosphate (PLP)-dependent enzyme which 
catalyses the cleavage of propachlor (2-S-cysteinyl)-N-isopropylanilide, 1,2-dihydro-1- 
hydroxy-2-cysteinylnapthalene and 6-(2-benzothiazolyl)cysteine. As of yet it remains 
unclear whether this enzyme is active as a monomer or polymer.
The 6-lyase from Fusobacterium varium has a molecular weight of approximately 
70kDa, and is most active with aromatic cysteine 6-conjugates (eg. benzyl-, p  - 
bromophenyl-, phenyl-), however some activity has been observed with alkyl cysteine
S-conjugates.
Eubacterium limosum also possesses 6-lyase, which has a molecular weight of 75kDa 
and is active as a dimer. The cofactor involved is possibly PLP, however the activity 
does not require added PLP. This enzyme has quite a broad specificity and is active 
with the cysteine conjugate of propachlor and moderately active with the 6-alkyl 
conjugate , S-ethy-L-cysteine. Furthermore, unlike F. necrophorum and F. varium, 
the 6-lyase from E. limosum also possesses 6-cystathionase activity.
1.10.2 Hepatic B-Lyase
Hepatic 6-lyase was first isolated in 1978 (Tateishi et al., 1978) from rat liver, where it 
was noted as being localised to the hepatic cell cytosol. Later, in 1985, Stevens purified 
the enzyme to homogeneity and discovered that it was a PLP containing enzyme 
identical to kynureninase (Figure 14b) and active as lOOkDa dimer. Kynureninase is an
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enzyme capable of metabolising kynurenine (a degradation product of tryptophan 
metabolism) to produce anthranilic acid and alanine (Soda and Tanizawa, 1979).
In 1986, Tomisawa et al. , first isolated the human form of hepatic 6-lyase. Using gel 
filtration, they found that human hepatic 6-lyase had a molecular weight of 88kDa and 
an optimum pH of 8.5, however it did not possess any kynureninase activity. Later in 
1992, Blagbrough et al, discovered that human hepatic 6-lyase co-purified with 
kynurenine aminotransferase. Buckberry (1992) went on to propose that the 
physiological role of human hepatic 6-lyase was that of kynurenine aminotransferase 
(Figure 1.14c). Two isoforms of kynurenine aminotransferase have been reported both 
present in the human liver (Kido, 1984) they have isoelectric points of 8.0 and 5.0, 
with each enzyme consisting of two identical subunits of dimeric molecular weight 
90kDa. The liver and kidney cytosolic enzymes are distinct proteins and antibodies 
raised against the liver cytosolic enzyme do not cross-react with the renal cytosolic 
enzyme. Only 10-15% of the renal cytosolic 6-lyase possesses kynureninase activity 
(Stevens and Jakoby, 1983; Stevens, 1985).
1.10 .3  Renal B-Lyase
Renal 6-lyase is an intracellular enzyme present in cytosol and to a lesser extent 
mitochondria. Rat renal 6-lyase has been isolated, purified and characterised from 
kidney cytosol(Stevens et al, 1986b; MacFarlane et a l, 1989; Yamauchi et a l, 1993) 
and is active as a dimeric protein of dimeric molecular weight lOOkDa (Jones et a l ,
1988). This enzyme is thermostable and PLP dependent (Stevens et a l , 1986b) with an 
optimum pH of 8.8 (50mM Tris-HCl). Mitochondrial forms of the enzyme have been 
isolated (Lash et a l , 1986a; Stevens et a l , 1988) which like the cytosolic form of 6- 
lyase also possess glutamine transaminase K (GTK) activity (EC 2.6.1.64; Fig 1.14d),
6-lyase activity being a subsidiary activity of the transaminase.
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The cysteine conjugate S-(2-benzothiazoyl)-L-cysteine (BTC) appears to be a poor 
substrate for purified renal cytosolic 6-lyase (Stevens et ah, 1988) however in the 
mitochondrial matrix it is as active as DCVC, suggesting the presence of other 6-lyases 
other than GTK. There is some dispute between researchers about the exact location of 
mitochondrial 6-lyase since Lash eta l, (1986a) report that 6-lyase activity is present in 
the mitochondrial outer membrane. The differences in opinion as to the localisation of 
mitochondrial 6-lyase may be explained by differences in experimental conditions. Lash 
et al, (1986a) proposed that both DCVC and CTFC were not toxic to mitoplasts, 
suggesting a outer membrane localisation for 6-lyase. However, the direct acting 
nephrotoxin CEC was toxic to both mitoplasts and mitochondria. MacFarlane et al, . 
(1989) demonstrated by use of Western blot analysis that antibodies raised against rat 
renal cytosolic 6-lyase cross-reacted with the mitochondrial form, and showed that they 
both had similar monomeric molecular weights of approximately 50kDa. In 1993, Perry 
et a l , (1993) isolated the cDNA encoding rat renal cytosolic cysteine conjugate 6-lyase 
and predicted the monomeric molecular weight to be 47.8kDa, similar to the 47.4kDa 
obtained for the purified protein (MacFarlane et a l , 1989;Yamauchi et a l , 1993). More 
recently, in 1994, the cDNA for rat renal 6-lyase was reported to be identical to the 
cDNA for rat kidney kynurenine aminotransferase (Mosca et a l , 1994).
Human renal 6-lyase activity on the other hand, has been found in cytosol, 
mitochondria and microsomes (Lash et a l , 1990), with the greatest activity being in the 
cytosol. Lash et al, (1990) isolated human renal cytosolic 6-lyase and determined its 
molecular weight to be approximately 45kDa, they also confirmed that it was a PLP- 
dependent enzyme which co-purified with glutamine transaminase K and was inhibited 
by aminooxyacetic acid. Two years ago, the cDNA encoding human renal cytosolic 6- 
lyase was isolated (Perry e ta l, 1995) from which the predicted molecular weight of the 
protein was 47.9kDa, again similar to that obtained by Lash et a l , (1990) for purified 
protein.
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specific enzyme activies have been obtained for human renal 6-lyase, it would appear 
that per gramme of tissue, the specific activity of human renal 6-lyase is only 10% that 
of rat renal 6-lyase (Lash et al, 1990), more recently Buckberry et a l, (1994) have 
reported that the specific activity of human renal cytosolic preparations may be as much 
as 28% of that obtained for rat renal cytosol preparations. Buckberry did note however 
that there were sex differences in 6-lyase specific activity between male and female 
subjects, the male subject having a lower percentage specific activity than the female in 
comparison to rat 6-lyase specific activity. Furthermore, the ratio of cytosolic to 
mitochondrial specific activity in man was found to be less than that observed in rat 
kidney. Since the mitochondria are targets for DCVC induced nephrotoxicity, it is 
possible that humans are at a greater risk from cysteine conjugate induced
nephrotoxicity than at first thought. Studies involving a-keto acids have shown that
their addition to rat renal cytosolic incubations increases rat renal 6-lyase activity by up 
to 30 times more than when they are excluded (Stevens et a l , 1986a). This result may 
be explained by the conversion of the pyridoxamine phosphate (PMP) which results 
from intrinsic transamination by 6-lyase, to PLP, the active form (Stevens et a l , 
1986a). The addition of a-keto acid stimulates 6-lyase activity by being transaminated 
into amino acids (Stevens et a l , 1986a) hence increasing toxicity induced by cysteine 
conjugates (Lash et al, 1986b; Elfarra et al, 1987). When the a-keto acid a-KMB 
was added to human renal cytosolic incubations, the increase in specific activity 
observed was much less, being only 1.3 fold greater than in its absence (Lash et a l , 
1990).
There have been reports of more than one form of human renal cytosolic 6-lyase, 
Buckberry et a l, (1990) isolated and purified two human renal cytosolic 6-lyase 
enzymes which had identical isoelectric points but different molecular weights. Both 
these enzymes displayed physico-chemical and biochemical properties consistent with 
glutamine transaminase K. In 1991, Abraham and Cooper discovered a high molecular
63
weight protein (330kDa) in rat kidney homogenate which possessed weak transaminase 
activity but higher DCVC-lyase activity. It was found that the high molecular weight 
enzyme was immunologically distinct from kidney cytosolic GTK and could not be 
detected in the brain (Cooper et ai, 1993). The high molecular weight 6-lyase also 
possessed the ability to metabolise leukotriene E4, also a cysteine conjugate, into 
pyruvate, ammonia and a reactive sulphydryl-containing compound (Abraham et a i , 
1995a).
Furthermore, Abraham et al, (1995b), claim that GTK is not the major cysteine S- 
conjugate 6-lyase of rat kidney mitochondria and that in fact it is the role of a high 
molecular weight enzyme. The mitochondrial high molecular weight enzyme is similar 
to the high molecular weight cytosolic enzyme described by Abraham et a l , (1991 & 
1995b) and possesses weak DCVC-lyase activity.
Gaskin et a l, (1995), reported that aspartate aminotransferase (ASAT) and alanine 
aminotransferase (ALAT) isolated from pig heart, also possessed 6-lyase activity. 
AOAA, the PLP-dependent enzyme inhibitor was seen to inhibit the 6-lyase activity of 
these enzymes. ASAT is normally involved in the malate-aspartate shuttle, generating 
NADH within mitochondria. ALAT is also involved in energy production, regulating 
pyruvate levels via its interconversion with alanine. Both enzymes are involved in the 
tricarboxylic acid cycle, therefore damage to either one would have serious 
consequences for the cellular chemistry of cardiac and other metabolically active 
tissue. Furthermore, Gaskin et al, (1995) postulate that 6-lyase activity is not solely 
confined to one enzyme but is probably a property of other PLP-dependent 
aminotransferases.
Further evidence to support the 6-lyase activities of aspartate and alanine 
aminotransferase comes from Kato et al, (1996), who found that both DCVC and 
TFEC inactivated purified cytosolic aspartate aminotransferase and alanine
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aminotransferase. Both cysteine conjugates also inactivate aspartate aminotransferase 
in cytosolic and mitochondrial fractions of rat brain and kidney, suggesting that certain 
halogenated alkenes may be toxic as a result of their conversion to the corresponding 
cysteine conjugates, inactivating key PLP-dependent enzymes.
In 1996, Abraham and Cooper, isolated a cDNA encoding rat kidney cytosolic GTK 
which possessed both GTK and 6-lyase activities and was present as a homodimer with 
each subunit of molecular mass 45.8 kDa. The cDNA bears strong sequence similarities 
with other aminotransferases, including 90% homlogy with kynurenine pyruvate 
aminotransferase (KAT). However, it was not the same enzyme isolated by Perry et 
al. , (1993). From this experiment it is clear that at least two distinct enzymes exist in rat 
kidney cytosol, both of which possess GTK/KAT/6-lyase activities.
1 .10 .4  Neural 6-Lyase
A more recent discovery in the field of C-S lyase, is its presence and activity in the 
brain. In 1991, Abraham and Cooper showed that there was a cysteine conjugate 6- 
lyase present in rat brain which had an apparent molecular weight comparible with that 
of liver and kidney enzymes and which co-migrated on non-denaturing PAGE with 
purified glutamine transaminase K. It would appear that both mitochondrial and 
cytosolic forms of 6-lyase are present in the brain and that with the use of DCVC, the 
only detectable form of 6-lyase present in rat brain homogenates is identical to rat 
glutamine transaminaseK (Cooper gt al, 1993). In the brain, however, approximately 
80-85% of glutamine transaminase K activity is present in the mitochondrial fraction 
(Cooper, 1988) and using antibodies raised against cytosolic 6-lyase, there appears to 
be only 10% cross-reactivity with the mitochondrial form, suggesting two distinct 
enzymes (Cooper gr al, 1993). Both the mitochondrial and cytosolic forms of 6-lyase 
have been purified from rat brain (van Leuven,1975; and Cooper and Gross, 1977), 
like the cytosolic enzyme, rat mitochondrial 6-lyase is a PLP-dependent enzyme
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composed of two identical subunits with a molecular weight of approximately 90kDa. 
Although substrate specificities appear to be quite similar between the cytosolic and 
mitochondrial enzymes, there are several subtle differences in substrate affinity between 
the two (Cooper and Gross, 1977).
Alberati-Giani et al, (1995) isolated the cDNA encoding kynurenine aminotransferase 
(KAT) from rat brain only to discover that its sequence was identical to that of rat 
kidney cytosolic 6-lyase/GTK (Perry etal, 1993). Furthermore, apart from two amino 
acid differences which are more than likely due to strain differences, it was also 
identical to rat kidney KAT (Mosca et a l , 1994).
As of yet, 6-lyase has not been isolated from human brain, but there is much evidence 
to support its existence. The haloalkene trichloroethylene is readily converted under 
alkaline conditions to dichloroacetylene, which appears to be a neurotoxin (Greim et a l ,
1984). Both trichloroethylene and dichloroacetylene are converted via the mercaptuiic 
acid pathway to the cysteine conjugate DCVC, which is the ultimate toxic species 
(Kanhai et a l , 1989). Workers exposed to either of these compounds, formerly used as 
an anaesthetic for humans as well as being degreasing or defatting agents, have shown 
signs of poisoning. Clinical symptoms of such poisoning are facial cold sores and 
trigeminal analgesia, sometimes accompanied by facial paresis, ptosis, dysarthria, vocal 
chord paralysis, visual loss and dysphagia. Most patients suffering from these 
symptoms recover within two years, except for those more severely affected who do 
not recover (Schaumburg, 1992). Post-mortem examinations performed on individuals 
who were severely affected by exposure to these compounds, revealed neuronal 
degeneration within the brain stem sensory nucleus of the trigeminal nerve and 
degeneration of axons within its tract (Buxton and Hayward, 1967; Schaumburg,
1992).
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1.11 TARGET ORGAN SPECIFICTY
As mentioned previously, 6-lyase is found in many tissues and intestinal microflora in 
the rat, despite this however, the nephrotoxicity induced by 6-lyase metabolism of 
cysteine conjuagtes is specific to the pars recta (or S3) region of the kidney proximal 
tubule of rats (Lock and Ishmael, 1979; Ishmael et al, 1982). More recently it is 
becoming accepted that the subtle changes in human kidney following exposure to 
perchloroethylene (Mutti et a l , 1992) and neurotoxicity observed in humans exposed to 
trichloroethylene (Schaumburg, 1992), are a result of cysteine conjugate metabolism by
6-lyase.
There are many factors which may contribute to the target organ specificity of cysteine 
conjugate metabolites. Tissue distribution of the bioactivating enzymes is a major 
factor in determining organ specific toxicity. The distribution of the toxic agent amongst 
the body tissue is another important factor in determining target organ specificity, 
accumulation of a xenobiotic in a specific organ may lead to toxic concentrations. Body 
tissues possess defence systems which protect the tissue against harmful interactions 
with reactive intermediates. For example, some tissues may repair the damaged cellular 
elements, others deactivate the toxicant. The process of deactivating enzymes also plays 
an important role in determining target organ specificity.
1.11.1 Kidney
One of the most important roles of the kidney is that of maintaining stable ionic 
conditions in the extracellular fluid. The concentrations of electrolytes such as calcium, 
hydrogen, potassium and sodium ions and water volume are controlled by a 
combination of active and passive transport systems together with hormonal regulation. 
The majority of substances in the glomerular filtrate such as glucose amino acid and 
soluble vitamins, are reabsorbed by active transport. Waste products such as urea,
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uric acid, and creatinine are also excreted by the kidney in urine, together with other 
foreign chemicals such as drugs, pesticides and food additives. Another function of the 
kidneys is that of endocrine glands, secreting erythropoietin, renin and the active form 
of vitamin D. Therefore due to the many important bodily functions performed by the 
kidney, it is not surprising that the result of toxicity to the kidney has severe or 
sometimes fatal consequences.
The kidney receives approximately 25% of the cardiac output, from which it eliminates 
chemicals and their metabolites. Exactly how chemicals produce a toxic effect in the 
kidney is not fully understood, but the concentration of potentially toxic compounds 
can occur both actively and passively. Since the kidney also contains most of the drug 
metabolising enzymes also found in the liver, bioactivation of chemicals in the kidney 
itself also occurs. This, together with the kidneys ability to concentrate xenobiotics and 
its high blood flow make it extremely susceptible to toxins compared to other organs.
Plasma glutathione and cysteine conjugates are handled primarily by the kidney. 
Following glomerular filtration and y-gt and dipeptidase processing of glutathione 
conjugates, a sodium dependent organic anion transport mechanism takes up the 
cysteine conjugates into the luminal membrane. This transporter mechanism can also 
facilitate entry of N-acetylcysteine conjugates, which are then deacetylated to cysteine 
conjugates. In the renal proximal tubule, the cysteine conjugates may then be converted 
to mercapturic acids by microsomal cysteine conjugate N-acetyl transferase, which are 
then either excreted or deacetylated back to the cysteine conjugate.
More recently, Kim et a l , (1997), have examined the intranephron distribution of two 
major cysteine S-conjugate 6-lyases, with the purpose of clarifying the role of these 
enzymes in haloalkene-induced nephrotoxicity. Various nephron segments, such as the 
S-1, S-2 and S-3 regions of the proximal tubule and distal tubule, were microdissected
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from collagenase treated rats, and following treatment with Hanks solution and Triton 
x-100, electrophoresed on a polyacrylamide gel. The position of cysteine conjugate 6- 
lyase and L-amino acid oxidase was visualised by incubating the gel with a solution 
containing DCVC, a-KMB, phenazine methosulfate and nitroblue tétrazolium, the 
presence of the enzymes being indicated by blue formazan dye. Three bands were 
detected which corresponded to the high molecular weight cysteine conjugate 6-lyase 
(Mw 330,000; Abraham et a l , 1995a), a lower molecular weight cysteine conjugate 6- 
lyase (Mw 90,000) and L-amino acid oxidase (Mw 240,000). 6-Lyase metabolism of 
DCVC was detected only in the S 1,S2 and S3 segments of the nephron in the order of 
S2 = S3 > S 1. HCBD was administered to rats which were then sacrificed 24hr later, 
and whole kidney homogenates electrophoresed and stained as above, the band which 
corresponded to the lower molecular weight 6-lyase was more intense than the other 
two bands. Proximal tubular cells isolated from HCBD-induced rats however, revealed 
that the 6-lyase activity in the SI, S2 and S3 segments was significantly reduced when 
stained as above (Kim et al, 1997).The results strongly suggested that the low 
molecular weight 6-lyase was inducible by HCBD and that impaired cell function in the 
SI, S2 and in particular the S3 segment of the proximal tubule resulted in proteins 
leaking out of the target cells. They went on to examine the relationship between HCBD 
nephrotoxicity and cysteine S-conjugate 6-lyase activity by comparing the ratio of ATP 
to protein in each nephron segment and in kidney homogenates, treated with HCBD 
together with the affect of AOAA. Kim et a l , (1997) concluded that HCBD is probably 
converted to toxic metabolites within the kidney and that this process leads to metabolic 
derangement and reduction of ATP in susceptible kidney cells.
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1 .11 .1 .1  Selective Nephrotoxicity in Rodents
The organ specific toxicity observed with cysteine conjugates has been studied 
extensively in rats. MacFarlane et al., (1989), found that nephrotoxicity induced by 
HCBD was specific to areas of localisation of cysteine conjugate 6-lyase as 
demonstrated using immunohistochemistry techniques. The location of cysteine 
conjugate 6-lyase was primarily in the S3 or pars recta area of the proximal tubule, this 
supports work performed by Jones et al, (1988). However, work performed by 
MacFarlane et a l, (1989), also indicates that 6-lyase is found in both the S^  and S^  
segments or pars convoluta, suggesting the requirement of additional factors in HCBD 
induced nephrotoxicity. The pars recta is known to be the site of accumulation of N- 
acetylated cysteine conjugates which are then processed via cysteine conjugate 6-lyase 
following deacetylation. The distribution and specificity of other enzymes such as 
glutathione transferases, y-glutamyl transpeptidases, dipeptidases, acylases, 
deacetylases and other cysteine conjugate 6-lyases also determines the site of 
nephrotoxicity, together with sulphoxidation reactions, the availability of a-keto-acids 
and transport systems.
In 1993 MacFarlane et a l , showed that 6-lyase and the associated GTK activity could 
be induced by the treatment of female rats with the N-acetyl conjugate of HCBD. A 
single dose of 3mg/kg was ample to significantly increase the enzyme activity, protein 
levels and corresponding mRNA synthesis. Whether or not it was the N-acetyl 
conjugate or one of its metabolites which caused the induction of 6-lyase remains 
unclear. Furthermore, these effects were only observed with the cytosolic form of 6- 
lyase, there were no changes in mitochondrial enzyme activity or protein levels.
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1 .1 1 .1 .2  Selective Nephrotoxicity in Humans
There appears to be growing evidence in support of xenobiotic induced nephrotoxicity 
in man. Workers exposed to trichloroethylene have been found to produce appreciable 
amounts of the two mercapturic acids, N-acetyl-S-(l,2-dichlorovinyl)-L-cysteine and 
N-acetyl-S-(2,2-dichlorovinyl)-L-cysteine conjugates in their urine (Bimer et al. ,
1993). The concentration of mercapturic acids excreted in these experiments was found 
to be higher than in the respective rat and mice models. The concentration of 
mercapturates present in urine is dependent on the balance between acétylation and 
deacetylation of the cysteine conjugates, however the levels of deacetylase in rat and 
human kidney cytosol were found to be comparable. It would therefore appear that the 
high concentrations of mercapturates excreted in humans compared to Wistar rats is due 
to greater metabolism of trichloroethylene by glutathione conjugation and hence 
increased mercapturic acid synthesis.
Chen et a l, (1990) have demonstrated cysteine conjugate 6-lyase mediated toxicity in 
isolated human proximal tubular cells. Workers occupationally exposed to the dry 
cleaning fluid perchloroethylene have been found to have early renal changes (Mutti et 
al. , 1992), with diffuse abnormalities occurring at the glomerular , proximal and distal 
tubule level. These abnormalities, however do not compare to the acute damage 
observed in rats, but possibly represent an early stage of a clinically silent but 
potentially progressive renal disease (Mutti et al. , 1992).
Bemauer et al, (1996) studied the biotransformation of trichloroethene in rats and 
humans. Human volunteers and rats were exposed to varying doses of trichloroethene 
over a period of 6hr after which the level of mercapturic acids in their urine was 
measured. A slow rate of elimination of N-acetyl-S-(dichlorovinyl)-L- cysteine was 
observed both for humans and rats. The results confirmed that exposure of humans to 
trichlororethene resulted in the urinary excretion of mercapturic acids and confirmed that
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the formation of reactive intermediates as a result of glutathione bioactivation of 
trichloroethene existed in humans.
In 1995, Henschler et a l , (1995) reported an increased incidence of renal cell tumors in 
workers occupationally exposed to trichloroethene . Their results suggested that 
exposure to high concentrations of trichloroethene over prolonged periods of time may 
cause renal tumors in man. Both the site and histopathological charactersitics of the 
tumors observed in their patients were identical to those found in experimental animals 
exposed to trichloroethene (Vamvakasef a/., 1993).
In experimental animals it was noted that the region of the kidney most susceptible to 
cysteine conjugate induced cytotoxicity was the proximal nephron, Cordon-Cardo et 
al, (1989) reported that in humans this region was where renal carcinomas arose. 
Cooper et a l, (1989), together with evidence for the mutagenicity of chloroalkene 
derived cysteine conjugates as a result of 6-lyase bioactivation (Vamvakas et a l , 
1988b), have come to the conclusion that low-level exposure to chloroalkenes may lead 
to renal cancer.
1.11.2 Brain
The adult human brain is composed of millions of neurons which relay signals of 
afferent input and efferent output between the spinal chord and the higher brain. It 
receives approximately 15% of the total blood supply which is necessary to support the 
high oxygen and glucose requirement of the neural tissues. In most other organs, the 
exchange of substances between the blood and tissue is largely unrestricted diffusion, 
in the brain however a complex group of blood-brain barrier mechanisms exist. This 
barrier strictly controls both the types of substances which can enter the extracellular 
fluid of the brain and the rate at which they enter. It is made up of anatomical structures 
and physiological transport systems which precisely regulate the chemical composition
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of the extracellular fluid and reduce the ability of harmful substances to reach the brain. 
The other fluid present in the brain is the cerebrospinal fluid (CSF), this is a clear fluid 
secreted by the choroid plexus tissues, which fills the ventricles in the brain and 
surrounds its outer surfaces. Certain xenobiotics are able to bypass the blood-brain 
barrier exploiting active transport mechanisms. It is believed that these may be 
substrates for cerebral enzymes which give rise to toxic metabolites and possibly having 
neuromodulatory effects.
1 .11 .2 .1  Neurotoxicity and Neuromodulation by Cysteine Conjugate 
6-Lyase
The hypothesis that haloalkenes such as dichloroacetylene and trichloroethylene via 
their bioactivation by cysteine conjugate 6-lyase can possibly induce neurotoxicity is not 
a new concept. Over the past thirty years several researchers have observed neurotoxic 
effects in both experimental animals and humans who have come into contact with these 
compounds (Buxton and Hayward, 1967; Reichert et a l, 1976). In rabbit models, 
inhalation of dichloroacetylene was seen to induce severe neurotoxicity in particular in 
the sensory trigeminal nucleus (Reichert et a l, 1976). It is thought that 
dichloroacetylene occurs as a decomposition product of trichloroethylene and 
tetrachloroethane, and may also be found as a contaminant in certain chlorinated plastic 
monomers. Schaumburg e ta l, (1992) discovered that workers occupationally exposed 
to trichloroethylene suffered from facial cold sores and trigeminal analgesia, sometimes 
accompanied by facial paresis, ptosis, dysarthria, vocal chord paralysis, visual loss and 
dysphagia, however most patients recovered within two years. Post mortem 
examinations of severely affected individuals showed neuronal degeneration of the 
brainstem sensory nucleus of the trigeminal nerve and degeneration of axons within its 
tract (Buxton and Hayward, 1967; Schaumburg, 1992).
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Recently it has been proposed that as with nephrotoxicity observed in humans and rats, 
exposure to halogenated alkenes may also induce neurotoxicity via 6-lyase 
bioactivation (Patel et a l, 1994). In the pulmonary circulation dichloroacetylene is 
metabolised leading to high concentrations of DCVG and DCVC, it is only DCVC 
however which may be taken up into the brain tissue via a sodium-independent L- 
amino acid transporter system (Patel et a l , 1993). DCVG however may be hydrolysed 
to DCVC by brain tissue and subsequently bioactivated by brain 6-lyase resulting in the 
formation of toxic metabolites.
There is much evidence to support the presence of 6-lyase activity in brain tissue. 
Coopérerai., (1993) showed that there was widespread GTK activity in the rat brain, 
with the choroid plexus being the more active. Activity staining using DCVC as a 
substrate showed that in rat brain 6-lyase 6-elimination is catalysed exclusively by 
GTK. This is confirmed by immunohistochemistry using a polyconal antibody raised in 
rabbit against cytosolic rat kidney GTK, which revealed the presence of GTK in the 
choroid plexus of the rat brain. Patel et a l, (1994), detected the formation of pyruvate 
from DCVC in the cerebellum region of rat brain. Firm evidence for the presence of 6- 
lyase in the rat brain is provided with the isolation of a cDNA from rat brain (Alberati- 
Giani et a l , 1995) which is identical to the cDNA for rat kidney cytosolic cysteine 
conjugate 6-lyase/GTK (Perry et a l , 1993).
Makar era/., (1994), discovered that not only was there GTK/ 6-lyase activity present 
in the chick brain , but that its levels increased 15 fold on the day of hatching. They 
suggest that the increase in GTK in the chick brain correlates with the maturation of 
astrocytes, indicating a possible role for GTK in glutamine cycling in astrocytes. Since 
GTK is one of the major cysteine conjugate 6-lyases in the brain, it is believed that it is 
also involved in neurotoxicity associated with haloalkenes. Furthermore, if as seen in
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chicks, there is an increase in GTK/6-lyase at birth, then exposure of the foetus or 
neonate to haloalkenes may increase the risk of neurotoxicity.
It has recently been shown that rat kidney cytosolic cysteine conjugate 6-lyase is 
identical to brain (Alberati-Giani et al, 1995) and kidney (Mosca et a l, 1994) 
kynurenine amino transferase, which has been implicated in neuromodulation and 
neurotoxicity. It is believed that the tryptophan metabolites, kynurenic acid and 
quinolinic acid interfere with the glutamate excitatory receptors. N-methyl-D-aspartate 
or NMDA receptors are influenced by kynurenic acid which acts as an antagonist and 
quinolinic acid which acts as an agonist at the glycine co-agonist site. KAT/GTK/6- 
lyase directs the tryptophan metabolites away from quinolinic acid metabolism, with the 
formation of kynurenic acid from L-kynurenine. Kynureninase, which also possesses 
6-lyase activity, does the reverse, directing the formation of quinolinic acid . In the 
brain, quinolinic acid is a powerful excitant and convulsant, which can activate NMDA 
receptors (Stone and Burton, 1988). Infusion of quinolinic acid directly into the brain 
can result in lesions which resemble those found in Huntington’s disease and temporal 
lobe epilepsy (Schwarcz et al, 1988). Jauch et al, (1995) examined the levels of 
kynurenic acid and the activity of kynurenine aminotransferase I and II in 12 regions of 
the brains of patients suffering with late-stage Huntington’s disease. They found that 
there appeared to be a selective impairment of kynurenic acid biosynthesis in the 
neostriatum of patients suffering from Huntington’s disease, which was possibly due 
to the loss of an endogenous KAT activator. Stone (1993) in his review, proposes that 
alteration in the balance between kynurenic acid and quinolinic acid may have a 
neuromodulatory function leading to several neurological disorders.
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1.12 THE B-LYASE REACTION - A MECHANISM
Cysteine conjugate 6-lyase is a pyridoxal phosphate dependent enzyme which catalyses 
6-elimination resulting in the formation of pyruvate, ammonia and a thiol of the original 
compound (Figure 1.14a). The reaction proceeds via an eneamino acid intermediate 
which has carbonium ion character at the 6-carbon (Bild and Morris, 1984), which is 
believed to be responsible for the inactivation of the enzyme. Two mechanisms of 
enzyme inactivation have been proposed.
Firstly, it is believed that the enzyme may be inactivated by the nucleophilic attack of an 
enzyme bound nucleophile on the 6-carbon of the eneamino acid intermediate (Reylea et 
al, 1974; Wang and Walsh, 1978). Secondly, it is possible that an aldol-type 
condensation reaction between an imino acid released following 6-elimination and the 
internal Schiffs base formed by the S-amino group of an enzyme bound lysine and 
pyridoxal phosphate may inactivate the enzyme (Likos et a l , 1982; Ueno et a l , 1982).
Using LLC-PKl cells as a model, Stevens et al, (1986a) studied the metabolism of 
DCVC and proposed a reaction scheme for 6-lyase (Figure 1.15). They proposed that 
the free amino group of DCVC enters a Schiffs base with PLP, with the possibility of 
two reactions occuring:
1) 6-elimination with thiol formation
2) Half transamination resulting in a pyridoxamine form of the enzyme.
6-lyase activity is therefore regulated by concurrent transamination and is noticeably 
increased by the addition of a-keto acids such as a-keto-y -methiolbutyrate. The 
pathways interact regulating each other, the presence of inadequate concentrations of a- 
keto acids results in transamination regulating the rate of 6-elimination. Following half
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transamination, the enzyme accumulates in the pyridoxamine phosphate form, inhibiting 
further 6-elimination since the cysteine conjugate substrate cannot form a Schiff’s 
base. The presence of a-keto acids stimulate 6-elimination by converting the 
pyridoxamine phosphate into the active pyridoxal phosphate form of the enzyme.
Stevens et ai, (1986a) proposed that the regulation of 6-elimination by the competing 
transamination pathways is different for each substrate and that in fact several 6-lyases 
may exist in rat kidney. In 1989, Stevens et al, administered DCVC to rats and 
discovered that 65% of the DCVC was metabolised to its corresponding a-keto acid (S- 
(l,2-dichlorovinyl)-2-oxo-3-mercaptoproprionate). Of that, 35% is the product of 
transamination via 6-lyase and the remaining 30% is the product of metabolism by L-a- 
hydroxy acid oxidase.
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Figure 1 .15 - A reaction scheme for 6-lyase enzyme activity (Stevens er a/., 1986a)
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1.13 THE MECHANISM OF THE TRANSAMINASE ENZYMES
All transaminases are dependent on pyridoxal phosphate (PLP), which is derived from 
pyiidoxine otherwise known as vitamin B6. During transamination, the pyridoxal 
phosphate is converted to pyridoxamine phosphate (PMP; Walsh, 1979; Figure 1.16).
When no substrate is present, the aldehyde group of PLP forms a Schiff’s base with the 
E-amino group of a specific lysine residue at the active site.
The a-amino group of the amino acid substrate displaces the e-NH^ group of the active
site. The resultant amino acid Schiff base remains bound tightly to the enzyme via 
non-covalent forces.
During catalysis, the double bond in the amino acid-PLP Schiff-base linkage shifts 
position resulting in the formation of a ketimine which is subsequently hydrolysed to 
PMP and an a-keto-acid.
The regeneration of PLP occurs by the reversal of the above reactions, a second a-keto- 
acid reacts with the enzyme-PMP complex giving rise to a second amino acid and an 
enzyme-PLP complex.
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Figure 1 .16 - Transamination - the reversible conversion of pyridoxal phosphate to 
pyridoxamine phosphate (Adapted from Elfarra et a l , 1987)
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1.14 AIMS OF THIS RESEARCH
For many years there has been a connection between nephrotoxicity and bioactivation 
of certain haloalkyl cysteine conjugates by cysteine conjugate 6-lyase (Commandeur 
and Vermeulen, 1990). In order to be able to predict the toxicity of such compounds, it 
is neccessary to gain an insight into the structure, function and selectivity of cysteine 
conjugate 6-lyase enzymes. Much work has been performed using the rat as a model for 
investigating the nature of haloalkyl-induced toxicity, however it is becoming 
increasingly clear that humans are also susceptible to such toxicity. Very few studies 
have been performed whereby the effects of bioactivation of haloalkyl cysteine 
conjugates by human kidney cysteine conjugate 6-lyase are assessed. This is primarily 
due to the lack of human tissue available to pursue these studies. In an attempt to 
compare the structure and function of rat and human renal cytosolic cysteine conjugate 
6-lyase, Perry et al, (1993 & 1995) isolated a rat and a human cDNA both of which 
encoded renal cytosolic cysteine conjugate 6-lyase.
The aim of this thesis was to assess the structure-activity relationships of the expressed 
rat and human cysteine conjugate 6-lyase using several haloalkyl cysteine S-conjugates, 
together with assessing the cytotoxicity of these haloalkyl cysteine S-conjugates using 
Hn vitro’ toxicity tests. This was achieved firstly by transiently expressing the cDNAs 
isolated by Perry et a l , in the COS-1 cell system, in order to confirm that they did in 
fact encode GTK/cysteine conjugate 6-lyase and to make initial comparisons between 
rat and human cysteine conjugate 6-lyase.
Once it was ascertained that the cDNAs did in fact express 6-lyase, an 'in vitro’ system 
was prepared by stably incorporating the cDNAs into the genome of the pig kidney 
epithelial cell line, LLC-PKl. The cell line LLC-PKl, is derived from the proximal 
tubules of a Hampshire pig’s kidney, and possesses transport systems which allow the
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uptake of cysteine conjugates. The creation of stable cell lines expressing varying levels 
of both rat or human cysteine conjugate 6-lyase allowed further characterisation of 
these enzymes, together with providing a plentiful supply of enzyme in the form of a 
cytosolic extract. The aim of this project was to use both rat and human 6-lyase 
enzymes derived from both transient and stable expression of the cognate cDNAs to 
study the effect of cysteine conjugate structure on enzyme function, and to characterise 
the enzymes with a panel of cysteine conjugates. The cytotoxicity of those same 
cysteine conjugates would also be assessed in the stable pig kidney cell lines.
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CHAPTER 2 
METHODS AND MATERIALS
2.1 INTRODUCTION
All experimental procedures used throughout this investigation are described in detail 
within this chapter. Procedures which are common to more than one protocol are 
described in the section entitled general methods (2.3).
2.2 MATERIALS
Where enzymes and kits are used, the suppliers are given in the appropriate methods 
section, so too are the suppliers of commercially available reagents and equipment.
2.2.1 Chemicals
All Chemicals are of the highest standard and unless stated otherwise, were purchased 
from Sigma Chemical Company. All cysteine conjugates used were a gift from Dr. 
Commandeur, with the exception of TFEC which was kindly donated by Dr. E. Lock.
Agarose, trypsin/BDTA, tissue culture media, anti-PPLO, gentamycin, Australian 
foetal calf serum : Gibco BRL
5-Bromo-4-chloro-3-indoyl-B-D-galactosidase (X-gal), IPTG, biophenol, biophenol: 
chloroform : Cat Biochem.
Agar N° 1, bacto tryptone, PBS (Dulbecco ‘A’), yeast extract: Oxoid Ltd.
Easigel (6% (w/v) acrylamide, 0,3% (w/v) bis acrylamide, 7M urea, IxTBE): Scotlah. 
HPLC grade methanol, glacial acetic acid, concentrated HCl, decon 90 : Fisons.
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Hypersolve HPLC grade water, Na2HP04, NaH2P04, NaOH, potassium sodium 
tartrate, Na2C03, CU2SO4.5H2O: BDH Chemicals Ltd.
2.2.2 Radiochemicals
All procedures involving the use of radiochemicals were carried out according to the 
guidelines stipulated in ‘ Local Rules for Protection Against Ionising Radiation’, 
published by the University of Surrey Safety Office.
Deoxyadenosine 5’-[a^^S] thiotriphosphate, triethylammonium salt. Specific activity 
approximately 1000 Ci/mmol: ICN Flow.
Deoxycytidine 5’-[a^^P] triphosphate, triethylammonium salt. Specific activity 
approximately 3000Ci/mmol.; Amersham.
2.2.3 Plasmids
Plasmid pUSlOOO gift from Dr P. Sanders. A map of this plasmid can be found in 
figure 2.1.
Plasmid pCR ™II, Invitrogen. A map of this plasmid can be found in figure 2.2.
2.2.4 Bacterial Strains
The E.coli bacterial strains used for the propagation of plasmid vectors are shown in 
table 2.1
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Strains Use of Strain Genotype
JM109 Supports the replication of 
pUSlOOO
recKl supEAA endAl MR17(rk- 
,nik+) gyrA69 relAl thi A(lac- 
proAB)
\F\traD36,proAB lacI^lacT/x 
AM15]
XL Blue 
MRF’
Supports replication of pUSlOOO A (mcrA)183 A {mcr CQ-hsd SMR-
mrr ), Y73endAl, supEAd, thi-1, 
recAl, gyrA96, relAl, lac
[F’proAB,/acPZAM15TnlO (Tet^]
INVaP Supports replication of pCR ™II end A l y recAl, /wt?R17(r-k,ni+k). 
supEM, X-. thi-l, gytA, relAl,
(|)80 /4cZaiM15i(/acZYA-argF), 
deoR=F’
Table 2.1 - E.coli strains and their genotypes.
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EpUSlOOOH
AMP
B
Figure 2.1 - The expression vector pUS 1000 (Jackson et a/., 1992). HCMV.P-E = 
human cytomegalovirus promoter-enhancer element, AMP = ampicillin resistance, 
MCS = multiple cloning site, B = BamHl, E = EcoBl, H = Hindlll. The arrow 
indicates the direction of transcription
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Ml3 Reverse Primer
CAG GAA ACA GCT ATG AC
GTC CTT TGT CGA TAC TG G TAC TAA TOC GGT TOG A
Sp6 Promoter
0  ATG ATT AGG CCA AQC T AT TTA GGT G^C ACT ATA
TA AAT CCA CTG TGA TAT
GfiA
err
Nsil Hindlll Kpnl S a d  BamHI Spel
TAC TCA AGO TAT OCA TCA AGC TTG GTA CCG AQC TCG G \T  CCA CTA GTA ACG GCC 
ATG AGT TCG ATA CGTT AGT TCG AAC CAT GQC TCG AGC CTA GGT GfiJ CAT TGC CGG
BstXI EcoRI
GCC AGT GTG CTG GAA TTC GQC TT 
CGG TCA CAC GAC CTT AAG CCG
EcoRI EcoRV
|A  GCC GAA TTC TGC AG4. TAT 
IT T  CGG CTT AAG ACG TCT ATA
Aval
PaeR7l
BstXI Notl Xhol Nsil Xbal Apal
CCA TCA CAC TGG CGG CCG CTC GAG CAT CCA TCT AGA GGG CCC AAT TCG IcCC TAT 
GGT AGT GTG ACC GCC GQC GAG CTC GTA CGT AGA TCT CCC GGG TTA AGC GGG ATA
T7 Promoter
AGT GAG TCG TAT TA 
TCA CTC AGC ATA AT
CAAT TCA 
G TTA AGT
CTG GCC GTC GTT TTA C 
GAC CGG CAG CAA AAT G
AA CG 
TT GC
T CGT GAC TGG GAA AAC 
A GCA CTG ACC CTT TTG
pCR™ll
3.9 kb
V2.9-140302sa
Figure 2.2 - The plasmid vector pCR™II; restriction sites, primer sequences of the 
multiple cloning site and promoter sequences are indicated.
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2.2.5 Tissue Culture Cells
2.2.5.1 COS-1 Ceils
COS-1 African green monkey kidney cells were used to support the transient 
expression of rat and human B-lyase cDNAs cloned into the expression vector 
pus1000 (Jackson et al., 1992). COS-1 cells originate from the cell line CV-1, an 
established line of simian cells which allow lytic growth of SV40. Gluzman (1981) 
transformed CV-1 cells using an origin-defective mutant of SV-40 which codes for a 
wild type T antigen. The resultant COS-1 cell line contains a single integrated copy of 
the complete early region of SV40 DNA allowing them to replicate plasmids which 
contain an SV40 ori.
2.2.5.2 LLC-PKl Cells
LLC-PKl cells are an epithelial cell line developed from pig kidney which display 
predominantly proximal tubule functions (Boogaard et a l, 1990). This cell line was 
used to support the stable incorporation of human and rat 6-lyase cDNAs cloned into 
the expression vector pUSlOOO.
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2.3 GENERAL METHODS
2.3.1 Sterilisation by Autoclaving
Glassware, plasticware and all solutions prepared for use with nucleic acids were 
sterilised in an RSI series 32 automatic autoclave. Items were sterilised for 20mins at
1 2 rc  at a pressure of 15 Ib/in^. DEPC treated water (0.1% (v/v)) was left overnight 
to destroy any nucleases present before being autoclaved.
2.3.2 Quantitation of Nucleic Acids in Solution
The purity and concentration of nucleic acids in aqueous solutions were determined 
by measuring the UV absorbance of the solutions over a wavelength range of 200- 
BOOnm. All samples were blanked against water and the concentrations were 
calculated using the following formulae (Sambrook e ta l, 1989):
Nucleic acid concentration (pig/pil) = A x D x E
1000
where A = Absorbance at 260nm 
D = Dilution Factor
E = Molar Extinction Coefficient ( at 26Qnm)
Where an absorbance of 1.0 is equivalent to a DNA concentration of 50pg/ml 
an absorbance of 1.0 is equivaent to an RNA concentration of 40//g/ml 
and an absorbance of 1.0 is equivalent to an oligonucleotide concentration of 20//l/ml.
Nucleic acid concentration (pmol//d) = A x D x 33000
number of nucleotides x 330
where A = Absorbance at 260nm 
D = Dilution Factor 
and 330 = the average molecular weight of a nucleotide
Nucleic acid purity (A260/A280) = 1.8 for pure DNA
2.0 for pure RNA
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2.3.3 Restriction Enzyme Digests
Type II restriction enzymes are endonucleases which have been isolated from many 
different types of bacteria. They have the ability to recognise specific palindromic 
DNA sequences which are generally 4 to 6 nucleotides in length and cut the DNA 
between two specific bases within the target sequence. Since different enzymes have 
different optimal salt concentrations in which they function, these enzymes are 
supplied with specific buffers.
Unless stated otherwise, restriction enzyme digests were carried out as follows:
l//g of DNA was digested in a microcentrifuge tube, using 1]A of enzyme in a total 
volume of not less than lOx the volume of enzyme used. An appropriate volume of 
lOx enzyme reaction buffer was included in the reaction mixture and the total volume 
was made up by the addition of distilled water. After an incubation of at least 90min, 
preferably overnight, at 37°C, the sample was analysed on a 1% agarose gel (see 
section 2.3.4)
A typical reaction mixture: H2O 18/d
lOx Buffer 2.5jA
DNA (l/<g//<l) IjÂ
Enzyme IjA
Total volume 25pi\
All enzymes used in this investigation are listed in table 2.2.
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2.3.4 Agarose Gel Electrophoresis.
Agarose gel electrophoresis is a procedure whereby samples of DNA and RNA may 
be analysed. With the incorporation of molecular weight markers both the 
concentration and size of nucleic acids may be estimated. This technique involves 
loading the nucleic acid samples into wells in an agarose gel, the negatively charged 
nucleic acid molecules will then move toward the anode (positive) electrode when an 
electric current is passed through the gel. Samples will then separate according to 
size along the gel since smaller molecular weight samples move more easily through 
the gel, whilst larger molecules are retarded.
2.3.4.1 DNA Gel Electrophoresis
Agarose gel electrophoresis of DNA was carried out as described by Sambrook et ah, 
(1989). The percentage of agarose used in each gel was dependent on the size of 
DNA to be separated. Generally, agarose gels of between 0.8 - 1.5% (w/v) were 
prepared in TAE buffer. In general, a 1% gel will enable the resolution of of DNA 
fragments of up to 8kb in size. The appropriate DNA markers were run alongside the
samples in order to estimate the molecular size of the sample. XHind III / Eco RI
phage DNA fragments were used to size samples between 500bp and 6kb in length. 
To each sample 3jA of loading dye (over O.lx the sample volume) was added (see
appendix for recipe) and the samples heated to 65°C for 4min prior to loading.
Heating samples before electrophoresis helps denature any tertiary structure present 
or aggregations. Gels were then run at 150mA at room temperature until the 
bromophenol blue running dye had travelled three quarters of the way down the gel. 
DNA samples were then visualised as in section 2.3.5.
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Enzyme Recognition Site ^Buffer Supplier
Eco RI G'^ATTC H Promega
Ap(Â GGG^CCC R4 Gibco BRL
Drol TTT'^AAA B Promega
Nael GCC'^GGC A Promega
Nsi I ATGCA'^T D Promega
Kpnl GGTAC'^C J Promega
Spel A^CTAGT M Amersham
Xbal T'^CTAGA D Promega
Stul AGG'^CCT M Amersham
Table 2.2 - A table of the restriction enzymes used in this investigation, the 
recognition site and the reaction buffers for optimum digestion. Arrows indicate 
cutting site. * see appendix for buffer concentrations.
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2.3.4 2 RNA Gel Electrophoresis
RNA was electrophoresed in formaldehyde denaturing gels as described by Sambrook 
et. al., (1989). 10ml of lOx MOPS buffer and 75ml DEPC-treated water were added
to Ig agarose and the mixture heated until the agarose dissolved. On cooling to 50°C,
5.4ml formaldehyde (37% v/v) was added, together with 10//1 of a lOmg/ml solution 
of ethidium bromide, the solution was mixed and the gel poured to a final 
concentration of 1% (w/v) agarose. 20pg RNA sample was diluted with 15]a\ RNA 
loading buffer which contained 720/<l formamide, 160ja\ lOx RNA electrophoresis 
buffer, 37% (v/v) formaldehyde, 180/d DEPC-treated water, 100/d 80% gycerol and 
80/d bromophenol blue. The resulting mixture was then denatured by boiling in a 
boiling water bath for 2min and cooling on ice before loading onto the gel. The gel 
was run at room temperature at 100mA until the bromophenol blue marker had 
travelled approximately three quarters down the gel. The RNA was visualised as 
described in section 2.3.5.
2.3.5 Visualisation of Nucleic Acids in Agarose Gels
Nucleic acids may be visualised in agarose gels by using the routinely used dye, 
ethidium bromide. The ethidium bromide intercalates into the nucleic acid molecules 
and upon exposure to UV light, absorbs the UV radiation at 300nm and re-emits it at 
590nm in the red/orange region of the visible spectrum. Nucleic acids can be seen as 
brightly stained orange/pink bands on the gel. Agarose gels containing nucleic acids 
were immersed in 3//g/ml ethidium bromide solution in TAE buffer for approximately 
lOmin with shaking. Excess ethidium bromide was removed by washing the gels in 
distilled water for lOmin or longer if necessary. The nucleic acids were then 
visualised on a transilluminator (model TM20, Genetic Research Instrumentation 
Ltd).
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2.3.6 Photography
Ethidium bromide stained agarose gels were photographed through an orange filter 
using a Polaroid Land Speed MP-4 camera and Polaroid type 667 (positive only film). 
The film was exposed for 13sec with an apperture of f4.5.
2.3.7 Recovery of DNA from Agarose Gels
After electrophoresis of DNA samples on an agarose gel (section 2.3.4.1), the bands 
of interest were excised from the gel using a sterile scalpel and purified using one of 
the two methods outlined below: Two extraction methods were used, as the first did 
not give consistant results and often lead to difficulties when the isolated DNA was 
used for cloning.
2.3.7.1 Genenclean Method of Gel Extraction
The Geneelean II® kit (Stratech Scientific) is based on the iodide/glass bead method
of Vogelstein and Gillespie (1979) and is effective for the purification of small 
samples of DNA from agarose gels. It may be used to purify samples from lOObp up 
to lOkb in size.
The bands excised from the agarose gels were placed in a Greiner tube 
(polycarbonate) and 3 volumes of Nal were added . The agarose was then melted in a
55°C waterbath with occasional mixing. For each pg of DNA in the gel, 1/d of glass
milk® (silica matrix) was added (minimum 5/d) and the mixture incubated on ice for
15min, shaking every 1 - 2min. The mixture was then transferred to microcentrifuge 
tubes and centrifuged for lOsec at 13000g. On removal of the supematent, the pellet 
was washed with lOOpil of ice cold NEW wash solution and recentiifuged. After two 
further washes, 10/d of sterile Milli Q water was added to the pellet and heated to
55°C for 3min in order to elute the DNA from the matrix. The tube was centrifuged
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for lOsec at 13000g and the supernatant transferred to a fresh microcentrifuge tube. A 
further 10/d of sterile Milli Q water was added to the pellet to elute any remaining 
DNA left in the matrix. 2/d of the eluent was then run on a 1% agarose gel in order to 
determine the concentration and purity of the DNA fragment.
2.3.T.2 BIO-Rad Prep-a-Gene Method of Gel Extraction.
The DNA excised from the gel was placed in a Greiner tube and 3 volumes of
purification buffer was added, the mixture was then heated at 55°C until the gel
melted. 5/d of prep-agene matrix per pig of DNA was then added and the sample 
vortexed briefly before being incubated at room temperature for lOmin with gentle 
shaking. The mixture was transferred to microcentrifuge tubes and centrifuged for 
20secs at lOOOOg. The supernatant was removed and the resultant pellet resuspended 
in purification buffer 925x the volume of matrix added) and centrfuged for 20sec at 
lOOOOg. The supernatant was removed and the pellet resuspended in wash buffer (25x 
the volume of matrix added) and centrifuged for 20sec at lOOOOg. The wash step was 
repeated once more before the DNA was eluted by the addition of an equivalent pellet 
volume of elution buffer. The resuspended DNA was then incubated at 50 ®C for 5min 
and centrifuged for 30secs at lOOOOg to elute the DNA from the matrix. The 
supematent was transferred to a fresh microcentrifuge tube and a further volume of 
elution bufer was added to the pellet in order to elute any further DNA remaining in 
the matrix. 2pi\ of the eluent was then electrophoresed on a 1% agarose gel to assess 
its purity and concentration.
2.3.8 Ethanol Precipitation of Nucleic Acids
In order to purify or concentrate DNA for subsequent manipulation, DNA was 
precipitated from aqueous solution. 0.5 Volumes of 7.5M ammonium acetate was 
added to the aqueous DNA solution and mixed briefly before 2 volumes of ice cold
95
(-20 °C) absolute ethanol (96.8% (v/v)) was added. The mixture was then incubated at
-70°C for 30min to precipitate the DNA and centrifuged for 20min at lOOOOg in a 
microfuge. The supernatant was removed immediately and the pellet washed in 70% 
(v/v) ethanol to dissolve any remaining salt and centrifuged as above. The resultant 
pellet was then dried at 37°C before being reconstituted in an appropriate volume of 
sterile water.
2.3.9 Autoradiography
Autoradiography was carried out using Kodak X-Omat AR high speed X-ray film.
For auto radiography of sequencing gels, the film was placed over the dried gel in 
a film cassette (X-ray Accessories Ltd) and exposed for 1-2 days at room temperature.
For autoradiography using the radiolabelled membrane was placed between two 
pieces of thin plastic and placed inside a film cassette with an intensifying screen 
(Croner Lightening Plus intensifying screen). The film was exposed for up to 2 weeks 
at -70°C. After exposure, the films were developed, fixed and washed in an automatic 
film processor (Fuji medical film processor RGII). The chemicals used were RG 
developer and RG fixer supplied by Wardray Products Ltd.
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2.4 POLYMERASE CHAIN REACTION: BASIC
PROCEDURES
2.4.1. Preparation of Oligonucleotide Primers
Oligonucleotides were synthesized on an Applied Biosystems Oligonucleotide 
Synthesizer (Applied Biosystems, California, U.S.A.) by Mrs. S. Wall at the 
University of Surrey. To remove the oligonucleotides from the solid phase support, 
1.5ml of fresh cold ammonia solution ( specific gravity 0.88, BDH AnalaR ) was 
passed through the column at a rate of 0.5 ml every 20 mins at room temperature. 
Once all the ammonia had been passed through the column, it was then passed 
backwards and forwards through the column several times using two 2ml Luer fitting 
syringes. This procedure helps liberate the oligonucleotides and removes the 
cyanoethyl groups which were protecting the phosphates. The solution was then 
transferred to a Reacti-vial with a gas tight screw cap which was placed in a glass
universal containing approximately 15ml of water and incubated overnight at 55°C. 
The reason for this is to remove the benzoyl and isobutyl groups present on the 
exocyclic amines of A and C (benzoyl) and G (isobutyl) during synthesis in order to 
prevent side reactions from taking place. The vial was cooled to room temperature, 
ethanol precipitated ( section 2.3.8) and dried before being reconstituted in an 
appropriate volume of sterile Milli Q water.
2.4.2 DNA Amplification
Samples of human and rat 6-lyase were amplified using the polymerase chain 
reaction. Each reaction mixture contained lO-lOOng of template DNA, lOOpmol of 
each oligonucleotide primer and 0.4 nmol of each dNTP contained in a PCR buffer of 
final concentration of lOmM Tris-HCl (pH 8.3 ), 50mM KCl and 2.5mM MgCl2. The
reaction mixtures were made up to a final volume of 50 pi with DEPC-treated water .
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A drop of mineral oil was placed over the mixture to minimize evaporation and the 
tube was then placed in a Hybaid programmable thermal reactor ( Hybaid Ltd,
Middlesex). After an initial denaturing period at 94°C for 5min, 2.5units of Taq DNA 
polymerase (Promega Ltd., Southampton) was added to the sample and the samples
subjected to 35 cycles of PCR. When the reaction was complete, 10pi of the product 
was kept for analysis on a 1% (w/v) agarose gel and the remainder stored at -20°C.
2.4.3 Isolation of a cDNA Coding for Human Cysteine
Conjugate B-Lyase
This work was performed with Mrs. S. Hill, as part of my training in molecular 
biology. My main involvement was to perform several of the PCR reactions and 
screen the colonies which resulted from cloning the PCR fragments into the TA
Cloning® vector.
2.4.3.1 5' Race Amplification of Human B-lyase cDNA.
The 5'-rapid amplification of cDNA ends (5'-RACE) was carried out using 5-RACE- 
ready cDNA (Clontech Laboratories Inc., USA). The initial PCR reaction was carried 
out using a 3' oligonucleotide primer specific to the cDNA and the 5' anchor primer 
provided with the kit. After 30 rounds of amplification following the procedure 
recommended by the manufacturer, a sample was removed and used in a second 
round of PCR amplification using a nested 3' oligonucleotide primer specific to the 
cDNA and the anchor primer provided with the kit. The PCR products were analysed 
by agarose gel electrophoresis (1% agarose gel) and subcloned into the TA Cloning® 
Vector, pCR™ II (Invitrogen, R & D Systems Europe Ltd, Abingdon ; Section 2.12).
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2.4 3.2 Reverse Transcriptase- Polymerase Chain Reaction Amplification
of Human B-lyase.
Total RNA was extracted from human kidney tissue samples using RNAzol™ B 
(Biogenesis Ltd, Poole) following the protocol recommended by the manufacturer. 
First strand cDNA synthesis was completed using reverse transcriptase (Life 
Technologies, Paisley, UK) as per the manufacturers instructions and a 3' 
oligonucleotide primer specific to the cDNA . The first strand product was then 
further amplified using a nested 3' oligonucleotide primer and a 5' oligonucleotide 
primer both specific to the gene .
2.4.4 Isolation of a Rat 15-Lyase cDNA Lacking the 5 '-Non- 
Coding Region
It was found that the 5' non-coding region of the original rat cDNA for 6-lyase 
contained an inverted repeat sequence which may form a secondary structure and 
interfere with the translation of the mRNA. Therefore it was decided to remove the 5' 
end of the rat clone, producing a truncated version which started at the first ATG 
codon of the 6-lyase sequence. This was achieved by cutting the original rat cDNA 
insert out of the expression vector pUS 1000 with restriction enzymes and using this 
fragment in a PCR reaction to obtain a final fragment which started at the first 
methionine codon and was the same length as the human 6-lyase cDNA.
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2.5 SUBCLONING OF PCR PRODUCTS USING THE TA
CLONING™ SYSTEM
The TA cloning™ system was produced by Invitrogen corporation (California, USA) 
and provides a quick, one-step cloning system which allows the direct insertion of a 
PCR product into a plasmid vector. The thermostable polymerase used in PCR adds a 
single deoxyadenosine to the 3' end of all duplex molecules. The vector used in the 
system takes advantage of this being linear and having a single 3' T overhang at the 
insertion site. Thus, this system allows simple cloning without the need for enzyme 
modification of the PCR product.
2.5.1 Ligation of PCR Product into the TA Cloning™ Vector
Purified PCR fragments were used in ligations set up as 1:1 and 1:3 molar ratio of 
vector to PCR product. The molar ratios were calculated as follows:
X ng of cDNA insert = No of bp of cDNA x ng of vector
No of bp of vector
Appropriate amounts of vector and PCR product were incubated together with lOx 
ligation buffer and T4 DNA ligase at 14°C overnight.
2.5.2 Transformation of Competent One Shot™ Cells
The competent cells used in this system are known as Oneshot competent cells, 
namely INVoF' cells. These cells are a strain of E.coli which provide stable 
replication of high copy number plasmids. INVoF' allows blue/white screening of 
recombinant plasmids by «-complementation of 6-galactosidase with the lacZÆMlS 
genotype.
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Each ligation reaction was transformed into a 50/d vial of competent cells. Competent 
cells were thawed slowly on ice, 2/d of 0.5M 6-mercaptoethanol was added to each 
vial and mixed gently. 1/d of ligation mixture was added to the competent cells, 
mixed gently and placed on ice for 30min. The vials were incubated at 42°C for 60sec 
in a water bath and chilled for a further 2min on ice to facilitate the bacteria to take up 
the plasmid. 450/d of SOC media, (a rich growth medium) was added to the vials 
which were then shaken at 37“C for Ihr at 225rpm in an orbital shaker incubator. 
25/d and lOOjA Of each transformation were spread on separate LB agar plates 
containing 50//g/ml ampicillin and 40/<g/ml X-Gal. The plates were incubated for 
24hrs at 37°C to allow the blue colour of the background colonies to develop.
2.5.3 Selection of Transformants
The TA vector (see figure 2.2) contains a short segment of E. coli DNA that contains 
the regulatory sequences and coding information for the first 146 amino acids of the 
6-galactosidase gene {Lac Z  ). Within this region is a multiple cloning site that does 
not disrupt the reading frame but results in the harmless interpolation of a small 
number of amino acids into the amino terminal fragment of 6-galactosidase. Neither 
the host nor plasmid encoded 6-galactosidase polypeptides are active themselves, but 
they can associate to form an enzymatically active protein after transfection. This
process is known as «-complementation. The resulting Lac + bacteria are recognised 
by their ability to form blue colonies in the presence of X-gal (5-bromo-4-chloro-3 - 
indolyl-6-D-galactoside). Insertion of foreign DNA into the multiple cloning site of 
the vector prevents «-complementation hence, bacteria carrying recombinant 
plasmids form white colonies.
Potential positive colonies detected as white colonies were selected, together with a 
few blue colonies as negative controls and replated on a separate ampicillin/X-Gal 
plate (Section 2.9.1). White colonies were picked for plasmid isolation.
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2.6 SUBCLONING OF cDNA FRAGMENTS INTO
PLASMID VECTORS
2.6.1 Dephosphorylation of Linearised Vectors
Where the plasmid was digested with a single restriction enzyme and could therefore 
religate to itself, it was necessary to dephosphorylate it. The linear plasmid was 
treated with calf intestinal alkaline phosphatase (CIAP; Promega) as follows:
CIAP lOx Buffer 10/d
CIAP O.Olu/pmol ends (2/<g of 5kb plasmid = 1.4pmoI ends)
Final Volume 100/d
The mixture was incubated at 37°C for Ihr, in order to inactivate the CIAP, the 
mixture was then heat inactivated at 85°C for 15min.
2.6.2 Ligation of cDNA into Plasmid
Ligation reactions were set up as 1:1 and 1:3 molar ratios of plasmid to cDNA insert. 
The restriction digested plasmid (lOOng) and the appropriate cDNA fragment 
(100ng//d) were incubated together with 5x ligation buffer, T4 DNA ligase (lu) and 
sterile Milli Q water (final volume \Q]A) at 14“C for at least 16hr.
Control ligations were also set up:
Control 1. No vector, insert or ligase - to confirm that the ampicillin was
working, E. coli will not grow on ampicillin plates since they are 
sensitive to it
Control 2. Uncut vector, no insert or ligase - to confirm that 6-galactosidase
activity is present as lac z gene will not be disrupted in uncut plasmid, 
therefore all colonies will be blue
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Control 3. Linearised vector, no insert or ligase - to confirm that the
dephosphorylation was successful, a few blue colonies may be present 
Control 4. Linearised vector and ligase - to confirm that the ligase is functional;
all colonies should be blue.
2.6.3 Transformation of Competent E, coli Cells
E. coli cells were prepared for transformation using the method of Cohen et al., 
(1972). Bacteria are treated with ice cold solutions of CaCl2 inducing a state of 
'competence' during which they can take up plasmid DNA.
2.6.3.1 Preparation of Competent Cells.
Glycerol stocks of the E. coli strains JM109 and XL Blue MRP (Promega) were used 
to inoculate 10ml of LB medium and incubated overnight at 37°C in an orbital shaker 
(225rpm). 0.5ml of the overnight culture was then used to inoculate a 30ml culture 
and incubated at 37°C in an orbital shaker until the culture reached an A^oo of 
between 0.5 - 0.6 (approximately 2hrs). The cells were placed on ice for 20min before 
being centrifuged at 3500rpm for 5min in a benchtop centrifuge. The supernatant was 
carefully disgarded and the cell pellet resuspended in 15ml of ice cold O.IM CaCl2.
The cells were recentrifuged and the resulting pellet resuspended in 1/20 the volume 
of the original culture (30ml) of ice cold CaCl2 and left on ice for at least 30min. The 
cells are now competent and should remain so for several hours.
2.6.3 2 Transformation of Competent Cells Using DMSO and Heat Shock.
200/d aliquots of competent cells were used for each ligation reaction. To each 
aliquot of competent cells, 3/d of DMSO was added together with 5/d of the ligation 
reaction mixture and incubated on ice for 30min. The cells were incubated at 42°C for 
2min and returned to ice for a further 30min. This heat shock procedure enables the 
bacteria to take up the DNA. 200/<l of LB medium was added to the cells which were
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then incubated at 37°C for 60min in an orbital shaker. The transformations were 
spread on LB agar plates which contained 50//g/ml ampicillin.
For vectors which contained the 6-galactosidase gene, 40//g/ml of X-Gal and 0.5mM 
IPTG was also included. The plates were incubated for at least 24hr at 37°C to allow 
the colonies to develop, and positive colonies could then be recultured on fresh agar 
plates in order to obtain enough material for the cracking procedure (section 2.6.4).
2.6.4 Cracking Procedure
The cracking procedure provides a quick method for screening multiple transformed 
colonies for the presence of plasmid containing a DNA insert. Although it is possible 
to use vectors which have selectable markers, usually upto 10% of the colonies 
formed are 'false positives', therefore the cracking procedure provides an inexpensive 
and rapid method for identifying these.
Single positive colonies were picked from the LB agar plate and placed in a 
microcentrifuge tube containing 50/d of lOmM EDTA (pHS.O) and 50/d of fresh 2x 
cracking buffer. Colonies were resuspended by briefly vortexing the samples before 
being incubated at 70°C for 15min to lyse the bacteria and release the plasmids. The 
samples were allowed to cool to room temperature slowly before l.Spil of 4M KCl 
was added in order to precipitate the proteins. 1/d of loading dye was added to the 
samples, which were vortexed and incubated on ice for 5min. After a centrifugation 
of 13000rpm in a microcentrifuge at 4°C, 50/d of each sample was electrophoresed 
on a 1% (w/v) agarose gel alongside a control which contained plasmid with no 
insert. Plasmids which contained DNA insert were seen to be retarded on the agarose 
gel compared to those which contained insert.
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2.6.5 Plasmid Preparation.
2.6.5.1 Promega Wizard ™ Mini Preparation
lOOjil of plasmid glycerol stock or a single colony from an agar plate was placed in
5ml L.B. Broth together with ampicillin (50pg/ml (w/v) ) and incubated overnight in a 
shaking incubator at 37°C. 3ml of the above culture was then used to isolate the 
plasmid DNA using the Wizard™ mini-prep kit (Promega Ltd, Southampton) as per 
the manufacturer's instructions. The kit depends on the binding of DNA to a 
positively charged silica-based resin which features a rapid rehydration, allowing 
quick release of DNA.
2.6.5 2 Promega Wizard™ Maxi Preparation
A 5ml culture was prepared (section 2.6.5.2) and transferred to a larger flask 
containing 500ml L.B. Broth and 50^ig/ml ampicillin. The culture was then incubated 
overnight at 37°C in a shaking incubator. The plasmid was purified using a Wizard™ 
maxi-prep kit (Promega Ltd., Southampton) following the protocol recommended by 
the manufacturer.
2.6.6 Preparation of Glycerol Stocks
Transformed bacteria may be kept at -70“C for many years. A 10ml bacterial culture 
in LB medium containing 50/<g/ml ampicillin was prepared. 850/d of bacterial culture 
was added to ISOpil of sterile glycerol in a sterile microeentrifuge tube. The tube was 
briefly vortexed to mix and then stored at -70°C. To prepare a culture from glycerol 
stocks involved either a) addition of lOjA of glycerol stock to 10ml of LB medium 
containing 50//g/ml ampicillin which was then incubated overnight at 37°C in an 
orbital shaker, or b) addition of 10/d of glycerol stock to an LB agar plate containing 
50//g/ml ampicillin which was then incubated overnight at 37°C.
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2.7 DNA SEQUENCING IN PLASMID VECTORS
cDNA inserts were sequenced in plasmid vectors using either the Sequenase® version 
2.0 DNA sequencing kit (Amersham Life Science, Bucks; manual) which is based on 
a modification of the dideoxy chain termination sequencing procedure of Sanger et. 
at, (1977) or the PRISM™ ready reaction DyeDeoxy™ terminator cycle sequencing 
kit (Perkin Elmer; automated) with an ABI Model 373A DNA Sequencer. The 
PRISM™ cycle sequencing kit relies on four dye-labelled dideoxynucleotides: A,C,G 
and T DyeDeoxy terminators. The terminators incorporate a dye label and a 
terminating base into the DNA when used in an enzymatic sequencing reaction and 
eliminates labelled false stops.
2.7.1 Sequencing Gel Electrophoresis Apparatus
The apparatus for manual sequencing of DNA was manufactured at the University of 
Surrey, in the School of Biological Sciences workshop. It consisted of two glass 
plates 58x20x0.5cm in size, between whieh the polyacrylamide gel was poured. The 
glass plates were placed vertically between higher and lower buffer reservoirs which 
contained the negative and positive electrodes respectively. The top of the back glass 
plate had a trough cut out which allowed the samples to be loaded into the gel as well 
as allowing the buffer reservoir to flow through the gel.
Before use the plates were scrubbed with Decon 90 (Fisons) to remove any residues, 
followed by water, acetone and finally absolute ethanol. Prior to cleaning, the plates 
were coated with dimethyl-dichlorosilane, to facilitate removal of the gel after 
electrophoresis and the plates were re-siliconised after every six electrophoresis runs. 
Wedge spacers (0.4mm thick) and combs were also cleaned with water and ethanol, 
prior to use. Spacers were put at the edge of either side of the plates and the plates
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taped together using sequencing grade tape (Genetic Research Instruementation Ltd). 
The plates were held together tightly using bulldog clips whilst the gel was poured.
2.7.2 Preparation of Sequencing Gels
Sequncing gels were cast using a 6% (w/v) polyacrylamide solution purchased from 
Scotlab, which contained 7M urea and IxTBE. Polymerisation of 75ml of 
polyacrylamide gel was initiated by the addition of 75/d of TEMED and 420/d of 
10% (w/v) ammonium persulphate (fresh). The solution was mixed on ice and drawn 
into a pre-chilled syringe before being poured between the glass plates of the 
sequencing apparatus, held at a 45° angle. The flat side of a sharks tooth comb was 
inserted into the gel approximately 5mm from the top of the back plate and held in 
place with a bulldog clip. The gel was then left to polymerise at room temperature for 
30min after which the top end of the gel was covered with moist tissue, wrapped in 
cling film and stored at 4°C for up to 3 days.
2.7.3 Preparation of Single Stranded Template DNA
In order for the DNA to be sequenced it first had to be denatured to provide a single 
stranded template for the T7 DNA polymerase to copy. 5/<g of DNA was diluted to a 
final volume of 16/d with sterile Milli Q water, to this 2/d of 2M NaOH and 2//1 of 
2mM EDTA were added and the mixture incubated at room temperature for 5min 
allowing the DNA to denature. The sample was neutralised by the addition of 2/d of 
2M ammonium acetate (pH 4.6). Denatured DNA was precipitated by the addition of 
60jwl Of ice cold absolute ethanol and incubated at -70° C for 20min. The sample was 
then centrifuged at 14,000g for 30min at 4°C, the supematent carefully removed and 
the denatured DNA pellet washed with SOpl of 70% (v/v) ethanol to remove salt 
residues and dried.
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2.7.4 Annealing of Primers
Denatured DNA was reconstituted in 7jÂ of sterile Milli Q water to which 2jA of 
sequencing buffer was added. 1//1 of the appropriate oligonucleotide primer 
(10|<g/ml) was added and the mixture heated to 65“C for 4min in a plastic container in 
a 65°C waterbath. The container was removed form the waterbath and allowed to 
cool slowly to below 37°C ensuring specific annealing of the primers. Once below 
37°C the samples were then placed on ice.
2.7.5 Labelling Reaction (Primer Extension)
The oligonucleotide primer was extended in the presence of limiting concentrations
of deoxyribonucleotide triphosphates (dNTPs) and dATP. To the above
mixture, 1/d of O.IM DTT, 2/d of diluted labelling mix (7.5/^M dTTP, dCTP, and
dGTP) and 0.5/d of dATP (0.185Mbq) were added. The reaction was initiated 
by the addition of 2//1 (3.25U) of diluted Sequenase™ enzyme to the above mixture, 
which was incubated at room temperature for 5min. 3.5/d of the labelling reaction 
mixture was removed and placed into each of 4 pre-prepared tubes, containing 2.5//1 
of dideoxynucleotide triphosphates, ddATP, ddCTP, ddGTP and ddTTP at 37°C. 
Elongation was terminated when one of the ddNTPs was incorporated into the 
sequence as the ddNTP has no free 3' OH group for the next nucleotide to bind to. 
There will be a polymer terminated at each of the nucleotide positions in the template, 
therefore the termination mixtures will contain a whole set of DNA fragments, each 
one base longer than the next. The four termination reactions were then run alongside 
one another on a polyacrylamide gel, as they separate according to size it is then 
possible to determine the nucleotide sequence of the template DNA. Any remaining 
elongation that has not been terminated by the addition of the ddNTPs will be 
terminated by the addition of 4/d of stop solution, which contains two loading dyes; 
xylene-cyanol and bromophenol blue. The two dyes migrate at different rates through
108
the gel and can be used as a guide for the running times of long (7hr) and short (3hr) 
gels.
2.7.6 Running a Sequencing Gel
The tape was removed from the bottom of the sequencing gels and the gel, contained 
between the two glass plates, was placed vertically in the sequencing apparatus. The 
top and bottom buffer reservoirs were filled wth Ix TBE buffer and the comb 
removed from the gel. The well formed by the comb was then washed out with buffer 
and the comb reinserted so that the teeth just entered the gel. A metal plate was 
attached to the back plate of glass to ensure even distribution of heat through the gel. 
The gel was then pre-run at 50W in order to heat the gel to 45-55°C. The samples 
were also heated to 75°C for 4min and 3/d of each samples was loaded onto the gel. 
The samples were electrophoresed at 50W for either 3hr (short gel) or 7hr (long gel), 
occasionally samples were run for 9-12hrs.
2.7.7 Fixing and Processing of Sequencing Gels
Once the gel had run, the apparatus was dismantled and one of the glass plates was 
gently removed leaving the gel attached to the remaining glass plate. The plate with 
the gel attached was carefully submerged in a 10% (v/v) acetic acid, 10% (v/v) 
methanol solution for 20min to fix the gel. The gel was then washed in water for 
20min to remove any of the fix solution and leach out any urea which interferes with 
the autoradiography. The gel was removed from the water and a piece of wetted 3MM 
paper was carefully placed on top of it. Two further sheets of dry 3MM paper were 
then placed on top of the wet sheet and light pressure was applied across the gel to 
absorb excess water. The gel sandwiched between the glass plate and the 3MM paper 
was turned over and the glass plate was carefully removed so that the gel remained
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attached to the wet 3MM paper. The gel was dried on a vacuum dryer at 80°C for 
45min and autoradiographed for between 48-72hr.
2.7.8 Preparation of DNA for use With the Automated
Sequencer
Ipig of double stranded DNA (0.25//g//<l) was mixed with 3.2pmol of the appropriate 
primer (0.8pmol//d) in a final volume of 12/d and sequenced on an ABI Model 373A 
automated sequencer. The DNA was sequenced using the PRISM™ Ready Reaction 
Dye Deoxy™ terminator cycle sequencing kit which involved mixing the template 
DNA (1/fg), primer (3.2pmol) and the terminator premix in a total volume of 20jâ 
and subjecting the mixture to a series of cycling reactions in a Perkin-Elmer Model 
480 thermal cycler. The mixture in 0.6ml microcentrifuge tubes was pre-heated to 
96°C and cycled as follows:
96“C for 30sec, 50°C for 15sec followed by 60°C for 4min.
This was carried out for 25 cycles with rapid ramping between each temperature. The 
extension products were then purified using spin columns to remove the excess 
DyeDeoxy terminators. 5/d of deionized formamide and 1/d of 50mM EDTA were 
mixed together and 4/d of the mixture was added to each extension tube and mixed 
vigorously.
The samples were briefly centrifuged to collect the mixture in the bottom of the tube, 
denatured at 90“C for 2min and placed immediately on ice. The samples were then 
ready to load onto an ABI automated sequencer.
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2.7.9 Analysis of DNA Sequences
Manual sequence data were read starting from the bottom of the gel (5-3'direction), 
using the sequence boy base reader (Integra Biosciences). The sequence information 
was then downloaded onto the Macintosh Genejockey DNA analysis program. This 
system can be used to compare two sequences, join two sequences together, look at 
different reading frames and translate reading frames into protein sequences.
2.7.10 Synthesis of Oligonucleotide Primers
Oligonucleotide primers used for sequencing were prepared as outlined in section 
2.4.1.
I l l
2.8 EXPRESSION OF B-LYASE cDNAS IN TISSUE
CULTURE CELLS
2.8.1 Cell Culture
2.8.1.1 c o s-1  Cells
COS-1 cells (African Green Monkey kidney, SV40 transformed, ECACC 
88031701) were purchased from the European Collection of Animal Cell Cultures 
(Porton Down) as a growing culture. The monolayers were grown in DMEM 
(minimal media; Life Technologies, Paisley) supplemented with 10% (v/v) fetal calf 
serum, 1% (v/v) gentamycin and 1% (v/v) anti-PPLO (Life Technologies, Paisley) in 
75cm^ tissue culture flasks. Cultures were incubated at 37°C with 5% CO2 and 
routinely passaged on reaching 95% confluence in order to prevent the formation of 
sincitia. Growth curves were obtained by seeding 1 x 10  ^cells and 2 x 10  ^ cells, into 
25cm^ tissue culture flasks (in duplicate) and counting the number of cells every 
24hrs.
Figure 2.3 shows an electron micrograph of COS-1 cells ( magnification x 5,250), 
they appear to possess few plasma membrane processes, with remnants of microvilli
present. Many intracellular organelles can be seen, such as mitochondria which are
very prominent, vacuoles and some endoplasmie reticulum. In general, the COS-1 
cells appear to be a larger cell than the other kidney derived cell line used in this 
thesis, LLC-PKl (see figure 2.4), with some giant cells being present (> 2 0 ]a).
2.8.1.2 LLC-PKl Cells
LLC-PKl cells are pig kidney cells isolated from the proximal tubule region. Again 
these cells were purchased from the European Collection of Animal Cell Cultures 
(Porton Down) and grown in medium 199 (Life Technologies, Paisley) at 37°C with 
5% CO2. Media was supplemented with 10% (v/v) fetal calf serum, 1% anti-PPLO
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and 1% (v/v) gentamycin (all Life Technologies, Paisley). Cultures were routinely 
passaged on reaching 95% confluence.
Figure 2.4 shows an electron micrograph of LLC-PK-1 cells (magnification x 5,250). 
LLC-PKl cells appear to have a larger number of plasma membrane processes which 
are distinctly polar, being located to one side of the cell. Several intracellular 
organelles are visible, such as the mitochondria, lysosomes and some endoplasmic 
reticulum.
2.8.2 Cell Subculture
Both cell types were sub-cultured in the same manner. The old growth media was 
removed by aspiration and the culture washed with 5ml of PBS. The PBS was 
aspirated and replaced with 2ml of trypsin/EDTA solution ( 0.125% trypsin in ImM 
EDTA). Trypsin is a protease and hence digests the protein attachments of the cells, 
whereas EDTA is a metal ion chelator which chelates all the positive metal ions in the 
solution causing the cells to repel each other, giving rise to the 'rounding up' of the 
cells. The cultures are incubated at 37°C, 5% CO2 for 5min to allow the 
trypsin/EDTA to function and the flasks were then tapped gently to loosen the cells. 
8ml of fresh tissue culture media was then added to the flask and mixed with the 
cell/trypsin/EDTA solution, inactivating the trypsin/ EDTA. The cells are then 
resuspended by pipetting up and down gently using a sterile 10ml pipette and seeded 
out into fresh flasks containing 25ml of growth media at a dilution of 1 in 5.
2.8.3 Cell Counting
Cells were counted using a Hawksley crisalite Neybauer haemocytometer. After 
trypsinisation the cells were resuspended in a total volume of 10ml of growth media 
and an aliquot of the cell suspension was placed on the haemocytometer allowing the 
number of cells /ml of growth media to be calculated.
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Figure 2.3 - An electron micrograph of COS-1 cells (magnification x 5,250)
Figure 2.4 - An electron micrograph of LLC-PKl cells (magnification x 5,250)
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2.8.4 Freezing Cells in Liquid Nitrogen for Long Term 
Storage.
Cells were trypsinised (section 2.8.2) and resuspended in a total volume of 10ml of 
growth media. The cell suspension was then centrifuged at 1500rpm for 5min in a 
benchtop centrifuge and the cell pellet resuspended in 1ml of growth media 
containing 20% (v/v) foetal calf serum and 10% (v/v) DMSO. The cells were 
dispensed in 0.5ml aliquots in cryo-tubes before being frozen at -70°C overnight. 
Cells could then be transferred to liquid nitrogen for long term storage. Cells were 
recovered from liquid nitrogen and thawed at 37°C before being placed into a tissue 
culture flask containing fresh growth media. The cells were incubated overnight at 
37°C, 5% CO2 before the media was removed and replaced with 25ml of fresh growth 
media thus removing dead cells and any traces of DMSO.
2.8.5 DNA-Mediated Gene Transfer of Tissue Culture Cells.
2.8.5.1 DEAE-Dextran Procedure.
This procedure depends on the binding of DNA to DEAE-dextran (diethylaminoethyl- 
dextran) particles and the pinocytosis of the particles into the cells. COS -1 cells were 
passaged to reach approximately 70 - 80% confluence before transfection. The growth 
media was removed and the cells washed with PBS. A transfection cocktail 
containing PBS (Oxid), DEAE-Dextran and DNA (test) or PBS and DEAE-Dextran 
(control) was added directly to the cells, and incubated at 37°C, 5% C02for 30 mins 
with occasional shaking to prevent drying out of the cells. 6ml of tissue culture media 
containing 80/<M chloroquine was added and the cells incubated for a further 2.5 hrs 
at 37°C, 5% CO2. The media/DNA coektail were removed and replaced with 3ml of 
tissue culture media containing 10% (v/v) dimethyl sulfoxide (DMSO) and the cells 
incubated at room temperature for exactly 2.5mins (if left for longer damage is caused
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to the cell membrane). The media was removed and replaced with 10ml of fresh tissue 
culture media. The cultures were incubated at 37°C, 5% CO2 for 48hrs.
2.S.5.2 Lipofectin Procedure.
This procedure depends on the encapsulation of DNA in lipid micelles and their 
uptake by coalescense with the cell membrane. Tissue culture cells were transfected 
with DOTAP (N-[- l-(2,3-dioleoxyloxy)propyl]-N,N,N-trimethylammonium-
methylsulfate; Boehringer Mannheim) as per the manufacturer's instructions. The 
DNA was added to the DOTAP in Hepes buffer and mixed gently. After an 
incubation of 10-15min at room temperature, the mixture was added to the cells 
together with fresh tissue culture media and incubated at 37°C, 5% CO2 for 3-6hrs.
The media was then replaced with 10ml of fresh media and incubated at 37°C, 5% 
CO2 for a further 48-72hrs.
2.8.6 Preparation of Cell Lines Stably Retaining the cDNAs
Encoding Rat and Human B-Lyase.
The pig kidney cell line, LLC-PKl (section 2.2.S.2) was used to create cell lines 
which had stably incorporated into their genome, the cDNAs encoding for either rat 
or human cysteine conjugate B-lyase. The stable cell lines were then used to study the 
kinetics and cytotoxic effects of various cysteine conjugates. The following 
experiments were performed by Dr. C. I. Scholfield.
2.8.6.1 DNA Mediated Gene Transfer of LLC-PKl Cells
LLC-PKl cells were transfected using the lipofectin procedure (see section 2.S.5.2; 
DOTAP, Boehringer Mannheim). The transfection was performed as detailed above 
except the transfection mixture was added to the cells and incubated for IShr. The 
media was removed and replaced with fresh media, the transfected cells were
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incubated for a further 24hr at 37“C, 5% CO2. Finally the cells were subcultured as 
outlined in section 2.8.2 (ratio 1:3) and incubated overnight at 37°C, 5% CO2 in 
preparation for clonal selection.
2.8.6 2 Clonal Selection of Cell Lines Stably Retaining the cDNAs
Encoding Either Rat or Human B-Lyase.
The expression vector pUSlOOO ( Figure 2.1) contains a GPT cassette which allows 
selection with mycophenolic acid. Cells were dosed with media containing 
mycophenolic acid and xanthine. The GPT cassette allows the eukaryotic cells to 
metabolise xanthine, mycophenolic acid is included to prevent “de novo” synthesis of 
purines (Mulligan and Berg, 1981). Hence only those cells which had stably 
incorporated the cDNAs encoding either rat or human 6-lyase in the expression vector 
pUSlOOO survived.
After subculture of the transfected cells, the old media was removed and replaced 
with 25ml of HAT media and incubated for between 7 to 14 days at 37“C, 5% CO2 
until colonies appeared ( HAT media was changed as neccessary).
HAT media was prepared as detailed below:
Medium 199 (supplemented with 10% FCS, 92ml
1% gentamycin and 1% anti-PPLO)
HAT supplement ( GIB CO BRL; 50x) 2ml
Xanthine (Sigma; 50x) 2ml
Mycophenolic acid (GIBCO BRL; 50x) 2ml
Approximately 600/<l of IM HCl was added in order to bring the media to a slightly 
acidic pH.
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Both xanthine and mycophenolic acid were prepared in NaOH (0.2M and O.IM 
respectively) and filter sterilised before use.
2.8.6 3 Colony Picking
Once the colonies had formed in the tissue culture flasks, they were removed and 
cultured in 96 well plates containing non-selective media (i.e. medium 199).
The cultures were washed with 4ml PBS before trypsinisation. Only 1ml of trypsin 
was used at this stage, providing an even coverage of the tissue culture flask, any 
excess trypsin was aspirated. The flasks were placed under a phase contrast 
microscope (Nikon) with the phase removed, on low magnification in a laminar flow 
cabinet. The colonies were gently removed using a sterile glass pasteur pipette with a 
hooked tip and placed in 0.5ml medium 199 containing 20% FCS on a 96 well 
microtitre plate. The 96 well plate was then incubated in a humidified atmosphere at 
37°C, 5% CO2 for approximately 1 week or until the cultures became confluent.
2.8 6.4 Subculture of the Selected Colonies
Confluent colonies grown on 96 well plates were harvested using 100/d of trypsin 
and subcultured in 2ml of medium 199 containing 20% FCS in 24 well plates. 
Again, once the cultures in 24 well plates had reached confluence they were
subcultured into 25cm^ tissue culture flasks (NUNC, Scotland) but grown in medium 
199 with only 10% FCS. From here on all stable cell lines were treated as per normal 
tissue culture cell line. Further selection in HAT media was performed occasionally 
to remove revertants which had lost the inserted plasmid DNA.
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2.8.7 Subcellular Fractionation of Transfected Cells.
2.8.7.1 Preparation of Cytosol.
The cells were trypsinized as in section 2.8.2, resuspended in 10ml of media and 
centrifuged at 2,500rpm for 5mins in a benchtop centrifuge (lEC Centra 4X). The cell 
pellet was washed twice in 20ml of ice cold PBS and the pellet resuspended in 3ml of 
ice cold homogenisation buffer. The cells were freeze-thawed three times by
immersing in liquid nitrogen and then quickly thawing in a water bath at 37°C . 
Samples were then sonicated three times for 15 secs and cooled on ice for 30 secs 
between each sonication. In order to remove the cell debris the samples were
centrifuged at 5000rpm for 5min at 4°C (lEC Centra-M2 centrifuge. Life Sciences 
International Ltd., Basingstoke). The supematent, which is the crude cytosol, was 
retained for analysis.
2.8.T.2 Preparation of Mitochondria.
Cytosol was prepared (section 2.8.7.1) and centrifuged at 13,000g at 4“C for 20min. 
The resulting pellet containing the mitochondria was resuspended in 500pi of ice cold
homogenisation buffer and the supematent (cytosol) was kept for subsequent assay. 
The centrifugation step was repeated twice and the resulting pellet resuspended in
500pl of homogenisation buffer. Before use, the mitochondrial sample was sonicated 
in a water-bath for 15secs in order to release the mitochondrial proteins.
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2.8.8 Preparation of Tissue Culture Cells for Electron 
Microscopy
Tissue culture cells were grown in 75cm^ tissue culture flasks as outlined in section
2.8.1 and sub-cultured as outlined in section 2.8.2. The cells suspended in 10ml of 
tissue culture media were fixed by the slow addition of 25% (v/v) glutaraldehyde until 
a final concentration of 4% (v/v) glutaraldehyde was reached. The cell suspension 
was then pelleted by centrifugation at 6000rpm for 5 min in a benchtop centrifuge. 
The supernatant was carefully discarded and the cell pellet fixed in 3-4 drops of 2% 
(w/v) low melting point agarose (40°C dissolved in 4% (v/v)
glutaraldehyde/cocodylate) and placed at 4°C to allow the agarose to set. Plugs of 
agarose were then carefully removed and the excess agarose removed using a scalpel, 
the agafose-cell pellet was then placed in a 5ml screw cap glass tube. The cell pellet 
was then washed twice in O.IM sodium cocodylate buffer (pH 7.4), counterfixed in 
2% (v/v) osmium tetroxide in O.IM sodium cocodylate buffer for Ihr and dehydrated 
through an alcohol series to absolute ethanol. The dehydrated cell pellet was then 
washed in a 50:50 absolute ethanol: propylene oxide solution, followed by propylene 
oxide alone and finally a freshly prepared 50:50 propylene oxide: Epon 812 solution. 
The cell pellet was then placed into the wells of a silicone rubber embedding tray 
containing Epon 812 and the resin incubated at room temperature for 4hr before being 
polymerised at 60°C for 12hr. The polymerised resin containing the cells was then cut 
into sections of between 200 - 300 Â which were then mounted on a copper grid and 
counterstained in lead citrate and 4% (w/v) uranyl acetate. Sections were then 
observed and photographed using an electron microscope (Phillips 400T).
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2.9. ASSAYS FOR DETERMINATION OF PROTEIN
CONCENTRATION, ENZYME ACTIVITY AND 
CYTOTOXICITY.
2.9.1 Protein Determination.
Protein determinations were carried out following the Miller (1959) modification of 
the method of Lowry et al. (1949). A standard curve was generated using duplicates 
of bovine serum albumin (BSA) at concentrations of 20, 40, 60, 80 and 100 //g/ml. 
25]Â of each sample was made up to 1ml with sterile Milli Q water. 1ml of freshly 
prepared reagent A (CuSO^iNaK tartrate: Na2C03 in 0.5M NaOH in the ratio 
1:10:100) was added to the standards, samples and a water blank and incubated at 
room temperature for exactly lOmin. 3ml of reagent B (Folin-Ciocalteu reagent 
diluted 1:10 with distilled water) was added to each of the tubes which were 
immediately vortexed before being incubated at 50°C for lOmin to allow the blue 
colour to develop. Samples were cooled to room temperature before the absorbance 
values were determined on a Kontron Uvicon spectrophotometer at 650nm and the 
protein content calculated. The sample and standard values were corrected by 
subtraction of the water blank.
2.9.2 Glutamine Transaminase K (GTK) Assay.
Glutamine transaminase K activity was determined using the method of Cooper and 
Meister (1985), which is based on the ability of GTK to catalyse the transamination 
reaction between L-phenylalanine and an a-keto acid, such as a-keto-y- 
methiolbutyrate, leading to the formation of phenyl pyruvate and an L-amino acid.
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GTK
L-Phenylalanine + a-Keto-y-Methiolbutyrate ^  Phenylpyruvate + L-Methionine
35/d of prewarmed (37°C) reaction mixture ( 0.2M ammediol buffer, pH9.0, lOmM 
L- phenylalanine and 5mM a-KMB) was added to 65/d of cytosolic sample ( 2.5/d of
cytosol and 62.5//1 of sterile water) in a 37°C water bath. The reaction was allowed to 
proceed for lOmin after which it was terminated by the addition of 0.9ml 3.33M 
NaOH. All assays, including blanks were performed in duplicate and the blanks were 
subjected to the same procedure except that the cytosol was added after the reaction 
was terminated. The product of the reaction, phenyl pyruvate, absorbs strongly at 
322nm, whilst the absorbanee due to a-KMB is negligible. It is the increasing 
intensity of this absorbance over time which is used to assess the specific activity of 
the GTK present. The specific activities of the samples were then calculated using the 
following formula;
Specific Activity (nmol/min/mg protein) = A x 1000
E x P
where: A = Absorbance at 322nm corrected per minute
E = Molar Extinction Coefficient of phenyl pyruvate at 322nm (24.1 mM "^on "1)
P = Amount of protein (mg)
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2.9.3. Cysteine Conjugate B-Lyase Assay
To analyse cysteine conjugate 6-lyase activity two different methods were used. 
Initially the spectrophotometric assay of Stevens and Jacoby was used, as at the time 
this was the only method available. Later, the more sensitive fluorescent HPLC based 
assay of Stijntjes etal. (1992) was adopted.
2.9.3.1 Spectrophotometric Method
The assessment of 6-lyase activity was carried out following the method of Stevens 
and Jacoby (1983) and is based on the continuous spectrophotometric estimation of 
activity with time. 6-Lyase catalyses the 6-elimination reaction of substrates such as 
TFEC or DC VC to form a reactive thiol, pyruvate and ammonia. The pyruvate 
produced is in turn reduced by lactate dehydrogenase to lactate. The concurrent 
oxidation of NADH/H+, (which absorbs at 340nm), to NAI> is measured by the 
decrease in absorbance at 340nm and is proportional to 6-lyase activity.
6-lyase
i) DC VC or TFEC ^  R-SH + Pyruvate + NHg
LDH
ii) Pyruvate + NADH/H+ ^  Lactate + NAD+
The reaction mixture (800/d) containing 0. IM sodium phosphate buffer, pH7.4, 5mM
glutathione (GSH), 140//M NADH/H+, 4 units LDH, O.lmM a-KMB and 5mM
substrate, was pre-incubated at 37 °C. A baseline was obtained by measuring the 
absorbance of the mixture against a water blank for 2min at 340nm and a constant
temperature of 37°C. 200/d of cytosol was added to the cuvette, mixed thoroughly
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with a pipette and the absorbance measured for a further 8min. The difference 
between the reaction rate in the presence and absence of substrate was taken as a 
measure of 6-lyase activity.
The specific activity of 6-lyase could then be calculated using the following formula:
Specific Activity = f AA/8 x 10001 (nmol/min/mg protein)
(ExP)
where AA/8 = Change in absorbance at 340nm per minute
E = Molar Extinction Coefficient of NADH/H+ at 340nm (6.2mM'Van'^)
P = Amount of protein (mg).
2.9.3.2 HPLC Method
The HPLC method of assessment of 6-lyase activity relies on the conversion of the 
cysteine conjugate into a thiol, pyruvate and ammonia. Here, the formation of the 
reaction product, pyruvate, was measured after a reaction time of 20min. A range of 
pyruvate concentrations, 1-80//M were prepared as a standard curve.
The sample tubes were set up as follows:
Cysteine Conjugate
(lOmM in O.IM sodium phosphate buffer)
a-KMB (0.2mM)
O.IM Sodium Phosphate Buffer 
Cell Extract 
Final Volume
]A
187.5
25
variable
variable
250
Final Concentration 
7.5mM
0.2mM
O.IM
0.2mg/ml
The tubes were incubated at 37“ C in a shaking water bath for 20 mins.
124
The reaction was terminated by the addition of 800/d of 12mM o-phenylenediamine 
(OPD; the derivatising agent) in 3M HCl which was also added to 200jA aliquots of 
each of the pyruvate standards (see below for derivatisation scheme). All the tubes 
were then incubated at 95“C for 30 mins and left to cool to room temperature before 
being centrifuged at 3000rpm to pellet any remaining protein. The reaction for OPD 
derivatisation of pyruvate occurs as outlined below:
o  OH
OPD
NHa o '^ ^ C H s  ^  CHs
Pyruvate 2-hydroxy-3-methylquinoaline
The resultant supematent was then extracted three times with 3mls ethyl acetate and 
excess NaSO^ with vortexing for 60 secs. Samples were then evaporated to dryness 
using oxygen free nitrogen before being resuspended in 200/d of HPLC running 
buffer, which consisted of 54% H2O, 45% HPLC grade methanol and 1% glacial 
acetic acid.
100/d of this final mixture was then separated on a reverse phase isocratic gradient 
spherisorb column (HiChrom, 5pim spherisorb packing, 150 x 4.6 mm, HiChrom, 
Reading, Berkshire) at a flow rate of 0.6ml/min. The HPLC system used consisted of 
a Thermo Separation Products gradient pump (Model Spectraseries P200), and a 
SpectraSystem flouresence detector (Model FL200). Fluorescence was measured at
Xex =336nm, = 422nm, peak determination and integration was performed with a
Thermo Separation Products SP4400 integrator.
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2.9.4 XTT Cytotoxicity Assay
This cytotoxicity assay allows the spectrophotometric quantification of cell 
proliferation and viability. It is based on the theory that only metabolically active 
cells can cleave the yellow tétrazolium salt XTT forming an orange formazan dye 
(Gerlier and Thomasset, 1986) An increase in living cells results in an overall 
increase of the mitochondrial dehydrogenases present in the sample, which directly 
correlates to the increases in the amount of orange formazan formed.
Tissue culture cells were seeded out to a density of 3 x 10"^  cells /well in 96 well 
microtitre plates (Life Technologies, Paisley) and incubated in a humidified
atmosphere overnight at 37°C, 5% CO2 .
The old media was aspirated off and 100/d of fresh media containing the appropriate 
amount of cysteine conjugate was added to each well before the plates were incubated
for 6hr at 37°C, 5% CO2. 50/d XTT labelling mixture (0.3mg/ml) was added to each
well and the microtitre plates incubated for a further 18hr in a humidified atmosphere
at 37°C, 5% CO 2. The absorbance of the samples was then measured on an Applied
Biosystems plate reader at a wavelength of 450nm and 620nm. From the absorbances, 
the percentage cell survival could then be calculated.
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2.10 HYBRIDISATION ANALYSIS OF NUCLEIC ACIDS
2.10.1 Isolation of Genomic DNA
Genomic DNA was isolated from tissue culture cells. Two confluent 75cm^ tissue 
culture flasks were washed with 5ml PBS each, the PBS removed and 5ml of fresh 
PBS added to both flasks. The cells were scraped using a rubber policeman into the 
PBS and the PBS/cell mixture from eaeh flask was combined in a universal and 
centrifuged at 1500g for 5min to pellet the cells. The supematent was carefully 
discarded and the cell pellet resuspended in 1ml of CVS buffer. 100/d of proteinase K 
(lOmg/ml) was added to the cell solution which was then incubated at 55°C for 3hr. 
The genomic DNA was extracted with an equal volume of phenol:chloroform:isoamyl 
alcohol (25:24:1) and centrifuged at 3500rpm for 5min in a benchtop centrifuge. The 
top aqueous layer was carefully removed and extracted with an equal volume of 
chloroform:isoamyl alcohol (24:1). The solution was centrifuged at 3500g for 5min to 
separate the aqueous layer. Again the top aqueous layer was carefully removed and 
transferred to a fresh Falcon tube, 3 volumes of absolute ethanol were added together 
with 10% (v/v) of 3M sodium acetate. The mixture was incubated at -70“C ovemight 
to precipitate the DNA before being centrifuged at lOOOOg for 30min to pellet the 
DNA. The DNA pellet was washed in 1ml of 70% (v/v) ethanol, transferred to a 
microcentrifuge tube and centrifuged at lOOOOg for 30min. The genomic DNA was 
resuspended in 200/d of TE buffer (pH 7.5) and a 2/d aliquot was used to assess the 
purity and concentration of the DNA by spectrophotometry. An aliquot of the 
genomic DNA was also mn on an agarose gel to check for purity and possible 
degradation.
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2.10.2 Isolation of Total RNA
Total RNA was extracted from tissue culture cells using the RNAzol ™ B method
(Biogenesis, Poole), which is based on the method of Chomczynski and Sacchi 
(1987). It is becoming increasingly important to isolate pure, undegraded RNA, and
RNAzol ™ B provides a quick and easy way of doing this. RNAzol ™ works on the
basis that it promotes the formation of complexes of RNA with guanidinium and 
water molecules, abolishing hydrophilic interactions of DNA and protein which are 
removed from the aqueous phase.
Cell monolayers were lysed directly in the culture flask with RNAzol™ B. The
growth media was removed from a confluent 80cm^ flask of cells. 8ml of RNAzol™
B was added and swirled gently over the monolayer, the lysate was pipetted up and 
down several times using a sterile 10ml pipette and transferred to a 50ml Falcoln tube. 
0.8ml of chloroform was added to the lysate and shaken vigorously for 15sec before 
being incubated on ice for 5min. The suspension was centrifuged at 12000g at 4“C for 
15min to separate the aqueous layer. The top clear aqueous layer was carefully 
removed and transferred to a fresh tube. An equal volume of isopropanol was added 
to the aqueous phase which was incubated at 4“C for 15min allowing the RNA to 
precipitate. The samples were centrifuged at 12000g at 4°C for 15min and the RNA 
pellet was washed with 75% (v/v) ethanol by vortexing and centrifuged at 7500g at 
4“C for 8min. The supernatant was discarded and the pellet dried at 37°C before being 
resuspended in 50/d of 0.5% (w/v) SDS. An aliquot was taken to determine the 
concentration and purity of the RNA spectrophotometrically. Another aliquot was 
electrophoresed on a 1% agarose, 0.1% SDS gel to check the integrity of the RNA.
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2.10.3 Southern Blot Analysis
Southern blot analysis was performed according to a modified version of that 
described by Sambrook et. al, (1989), after the original technique of Southern (1975) 
and was used for recombinant plasmid DNA and genomic DNA analysis.
2.10.3.1 Sample Preparation and Electrophoresis Plasmid DNA
5ng of EcoR I digested plasmid DNA was electrophoresed on a 1% (w/v) agarose gel 
as a positive control for the stable incorpoation of the 6-lyase cDNA into the genome 
of the LLC-PKl cells.
Genomic DNA
S O jA g  of genomic DNA was digested with EcoR I in a total volume of 30/d and 
electrophoresed on a 1% (w/v) agarose gel at 50mA, stained with ethidium bromide 
and photographed as in sections 2.3.3,2.3.4.1, 2.3.5 and 2.3.6.
2.10.3.2 Depurination and Dénaturation of DNA Fragments.
DNA fragments were denatured prior to transfer and probing in order to produce 
single strands for hybridisation.
After electrophoresis the gels were soaked in 0.25M HCl for lOmin or until the 
bromophenol blue dye used turned yellow. The gel was briefly washed in distilled 
water and transferred to denaturing solution for 2x20min then neutralising solution 
for 2x20min.
2.10.3.3 Transfer of DNA onto a Nylon Membrane
After depurination the DNA was transferred by capillary action to a nylon membrane 
using the method described by Sambrook et. al., (1989) using 20xSSC. Transfer was 
usually complete after about 16hr, after which time the membrane was removed, 
soaked in 5xSSC for 5min then baked at 80“C for lOmin. To further fix the nucleic
129
acid, the membrane was UV irradiated for 3min on a UV transilluminator (model 
TM20, Genetic Research Instrumentation Ltd.).
2.10.3.4 Probe Labelling, Hybridisation and Detection.
Labelling of the cDNA probe, hybridisation and detection were carried out using the 
ECL direct nucleic acid labelling and detection system (Amersham). The system 
involves labelling the probe with the enzyme, horseradish peroxidase. The peroxidase 
is a positively charged polymer which forms a loose attachment with the nucleic acid 
by charge attraction. The addition of glutaraldehyde induces the formation of covalent 
bonds between the enzyme and the probe. The detection reagent 1 decays to hydrogen 
peroxide, the substrate for peroxidase, reduction of hydrogen peroxide by the 
peroxidase is coupled to the light producing reaction by detection reagent 2 which 
contains luminol. The result of the oxidation of luminol is the production of blue light 
which is increased and prolonged by the presence of an enhancer allowing the light 
to be detected on blue-light sensitive film.
Probe Labelling
The DNA probe was diluted to 10ng//d using the water supplied with the k it , lOOng 
of probe was placed in a microcentrifuge tube was and denatured in a boiling 
waterbath for 5min. The denatured probe was immediately placed on ice for 5mins 
and the tube centrifuged briefly to collect the liquid in the bottom of the tube. An 
equivalent volume of DNA labelling reagent was added to the denatured DNA and 
mixed gently, after which an equivalent volume of glutaraldehyde was added, mixed 
and incubated at 37“C for lOmin. The labelled probe can then be kept on ice for upto 
15min or stored in 50% (v/v) glycerol at -20“C for up to 6 months.
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Hybridisation
Hybridisation buffer (0.25ml/cm^ of blot) with 5% (w/v) of blocking reagent and 
0.5M NaCl was pre-heated to 42“C for Ihr. The blot was placed in the buffer and pre­
hybridised at 42“C for Ihr in a Hybaid rôtisserie oven. After pre-hybridisation, the 
labelled probe (lOng/ml of hybridisation buffer) was added to the pre-hybridisation 
buffer and hybridised at 42“C ovemight in a rôtisserie oven. The hydridisation buffer 
was disearded and the blot washed in 5xSSC at 42°C for 5min. The 5xSSC wash was 
discarded and the blot washed for 2xl0min in 30ml of primary wash buffer preheated 
to 55°C. The blot was removed from the hybridisation tube and washed in secondary 
buffer at room temperature for 2x5min with gentle agtiation, fresh buffer being used 
each wash.
Detection
Equal volumes of detection reagent 1 and detection reagent 2 were mixed to give
sufficient volume to cover the membrane (0.125ml/cm^) and placed on ice until 
needed (no longer than 30min). Excess secondary buffer was drained from the blots 
which were placed in a fresh container or on a piece of SaranWrap, DNA side 
uppermost. The detection reagent was added directly to the blots and incubated at 
room temperature for Imin. The excess detection reagent was drained off and the blot 
wrapped in SaranWrap with any air bubbles gently smoothed out. Blots were then 
placed in an X-ray cassette DNA side uppermost and a sheet of autoradiography film 
was laid ontop of them. The film was exposed for several days before being 
developed as in section 2.3.10.
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2.10.4 Northern Blot Analysis
Northern blot analysis was performed as described by Sambrook et al, (1989) and 
was used to analyse total RNA samples extracted from the cell lines which had stably 
retained the cDNA for 6-lyase.
2.10.4.1 Sample Preparation and Electrophoresis
lOjAg of total RNA was mixed with 15pc\ of RNA loading buffer, boiled vigorously 
for 2min and cooled on ice before being electrophoresed on a 1% (w/v) agarose 
denaturing gel. The gel was then visualised on a UV transilluminator and 
photographed as in sections 2.3.4.2,2.3.5 and 2.3.6.
2.10.4.2 Transfer of RNA to Nylon Membrane
After electrophoresis the gel was rinsed for 3xl0min in lOxSSC to remove any 
formaldehyde. The RNA was transferred to Hybond N nylon membrane using the 
capillary method outlined in section 2.10.4.3 and processed afterwards as outlined in 
section 2.10.4.4.
2.10.4.3 Preparation of RNA Probes
Since probing the Northern blot with a DNA probe was unsuccessful, it was decided 
to create an RNA probe. The probe was produced using the Riboprobe® in vitro
Transcription System by Promega. Transcription of RNA from pSP64-pSP73 vectors 
is performed using SP6 or T7 RNA polymerase which are very promoter-specific 
making it possible to obtain virtually homogeneous RNA from a plasmid DNA 
template.
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The following components were added together at room temperature:
5x Transcription optimised Buffer 4/<l
lOOmMDTT 2//1
Rnasin® Ribonuclease Inhibitor 20u
ATP, GTP,UTP and CTP(2.5mM each) A ]a \
Linearised Template DNA
(0.2-1 .Omg/ml in water or TE Buffer) 1 pi\
T7RNA Polymerase (15-2Gu// l^) 1/d
Final volume 20jÂ
The mixture was incubated for 60min at 40°C. After transcription, the remaining 
DNA in the transcription mixture was removed by treatment with RQl RNase-free 
DNase (lu//<g of template DNA) at 37°C for 15min. The RNA could then be labelled 
as described in section 2.10.4.4.
2.10.4.4 Probe Labelling, Hybridisation and Detection
Since it seemed that the ECL labelling kit did not provide a strong enough signal to 
allow the detection of small quantities of RNA, it was decided to revert to the more 
traditional radioactive labelling method.
Probe Labelling using Rediprime DNA Labelling Kit
cDNA probes were labelled with ^^ P using the Amersham Rediprime™ DNA
labelling system. This procedure is based on the method of Feinberg and Vogelstein 
(1983 & 1984), where DNA synthesis is randomly primed from a cDNA template 
using random nonomers. 32P labelled dCTP is incorporated together with dNTPs 
using the Klenow fragment (exonuclease free) of DNA polymerase.
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25ng of cDNA was made up to 45/d with sterile water in screw-capped eppendorf 
tubes and denatured in a boiling waterbath for 5min. The tube was centrifuged briefly 
and the contents added to one tube of the Rediprime mixture which contained dNTPs, 
buffer and Klenow enzyme. The sample was gently mixed, then placed in a perspex 
box behind a perspex screen for the addition of 5/d of ^^ P dCTP and incubated in a 
water bath for lOmin at 37“C. The reaction was stopped by the addition of 5 jaI of 
0.2M EDTA and the tube boiled for a further 5min before being placed on ice for 
5min. The tube was then centrifuged to collect the sample in the bottom of the tube 
before being added to the pre-hybridisation buffer.
Hybridisation
The Hybond N™ membranes were placed between two sheets of bolting cloth which 
in turn were placed in Hybaid ™ hybridisation tubes. The membranes were pre-wetted
with 5xSSC before being pre-hybridised in hybridisation buffer (Iml/cm^) in a 
Hybaid incubator and rôtisserie for at least 6hrs at 42°C. Where hybridisation was 
across species 50% deionised formamide was added to the hybridisation buffer. 
Formamide reduces the melting temperature of nucleic acid hybrids enabling 
hybridisation to be performed at lower temperatures. Lower hybridisation 
temperatures give rise to less stringent conditions therefore allowing nucleotide 
mismatches to occur, this is necessary when probing with cDNAs from different 
species as they will not be 100% similar.
After pre-hybridisation, ensuring all non-specific binding sites are blocked, the
hybridisation buffer was transferred into a 50ml Falcon tube and the ^^P labelled 
probe added. The radioactive hybridisation buffer was then returned to the 
hybridisation bottle and the filters hybridised overnight at 42“C in the rôtisserie oven.
134
Washing and Detection
After hybridisation, the membranes were washed in 5xSSC; 0.1%SDS for 45min at 
room temperature. The wash was then discarded and the membranes washed in 
IxSSC; 0.1% SDS for Ihr at 65“C. The background radioactivity was monitored, if it 
still remained high, more washes were performed, if however, the radioactive signal 
was only found at specific points on the membranes, then the membranes were rinsed 
in 5xSSC at room temperature before being autoradiographed (section 2.3.9).
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CHAPTERS
HETEROLOGOUS EXPRESSION OF cDNAS CODING FOR RAT 
AND HUMAN KIDNEY CYTOSOLIC CYSTEINE CONJUGATE 
B-LYASE IN TISSUE CULTURE CELLS
3.1 INTRODUCTION
Cysteine conjugate 6-lyase activity is found in many different organs in the body. At 
present much attention is focused on the GTK form of cysteine conjugate 6-lyase 
found in the kidney. As indicated in the introduction (section 1.11.1.2) there is 
growing evidence that whilst the acute nephrotoxicity observed in rodents on 
exposure to halogenated alkenes is not observed in man, there is strong evidence of 
kidney damage and also of specific neurotoxicity. For this reason, it has become 
increasingly important to determine whether the mechanistic basis of this difference 
relates to the properties of the 6-lyase/GTK enzyme in these species. Heterologous 
expression of cDNAs in tissue culture cells provides an easy means of obtaining 
enzyme for such studies.
The full length cDNAs encoding rat and human renal cysteine conjugate 6-lyase have 
previously been isolated by Perry et. al., (1993 & 1995) in this laboratory. Although I 
was involved with the latter stages of the isolation of the human 6-lyase cDNA, this 
shall not be discussed in detail here.
The results presented in this chapter describe the characterisation of rat and human 
renal cysteine conjugate 6-lyase prepared from COS-1 cells transfected with the 
cDNAs encoding rat and human cysteine conjugate 6-lyase. The creation of a 
truncated rat 6-lyase cDNA lacking the 5’non-coding region of the original clone, was 
also performed in order to attempt to explain the differences in enzyme levels
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between the rat and human enzymes expressed in these cells. Finally the creation of 
cell lines which stably express rat and human renal cysteine conjugate 6-lyase is 
examined. The goal here was to develop an in vitro system for assessing the 
nephrotoxicity of cysteine conjugate metabolites of halogenated compounds.
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3.2 HETEROLOGOUS EXPRESSION OF THE cDNAs CODING
FOR RAT AND HUMAN CYTOSOLIC CYSTEINE 
CONJUGATE B-LYASE IN COS-1 CELLS
Once the cDNAs for rat and human cysteine conjugate 6-lyase had been isolated, it 
was decided to transiently express them in the COS-1 cell line. Cysteine conjugate 6- 
lyase being a cytosolic enzyme could then be extracted from the cells after successful 
transfection, and used for enzyme characterisation sudies.
COS-1 cells are derived form the monkey cell-line, CV-1. Gluzman (1981), 
transformed the CV-1 cell line using a segment of SV40 early region DNA (cloned in 
an E. coli plasmid) in which the SV40 origin of replication had been inactivated. The 
result was the COS-1 cell line - CV-1 origin, SV40, which expresses T antigen 
protein from the integrated SV40 sequences and is permissive for SV40 DNA 
replication. Thus, any circular DNA containing an SV40 origin of replication should 
be replicated independently of the cellular DNA as a plasmid-like episome. The 
extensive vector replication of the cells makes them unviable after approximately 
72hrs, therefore they are not suitable for the creation of stable cell lines. However, 
due to the high copy number of the plasmid, only a small proportion of the cells need 
to be transfected in order to obtain sufficient input DNA amplification for subsequent 
high level transcription, translation and expression.
3.2.1 DNA Mediated Gene Transfer in COS-1 Cells.
Initially the DEAE-dextran method of gene transfer was used, but in an attempt to 
increase the transfection efficiency, a lipid based method - DOTAP, was also 
investigated.
138
3.2.1.1 DEAE-Dextran Mediated Gene Transfer.
The DEAE-Dextran method of transfection was first established in 1965 by Vaheri 
and Pagano (Vaheri and Pagano, 1965) who used it to transfer DNA into mammalian 
cells. DEAE-dextran is a polymeric cation which allows a tight binding of negatively 
charged DNA, which is then carried into the cell by pinocytosis. Due to its toxicity 
however, DEAE-dextran is only suitable for transient transfections. In addition to the 
DEAE-dextran, chloroquine was also added to the transfection mixture, as this is 
believed to enhance transfection efficiency by binding to the DNA and inhibiting 
liposomal degradation (Cohen & Yielding, 1965; Luthman & Magnusson, 1983). 
Furthermore, a DMSO shock was also included in the protocol as it is believed that 
this modifies the cell membrane structure, enhancing DNA uptake, although, the 
exact mechanism of this is currently unclear.
COS-1 cells cultured in Dulbecco's Modified Eagles Medium containing 10% (v/v) 
Australian foetal calf serum, 5% (v/v) gentamycin and 5% (v/v) anti-PPLO, in an 
atmosphere of 5% CO  ^at 37°C were seeded out the evening before the experiment at 
a density which would allow them to have reached 60 - 80% confluency the following 
morning (1:2). DNA transfection using DEAE-dextran and chloroquine was 
performed as outlined in section 2.8.5.1. Three 75cm ^  tissue culture flasks were 
transfected for each of the sense DNA, anti-sense DNA and no DNA control for both 
rat and human in order to provide adequate quantities of cytosol for the enzyme 
assays. The transfected cells were incubated for periods of 48 and 72 hrs at 37°C, 5% 
CO  ^before harvesting and cytosol preparation.
3.2.1.2 DOTAP Mediated Gene Transfer.
DOTAP is a cationic lipid, first used for transfection in 1987 (Feigner et. al., 1987). 
The cationic head of the lipid associates with the negatively charged phosphate 
moieties of the DNA forming a lipid/ DNA complex. This complex then fuses or
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associates with the cell membrane resulting in the internalization of the DNA into the 
cell.
COS-1 cells cultured as outlined above, were seeded out the evening before the 
experiment at a density which would allow them to have reached approximately 60 - 
80% confluency by the following morning. DNA transfection using DOTAP was 
performed as outlined in section 28.5.2. Three 75cm^ tissue culture flasks were used 
for each of the sense DNA, anti-sense DNA and no DNA control transfections. 
Transfected cells were incubated for 48hrs at 37®C, 5% COg before harvesting and 
cytosol preparation.
3.2.2 Preparation of Cell Fractions from Transfected COS-1
Cells.
It was decided that two cell fractions would be considered in this study, namely the 
13000xg supematent (which shall be called cytosol for the purpose of this thesis) and 
the mitochondrial fraction (13000xg pellet).
3.2.2.1 Optimisation of the Cytosol Preparation from COS-1 Cells
The cytosolic fraction from the COS-1 cells was prepared as outlined in section 
2.8.7.1, however several parameters were modified in order to optimise the 
preparation. The effect of the alterations was measured as a function of GTK activity 
displayed by the resultant enzyme, as this was routinely easier to assay than 6-lyase 
activity.
Firstly, the original protocol used by Perry et al, (1993) involved three freeze/thaws 
using liquid nitrogen followed by sonication of the cell extract in microcentrifuge 
tubes in a water bath sonicator. Samples were sonicated for 15secs with a 30sec 
incubation on ice between each sonication.
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The effect of a gentler freeze/thaw was investigated using a 10 min incubation at 
-80® C followed by a thawing period in a 37®C water bath, and this was repeated two 
further times.
The number of freeze/thaws used in the preparation was also investigated, the effect 
of both an increase and a decrease in freeze/thaw cycles was evaluated.
Next, the number of sonications was investigated, with the amount of sonications 
being increased and decreased. The method of sonication was also investigated, by 
use of a sonicating probe (Soniprep 150, MSE) as was the type of vessel used for 
sonication. Sonication was originally performed in a microcentrifuge tube, an 
alternative providing a larger volume was to use an universal tube. Also the length of 
time that the sample was sonicated for was varied from 5 to 15 secs.
Cytosol samples were kept on ice throughout the procedure in order to prevent 
inactivation by proteases, and stored at -20®C until required for enzyme activity 
determinations.
Results from this experiment are described in Table 3.1
3.2.2 2 Preparation of Mitochondrial Fractions From COS-1 Cells
COS-1 cell mitochondrial samples were prepared as outlined in section 2.8.7.2. 
Samples were kept on ice throughout the procedure in order to prevent inactivation by 
proteases, and stored at -20®C until required for analysis.
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3.2.3 Enzyme Analysis of COS-1 Cell Cytosol and
Mitochondria
The crude cytosol prepared from the transfected COS-1 cells was assayed for GTK 
and 6-lyase activity. The mitochodrial samples were assayed for GTK activity only, 
since the current 6-lyase assay was not sensitive enough to detect 6-lyase activity in 
small volumes of sample. Specific activities of the samples were calculated using 
protein concentration values determined by the method of Miller (see section 2.9.1).
GTK activity was used as an indicator of how well a transfection had worked, and 
what effect a change in cytosol preparation had on the resultant cytosol sample.
The kinetics for GTK activity of rat and human renal cysteine conjugate 6-lyase were 
calculated using phenylalanine as a substrate.
3.2.3.1 Glutamine Transaminase K Activity
Glutamine Transaminase K (GTK) activity was determined using the method of 
Cooper and Meister (1985) as outlined in section 2.9.2.
Optimiscdon of The Glutamine Transaminase K  Assay
In order to obtain accurate values for enzyme activity it was decided to optimise the 
assay for the cytosol extracted from transfected COS-1 cells.
The Effect of Increasing Cytosol Volume on GTK Activity
The GTK assay was performed as outlined in section 2.9.2, however, varying 
amounts of cytosol were added to each reaction (2.5 - 20/d). It was found that 2.5/<l of 
cytosol per reaction gave the highest specific activity, figure 3.1 shows the effect of 
increasing cytosol volume. Since the protein content of each cytosol preparation was
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always very similar, using a constant volume of cytosol in the GTK reaction ensured 
that each reaction had a similar protein content.
The Effect of Increasing Reaction Time on GTK Activity
It was decided that in order to have optimal enzyme activity, the length of time that 
the enzyme was allowed to react was a critical factor. Also, due to the large number 
of samples assayed, together with the fact that the reaction product only remained 
stable for up to of 15min, it was necessary to keep the reaction time as short as 
possible.
The reaction was carried out as outlined in section 2.9.2, with the exception that 
reaction times were increased from 5min through to 20min. As expected, the amount 
of reaction product formed increased in a linear fashion as a function of time (data not 
shown). A reaction time of lOmin was chosen to be used in the optimised assay, as 
this provided sufficient enzyme activity together with allowing a faster throughput of 
samples (data not shown).
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Figure 3.1 - Glutamine transaminase K activities observed with increasing volumes 
of cytosolic protein per assay.
Cytosol was extracted from COS-1 cells transfected with the cDNA encoding human 
renal cysteine conjugate 6-lyase. GTK assays were performed according to the 
method of Cooper and Meister (1985) as outlined in section 2.9.2, alterations to the 
protocol were as outlined in section 3.2.3.1.
All results are expressed as the mean ± standard deviation of 4 determinations.
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The Effect of Alterations to the Cytosol Preparation on GTK Activity 
Optimisation of the cytosol preparation for use with the transfected COS-1 cells was 
evaluated using the GTK assay. GTK activity of the resultant cytosol preparations 
was assessed (2.9.2) and used to determine the success of method alterations.
Table 3.1 sumarises the results obtained. As can be seen, the sonicating probe used 
was far too harsh a method for this preparation even when samples were only 
subjected to lx5sec sonication with the probe. The type of vessel used for the 
sonication appeared to have an effect on the resulting enzyme activity, with cytosol 
sonicated in microcentrifuge tubes producing a higher enzyme activity. Both an 
increase and decrease in the number of freeze/thaw cycles that the samples were 
subjected to appeared to decrease the resultant cytosolic enzyme activity. Increasing 
the number of sonications that the samples were subjected to, even when each 
sonication was of 5secs, appeared to decrease the resultant cytosolic enzyme activity. 
The only alteration made to the cytosol preparation which appeared not to have a 
great effect on enzyme activity was performing the freeze/thaws at -80°C for 3 x 
lOmin instead of using liquid nitrogen. However, there was still a decrease in enzyme 
activity observed with the resultant cytosol.
As a result of this experiment, no alterations were made to the standard protocol 
(section 2.8.7).
The Effect of Increasing the Incubation Time From 48hrs to 72hrs on Transfection 
Efficiency -  as Evaluated by GTK Activity
Transfection of the COS-1 cells was performed as outlined in section 2.8.5.1, 
however the final incubation period, before harvesting the transfection was increased 
from 48hrs to 72 hrs. The effect this increased incubation had on transfection 
efficiency
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Preparation Glutamine Transaminase K Activity 
(nmol/min/mg of protein)
Rat Sense 
cDNA
Rat Antisense 
cDNA
Control 
No DNA
A 492.4 ±51.7 17.8 ±1.6 13.7 ±2.1
B 88.1 ± 17.9 27.6 ±4.8 23.7 ± 8.4
C 110.6 ±5.0 7.5 ±4.6 13.4 ±2.1
D 287.0 ±17.8 13.9 ±4.6 9.2 ±1.5
E 99.9 ±24.8 16.6 ± 4.6 8.4 ±3.5
F 107.4 ± 15.7 12.9 ±3.5 23.4 ±8.6
G 284.7 ±24.7 4.3 ±2.7 19.8 ±0.7
H 193.1 ±3.1 86.0 ±26.8 12.6 ±3.7
I 200.5 ±21.2 13.3 ±4.6 18.5 ±1.7
J 210.4 ±11.3 14.3 ±3.7 24.4 ±3.9
Table 3.1 - Optimisation of the cytosol preparation evaluated by the measurement of 
GTK activity.
Cytosolic preparations (see below) from COS-1 cells transfected with the sense and antisense cDNAs 
encoding rat cysteine conjugate B-lyase were optimised by evaluation of GTK activity.
A = Cytosol prepared as outlined in section 2.8.7.1 
B = 2 freeze thaws 
C = 4  freeze thaws 
D = 3x lOmin freeze thaws at -80°C
E = 2 freeze thaws followed by 4x5sec sonication in a water bath 
F = 4 freeze thaws followed by 4x5sec sonication in a water bath 
G = sonicated in a water bath in a universal tube 
H = sonicated for lx5sec with a probe 
I = sonicated for 2x5sec with a probe 
J = sonicated for 3x5sec with a probe
All values in the table are expressed as the mean ± sem of 8 determinations except for 
preparations B, C, E, G and H which were only 4 determinations.
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Preparation Glutamine Transaminase K Activity 
(nmol/min/mg) of protein
Rat Sense 
cDNA
Rat Antisense 
cDNA
Control 
No DNA
48hr Incubation 492.4 ±51.7 17.8 ±1.6 13.7 ±2.1
72hr Incubation 694.4 ± 36.6 6.9 ±2.3 18.0 ±7.1
Table 3.2 - Glutamine transaminase K activities observed in cytosol extracted from 
COS-1 cells transfected with cDNAs encoding rat cysteine conjugate 6-lyase 
(orientated either in the sense or antisense direction relative to the CMV promoter) 
after 48 and 72 hr post transfection incubation periods.
All values are expressed as the mean ± sem of 8 determinations.
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was monitored by evaluating the GTK activity of the resultant cytosolic enzyme 
prepared from the transfected cells.
It was found that by increasing the final incubation period of the DEAE-dextran 
transfection by 24hrs, the GTK activity of the resultant cytosol was approximately 1.5 
fold greater than when transfection were incubated for 48hr (see table 3.2). Therefore 
it was decided that all transfections should now be subjected to a post transfection 
incubation period of 72hrs.
DEAE-Dextran Transfection versus DOTAP Transfection -  as Evaluated by GTK 
Activity,
COS-1 cells were transiently transfected using DOTAP as outlined in section 2.S.5.2 
and the cytosol prepared as outlined in section 2.8.7.1. The resultant cytosol 
preparations were assayed for GTK activity as outlined in section 2.9.2, and it was 
found that the rat sense cDNA exhibited a specific activity of 156.2 ± 22 
nmol/min/mg. Although this value appears to be quite acceptable, it is not however 
greater than any of the enzyme activities obtained using cytosol prepared from 
DEAE-dextran transfections. Since the DOTAP transfection reagent is also very 
expensive compared to the DEAE-dextran it was decided not to proceed any further 
with this former method of transfection.
A Comparison of GTK Activity Observed with Human and Rat Cytosolic and 
Mitochondrial Fractions Prepared from C0S~1 Cells Transfected with Rat and 
Human Cysteine Conjugate Ji~Lyase,
Previously, it was reported (Final Year Project - Christopher Lord) that there was no 
GTK activity found in mitochondrial samples prepared from COS-1 cells transfected 
with the cDNA encoding rat cytosolic cysteine conjugate 6-lyase. However, in the
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experiments presented within this thesis we have detected low levels of GTK activity 
present in the mitochondrial fractions of such transfected cells.
The results of this experiment are shown in table 3.3, and clearly indicate that for 
human cysteine conjugate 6-lyase, the specific activity for mitochondrial GTK is 
approximately one third of that obtained for the corresponding cytosolic GTK. The 
same ratio is observed for rat cysteine conjugate 6-lyase.
The cytosolic GTK activity observed for human 6-lyase is approximately 2 fold 
greater than that observed for the rat cysteine conjugate 6-lyase, a similar ratio is 
observed between the rat and human mitochondrial GTK activities.
When comparing the total amount of enzyme activity for that particular preparation 
(i.e. 3 X 75 cm^ tissue culture flasks of transfected cells) it was found that the 
mitochondrial enzyme activity accounted for 1% of the total enzyme activity for both 
the rat and human forms of the enzyme. Table 3.4 compares the total enzyme 
activities found for the rat and human forms of GTK for both the cytosolic and 
mitochondrial fractions.
Kinetic Analysis of Rat and Human Kidney Glutamine Transaminase K  Activity 
In order to assess the kinetics for GTK activity for the rat and human forms of 
cysteine conjugate 6-lyase/glutamine transaminase K, the cytosolic fractions isolated 
from COS-1 cells transfected with the cDNAs encoding rat and human 6-lyase were 
used. The experiment was performed as outlined in section 2.9.2, with the exception 
that the concentration of the substrate, phenylalanine, was varied from 0.2mM to 
lOmM. The level of specific activity varied slightly between transfections, however 
the ratio between rat and human forms of the enzyme remained reproducible 
throughout. The Km and Vmax values for GTK activity were calculated for both
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forms of the enzyme using the Hanes-Woolf method of analysis. The human cysteine 
conjugate 6-lyase was found to have a Km of 0.83mM and a Vmax of 2118 
nmol/min/mg, whereas the rat cysteine conjugate 6-lyase was found to have a Km of 
0.48mM and a Vmax of 1258 nmol/min/mg.
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Cellular
Fraction
Glutamine Transaminase K activity 
(nmol/min/mg of protein)
Human
Sense
cDNA
Rat Sense 
cDNA
Human
Antisense
cDNA
Rat
Antisense
cDNA
Control
NocDNA
Cytosolic 558.3 ±84 320.3 ±32 17.9 ±3 13.0 ±3 9.8 ± 2
Mitochondrial 173.6 ±42 85.3 ± 15 19.0 ±14 17.5 ± 8 10.1 ± 5
Table 3.3 - Glutamine Transaminase K activity (nmol/min/mg) found in cytosolic 
and mitochondrial fractions prepared from COS-1 cells transfected with the sense and 
antisense cDNAs encoding rat and human cytosolic cysteine conjugate 6-lyase.
Cellular
Fraction
Glutamine Transaminase K Activity 
(nmol/min/ preparation)
Human
sense
cDNA
Rat Sense 
cDNA
Human
Antisense
cDNA
Rat
Antisense
cDNA
Control 
No cDNA
Cytosolic 2989.1 ± 
299
2012.1 ± 
218
94.7 ± 13 72.3 ± 17 85.7 ±16
Mitochondrial 31.6 ± 7 17.0 ±3 3.3 ± 2 3.7 ±1 2.8 ±1
Table 3.4 - Total Glutamine Transaminase K activity (nmol/min/ preparation) found 
in cytosolic and mitochondrial fractions prepared from COS-1 cells transfected with 
the sense and antisense cDNAs encoding rat and human cytosolic cysteine conjugate 
6-lyase.
Cytosolic and mitochondrial fractions were prepared as outlined in section 2.8.7. All 
values are expressed as the mean ± sem of 18 determinations.
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3.2.3 2 6-Lyase Activity
The 6-lyase activity exhibited by the cytosolic fractions isolated from COS-1 cells 
transfected with cDNAs encoding rat and human cysteine conjugate 6-lyase was 
assessed as described in section 2.9.3.1 using 5mM TFEC and 5mM DC VC as 
substrates.
It was noted that the specific activity of the human form of the enzyme was higher 
than the rat. When TFEC was used as the substrate, the specific activity for the human 
enzyme was found to be 87.5 ± 4 nmol/min/mg, which was approximately 5 fold 
greater than that observed for the rat form of the enzyme. When DC VC was used as 
the substrate, the human form of the enzyme exhibited a specific activity of 27.6 ± 9 
nmol/min/mg which was 14 fold greater than that observed for the rat form of the 
enzyme. Figure 3.2 shows a comparison of the specific activities found for the rat and 
human forms of the enzyme when TFEC and DC VC were used as substrates. It would 
appear that specifically under these conditions, TFEC was the better substrate for both 
rat and human cysteine conjugate 6-lyase. However, it must be recognised that these 
experiments only confirm that the transient transfection works to generate enzyme 
activity. In addition, because fixed substrate concentrations for both TFEC and DC VC 
were used, 1 can make no conclusions as to the kinetic characteristics of both 
enzymes. Accordingly, 1 decided to perform the comparative enzyme characterisation 
in the stably transfected cell lines as described in Chapter 4.
Unfortunately, due to the poor availability of the substrates, multiple assays could not 
be performed, therefore the experiment was performed twice in duplicate.
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Figure 3.2 - Cysteine conjugate 6-lyase activity of cytosolic extracts from COS-1 
cells transfected with the cDNAs encoding rat and human cysteine conjugate 6-lyase. 
6-Lyase activity was measured by incubating cytosolic protein extracted from COS-1 
cells transfected with the cDNAs encoding rat and human cysteine conjugate 6-lyase 
with 5mM tetrafluoroethyl cysteine (TFEC) or 5mM dichlorovinyl cysteine (DCVC) 
as outlined in section 2.9.3.1. Activity is expressed as nmol of pyruvate formed 
/min/mg of protein. Results are expressed as the means ± SD of two determinations 
with the exception of the no cDNA control which is the result of one determination 
only.
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3.3 ISOLATION AND HETEROLOGOUS EXPRESSION OF A
TRUNCATED cDNA CODING FOR RAT CYSTEINE 
CONJUGATE B-LYASE IN COS-1 CELLS
Enzyme analysis of the newly isolated rat and human cysteine conjugate 6-lyase 
cDNAs expressed in COS-1 cells, clearly showed that for both GTK and 6-lyase 
activities the human exhibited a higher specific activity. There are several possible 
explanations for this, including differences in the active sites of the two forms of 
enzyme (90% homology around PL? site) which could affect substrate binding or 
differences in expression levels of cDNAs due to differences in the 5’ non-coding 
region.
On examination of the DNA sequences of the rat and human cysteine conjugate 6- 
lyase, the most obvious difference between the two cDNAs is that the human cDNA 
had no 5' non-coding region but starts at the first AUG codon and finishes 58 bases 
into the 3' non-coding region. The rat cDNA on the other hand contains 244 
nucleotides of 5' non-coding region and 351 nucleotides of 3’ non-coding region. 
Closer inspection of the rat cDNA sequence also shows that there were two 70 
nucleotide inverted repeats in the 5' non-coding region of the rat cDNA which may 
result in secondary mRNA folding and hence lower translation rates thus accounting 
for the differences in activity observed.
In order to reduce the possibility that the differences in specific activity between the 
COS-1 cells expressing rat and human enzymes were due to differences in mRNA 
translation, a shortened version of the rat cDNA, more like the human cDNA was 
produced. The 5’ non-coding region and most of the 3’ non-coding region were 
removed using a PCR-based method.
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3.3.1 Truncation of the cDNA Encoding Rat Cysteine
Conjugate B-Lyase
There are several methods available for truncating DNA, the easiest approach would 
have been to digest the rat cDNA with restriction enzymes. However, in this case, due 
to the large and varied number of restriction sites within the cDNA itself, it proved 
very difficult to find a restriction enzyme that would digest the cDNA in the required 
positions without actually cutting the coding region of the cDNA itself. The next 
obvious method was to truncate the rat cDNA using polymerase chain reaction, with 
primers specific to the regions which were to be the start and finish of the resultant 
truncated cDNA.
3.3.1.1 Preparation of a Truncated cDNA Encoding Rat Cysteine 
Conjugate B-Lyase
In order to truncate the rat cDNA using PGR, firstly the template, in this case the 
original rat cDNA, had to be digested to remove the first 150 - 200 bases since the 
sense direction primer could also bind to the antisense DNA strand in this region.
Preparation o f the cDNA Template.
The rat cysteine conjugate 6-lyase cDNA was prepared as outlined in section 2.6.5. 
Restriction Digest o f cDNA Template
On assessing the possible restriction enzymes which could be used to remove part of 
the 5’ non-coding region of the rat cDNA without cutting within the coding region of 
the cDNA, it was found that there were two commercially available enzymes. Firstly, 
the restriction enzyme, Dra I would produce a blunt cut of the cDNA template at the 
position 153. Secondly, the restriction enzyme Nae I would cut the cDNA at the 
position 198, also producing blunt ended fragments ( see table 2.2 for information on 
restriction enzyme cutting sites).
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The cDNA template was digested as outlined in section 2.3.3, the digestion product 
was electrophresed on a 0.7% (w/v) agarose gel and visualised by ethidium bromide 
staining (2.3.4.1& 2.3.5).
Figure 3.3 shows the resultant DNA fragments and it can be seen that the restriction 
enzyme Dra I  appeared to cut the expression vector containing the cDNA several 
times, making isolation of the correct band containing the cDNA very difficult. The 
restriction enzyme Nae I  on the other hand only cut the vector once, producing two 
clearly separated fragments of approximately 4200 bp and 3200 bp. Further analysis 
of the vector map containing the cDNA insert indicated that the cDNA fragment 
would be found in the larger fragment.
The larger 4200 bp fragment was then cut out of the agarose gel using a sterile scalpel 
and concentrated by Geneclean (2.3.7.1; data not shown).
3.3.1.2 PCR Amplification of a Shortened Rat B-Lyase cDNA
PCR amplification was performed as outlined in section 2.4 using 5 pi\ of the cDNA 
from section 3.3.1.1. A 5’ gene specific oligonucleotide primer was (PR I) was used 
to prime the synthesis of the top strand, starting at the start codon, together with a 3’ 
gene specific oligonucleotide primer to prime the bottom strand, 58 nucleotides 
downstream of the stop codon (see figure 3.4). The PCR amplification was performed 
at an annealing temperature of 55 “ C, and the product electrophoresed on a 1% (w/v) 
agarose gel (2.3.4.1). Figure 3.5 shows that although the amplification was successful, 
there were some non-specific bands present, together with contamination of the no 
DNA control.
Therefore the amplification was performed again under similar experimental 
conditions with the exception that the annealing temperature was raised to 58“ C and
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Figure 3.3 - 1% (w/v) agarose gel electrophoresis of the cDNA encoding rat renal 
cysteine conjugate B-lyase in the expression vector pUSlOOO following digestion with 
Nae I (lanes 4 & 5) and Dra I (lanes 2 & 3). Lane 1 contains the molecular weight
marker XHind III/ EcoRI.
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Figure 3.4 - The isolation of a truncated cDNA encoding rat cysteine conjugate 6- 
lyase by PCR amplification using the oligonucleotide primers PRI and PRII.
Removal of the 5' and most of the 3 ’ non-coding region from the original rat B-lyase 
cDNA was achieved using oligonucleotide primers specific to the regions indicated 
above.
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Figure 3.5 - 1% (w/v) agarose gel electrophoresis of the PCR amplification of the 
truncated rat cysteine conjugate B-lyase cDNA (lane 2). Lane 1 contains the molecular
weight marker XHindlll/EcoRI and lane 3 contains the no DNA control which in this 
case is clearly contaminated.
1 2 3  4  5
1 - 3 K b
Figure 3.6 - 1% (w/v) agarose gel electrophoresis of the PCR amplification of a 
truncated rat cysteine conjugate B-lyase cDNA (lanes 2 & 3). Lane 1 contains the 
molecular weight marker kHindlll/EcoRI, lane 3 contains the non-UV irradiated PCR 
amplification of the truncated rat 6-lyase, lane 4 contains the non-UV irradiated no 
DNA control and lane 5 contains the UV irradiated no DNA control.
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also the samples were UV irradiated before the addition of the cDNA template, to 
prevent contamination.
The PCR amplification product was electrophoresed on a 1% (w/v) agarose gel and 
visualised by ethidium bromide staining (23.4.1 & 2.3.5). Figure 3.6 shows that the 
PCR amplification was successful with no non specific bands present. Furthermore, 
the use of UV irradiation had solved the problem of the contamination of the no 
DNA control reactions.
The PCR amplification was cut out of the agarose gel and concentrated using the 
Geneclean method (2.3.7.1). The 5/d of the resultant 1.3kb fragment were 
electrophoresed on a 1% (w/v) agarose gel in order to assess its purity and 
concentration (data not shown). The truncated rat cDNA was found to have a 
concentration of approximately 200ng / /d.
3.3.2 Subcloning of PCR Products Using the TA Cloning ™
System
The TA cloning™ system (Invitrogen corporation) takes advantage of the non­
template dependent activity of the thermostable polymerase used in PCR, which 
incorporates a single deoxyadenosine to the 3’ end of all duplex molecules. The 
vector provided with the TA cloning™ kit, pCR™II, in its linear form has single 3’ 
deoxythymidine overhangs either end of the insertion site, allowing one step cloning 
without the need for further modification of the PCR product. The vector containing 
the insert can then be transformed into the E. coli strain INVoF’ which allows 
blue/white screening of recombinant plasmids by «-complementation of 6-
galactosidase with the lacTMAlS genotype (see section 2.2.4).
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3.3.2.1 Subcloning of the PCR Product into the Vector pCR ™II
The concentrated PCR fragment was ligated into the vector pCR™II following the 
protocol outlined in section 2..5.1. Competent E.coli cells (INVoF’), were 
transformed with the ligation products (section 2.5.2) and plated on LB agar plates 
(50|/g/ml ampicillin, 40//g/ml X-gal). The plates were incubated at 37“C for up to 
48hrs allowing the blue background colour of the non-insert containing cells to 
develop. White colonies, together with a single blue colony as a negative control, 
were re-cultured on 1cm squares of ampicillin/X-gal plates and incubated at 3TC  for 
24hrs. Those colonies which still remained white were examined for inserts using the 
cracking procedure (see 3.3.2.2).
The first plates produced four possible white colonies, these were re-cultured and left 
for 24hr, after which time only two of the possible four colonies remained white. This 
was probably due to the low DNA concentration used in the ligation mixture.
3.3.2 2 Cracking Procedure
The white colonies produced in the experiment above were analysed for the presence 
of DNA insert using the cracking procedure (see 2.6.4). Samples were 
electrophoresed on a 1% (w/v) agarose gel (2.3.4.1) alongside a sample of pCR™II 
(see figure 3.7). Analysis of the resultant gel showed that only one of the two possible 
insert containing colonies actually contained the insert DNA, which was retarded in 
comparison to the control pCR™II. A small scale plasmid preparation using the 
Promega Wizard mini preparation method (section 2.6.5.1) was then performed on the 
insert containing sample and the DNA analysed by restriction enzyme digest to 
confirm the size of the insert DNA.
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Figure 3.7 - A cracking gel to detect recombinant clones by DNA retardation on 1% 
(w/v) agarose gel electrophoresis. Lane 1 shows a clone which contains plasmid DNA 
only, lane 2 shows a false positive clone which contains neither plasmid or insert 
DNA, lane 3 shows a positive clone which contains both plasmid and insert DNA.
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Figure 3.8 - 1% (w/v) agarose gel electrophoresis of the truncated rat B-lyase
subclone in the plasmid pCRIII following digestion with EcoRI (lane 2). Lanes 1 and
3 contain the molecular weight markers XHindlll/EcoRI and (j)X174 Haelll 
respectively.
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3.3.2.S Confirmation of the Truncated cDNA Size
Plasmid DNA from the clone containing DNA insert was digested with EcoRI 
(section 2.3.3) and electrophoresed on a 1% (w/v) agarose gel before being visualised 
by ethidium bromide staining (2.3.4.1 & 2.3.5). Figure 3.8 clearly shows that the 
plasmid containing DNA insert when digested with EcoRI produces three fragments
as expected. Firstly the larger band of approximately 4kb is the vector pCR™II, the
remaining fragments are approximately 840 bp and 497 bp respectively which are the 
expected size if the truncation had been successful. To confirm that what was seen on 
the agarose gel was infact a truncated version of the rat B-lyase cDNA, plasmid 
containing the original rat B-lyase cDNA was digested with EcoRI (section 2.3.3) and 
electrophoresed on a 1% (w/v) agarose gel together with the EcoRI digested truncated 
rat, uncut plasmid containing the original rat B-lyase cDNA and uncut plasmid 
containing the truncated rat B-lyase cDNA. As can be seen from figure 3.9, the 
trunacted rat B-lyase is clearly shorter than the original rat B-lyase.
3.3.3 DNA Sequencing of the Truncated Rat B-lyase cDNA
DNA sequencing was performed using two different methods. The first was manual 
sequencing using both vector primers SP6 and T7, together with gene specific primers
using Sequenase™ version 2.0 (see section 2.7). Unfortunately manual sequencing
proved to be unsuccessful, probably due to the quality of the DNA template and the 
age of the Sequenase kit.
The second approach was to use the ABI 373A automated sequencer which was run 
by a university employed technichan. The template DNA and primers were prepared 
as outlined in section 2.7.8. Sequence data was analysed using the Genejockey 1.1 
software package (Biosoft Ltd, UK).
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Figure 3.9 - 1% agarose gel electrophoresis of truncated and original rat B-lyase 
cDNA in their respective plasmids.
Lane 1 - Truncated rat B-lyase in pCRIII digested with the restriction enzyme EcoRI 
Lane 2 - Original rat B-lyase in pUSlOOO digested with the restriction enzyme EcoRI
Lane 3 - Molecular weight marker - bacteriophage \  digested with Hindlll and 
EcoRI
Lane 4 - Undigested truncated rat B-lyase in pCRIII 
Lane 5 - Original rat B-lyase in pUSlOOO.
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Figure 3.10 - Nucleotide sequence of the truncated rat cysteine conjugate B-lyase 
cDNA.
165
1 Met Thr Lys Arg Leu Gin Ala Arg Arg Leu Asp Gly H e Asp Gin
16 Asn Leu Trp Val Glu Phe Gly Lys Leu Thr Lys Glu Tyr Asp Val
31 Val Asn Leu Gly Gin Gly Phe Pro Asp Phe Ser Pro Pro Asp Phe
46 Ala Thr Gin Ala Phe Gin Gin Ala Thr Ser Gly Asn Phe Met Leu
61 Asn Gin Tyr Thr Arg Ala Phe Gly Tyr Pro Pro Leu Thr Asn Val
76 Leu Ala Ser Phe Phe Gly Lys Leu Leu Gly Gin Glu Met Asp Pro
91 Leu Thr Asn Val Leu Val Thr Val Gly Ala Tyr Gly Ala Leu Phe
106 Thr Ala Phe Gin Ala Leu Val Asp Glu Gly Asp Glu Val H e H e
121 Met Glu Pro Ala Phe Asp Cys Tyr Glu Pro Met Thr Met Met Ala
136 Gly Gly Cys Pro Val Phe Val Thr Leu Lys Pro Ser Pro Ala Pro
151 Lys Gly Lys Leu Gly Ala Ser Asn Asp Trp Gin Leu Asp Pro Ala
166 Glu Leu Ala Ser Lys Phe Thr Pro Arg Thr Lys H e Leu Val Leu
181 Asn Thr Pro Asn Asn Pro Leu Gly Lys Val Phe Ser Arg Met Glu
196 Leu Glu Leu Val Ala Asn Leu Cys Gin Gin His Asp Val Val Cys
211 lie Ser Asp Glu Val Tyr Gin Trp Leu Val Tyr Asp Gly His Gin
226 His Val Ser lie Ala Ser Leu Pro Gly Met Trp Asp Arg Thr Leu
241 Thr lie Gly Ser Ala Gly Lys Ser Phe Ser Ala Thr Gly Trp Lys
256 Val Gly Trp Val Met Gly Pro Asp Asn H e Met Lys His Leu Arg
271 Thr Val His Gin Asn Ser lie Phe His Cys Pro Thr Gin Ala Gin
286 Ala Ala Val Ala Gin Cys Phe Glu Arg Glu Gin Gin His Phe Gly
301 Gin Pro Ser Ser Tyr Phe Leu Gin Leu Pro Gin Ala Met Glu Leu
316 Asn Arg Asp His Met lie Arg Ser Leu Gin Ser Val Gly Leu Lys
331 Leu Trp lie Ser Gin Gly Ser Tyr Phe Leu H e Ala Asp H e Ser
346 Asp Phe Lys Ser Lys Met Pro Asp Leu Pro Gly Ala Glu Asp Glu
361 Pro Tyr Asp Arg Arg Phe Ala Lys Trp Met H e Lys Asn Met Gly
376 Leu Val Gly lie Pro Val Ser Thr Phe Phe Ser Arg Pro His Gin
391 Lys Asp Phe Asp His Tyr lie Arg Phe Cys Phe Val Lys Asp Lys
406 Ala Thr Leu Gin Ala Met Asp Glu Arg Leu Pg© Lys Trp Lys Glu
421 Leu Gin Pro
Figure 3.11 - The amino acid sequence encoded by the truncated rat B-lyase cDNA. 
The proline residue at position 416 represents the only amino acid change compared 
to the original sequence (Perry et al., 1993).
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The nucleotide and the deduced amino acid sequence of the truncated rat B-lyase is 
shown in figures 3.10 and 3.11. It was found that there were several differences in 
nucleotides between the original rat B-lyase and the truncated rat B-lyase, only one of 
which produced a change in the amino acid sequence, replacing a arginine residue 
with a proline residue eight amino acids from the stop codon.
3.3.4 Subcloning of the Truncated Rat B-lyase cDNA into the
Expression Vector pUSlOOO
In order to express the truncated rat B-lyase cDNA in tissue culture cells, it was 
necessary to insert the cDNA into an expression vector. In this case the expression 
vector pUSlOOO (Jackson et. al., 1992) was used.
3.3.4.1 Retrieval of the Truncated Rat B-Lyase cDNA from the Vector
pCR™II
The truncated rat B-lyase was removed from the vector pCR™II by digestion with the 
restriction enzymes Spe I  and Xba I. A  double digest was performed, since the 
restriction enzyme Spe I  had the lower salt concentration in its digestion buffer, the 
plasmid containing the truncated rat B-lyase insert was digested first with Spe I  (see 
section 2.3.3) for Ihr. The enzyme Xba I  was added to the initial enzyme digest 
mixture together with the appropriate amount of enzyme digestion buffer and the 
volume made up with sterile distilled water. The digest was then electrophoresed on a 
1% (w/v) agarose gel, where all but two of the teeth of the gel comb had been taped 
together to form one large well (figure 3.12). The resultant 1.4kb band was extracted 
from the agarose and the DNA concentrated using the Geneclean method (see section
2.3.7.1), the concentrated truncated rat cDNA was then electrophoresed on a 1% 
(w/v) agarose gel in order to assess concentration and purity (figure 3.13).
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Figure 3.12 - 1% (w/v) agarose gel electrophoresis of the truncated rat B-lyase
cDNA in the plasmid pCR™II following double digestion with the restriction 
enzymes Spel and Xbal (lane 2). Lane 1 contains the molecular weight marker
LHindlll/EcoRI.
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Figure 3.13 - 1% (w/v) agarose gel electrophoresis of the Spel/ Xbal digested
truncated rat B-lyase following concentration using the geneclean method.
Lane 1 contains the molecular weight marker kHindlll/EcoRl
Lane 2 contains genecleaned truncated rat B-lyase digested with Spel/ Xbal
Lane 3 contains the genecleane concentrated PCR amplification of the truncated rat B-
lyase (undigested).
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3.3.4 2 Subcloning of the Truncated Rat B-Lyase cDNA into pUSlOOO
The truncated rat 6-lyase cDNA was ligated into the Xba I  linearised vector pUSlOOO 
as outlined in section 2.6.2, using the 5:1,3: land 1:1 molar ratios of vector to insert.
The expression vector pUSlOOO does not contain a selectable marker for blue/white 
screening, therefore it is not possible to distinguish between recircularised plasmid 
and recombinants. Due to this, it was necessary to treat the linearised plasmid with 
calf intestinal alkaline phosphatase prior to ligation (see section 2.6.1). The alkaline 
phosphatase dephosphorylates the 5’ ends of the linearised plasmid preventing 
recirculaiisation. The dephosphorylated ends can still ligate to the DNA which has not 
been dephosphorylated, therefore if dephosphorylation has been 100% successful, 
only recombinant plasmids will produce transformants on the ampicillin plates. 
Unfortunately complete dephosphorylation is difficult to achieve resulting in the 
presence of some false positives.
The recombinant plasmids were transformed into E.coli JM109 bacterial cells (section 
2.6.3) and cultured on ampicillin plates overnight at 37° C. A selection of the colonies 
were streaked out in a 1cm square grid pattern on an ampicillin plate and incubated 
overnight at 37°C. These colonies were examined for the cDNA insert using the 
cracking procedure (3.3.4.3).
3.3.4 3 Analysis of Plasmids from Transformed Bacteria
Crude preparations of plasmid DNA were prepared using the cracking procedure 
(section 2.6.4), and samples were analysed on a 0.7% (w/v) agarose gel (2.3.4.1) 
together with a sample of the plasmid pUSlOOO containing no insert (Figure 3.14) . 
The plasmid migration of clones 7, 24, 25, 38, 44, 45, 50 and 54 showed retarded 
mobility compared with the control pUSlOOO. Small scale plasmid preparations of 
these clones using the Promega mini preparation method (section 2.6.5.1) were
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digested with the restriction enzyme EcoRI and the resultant digest electrophoresed 
on a 1% (w/v) agarose gel (section 2.3.4.1). It was clear from the gel (data not 
shown), that the plasmid contained the truncated rat 6-lyase cDNA insert which 
corresponded to two fragments of 840bp and 497bp since the rat cDNA contained an 
EcoRI restriction site.
3.3.4 4 Determination of the Orientation of the Truncated cDNA in the
Recombinant Clones
Before expression studies could commence, it was necessary to determine the 
orientation in which the truncated rat cDNAs had been inserted into the plasmid 
pus1000. In order to obtain successful expession, the insert had to be orientated in 
the sense direction with the promoter being upstream of the cDNA consensus start 
site. An anti-sense orientation plasmid would be used as a negative control. The 
orientation of the eight recombinants were determined using the restriction enzyme 
Stu I (figure 3.15). It was found that clones 7,38,44,45 and 54 were in the anti-sense 
orientation, whereas clones 24,25 and 50 were in the sense orientation. (Clone 44 was 
very difficult to see on the gel, but it was actually in the anti-sense orientation.)
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Figure 3.14 - A cracking gel to demonstrate recombinant clones by retardation on 
0.7% (w/v) agarose gel electrophoresis. The plasmid migration of clones in lanes 3, 
9, 13 and 19 show retarded mobility compared to pUSlOOO only in lane 2.
Lane 1. LHindlll/EcoRI
2. subclone 36 
3 -1 1 . subclones 38 - 46
12. subclone 48
13. subclone 50
14-15. XHindlll/EcoRl 
16 - 21. subclones 51 - 56 
22. XHindlll/EcoRl
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Figure 3.15 - 1% (w/v) agarose gel electrophoresis of eight truncated rat B-lyase 
subclones following digestion with the restriction enzyme Stu I.
Digestion of these clones with StuI would allow the orientation of the truncated 
cDNA inserts to be determined. Clones in lanes 3,4 and 8 are in the sense orientation 
as indicated by the presence of bands of size 6190bp and 702bp. StuI digests of clones 
in the anti-sense direction produced bands of 4893bp and 1999bp.
1. XHindlll/EcoRl
2. subclone 7
3. subclone 24
4. subclone 25
5. subclone 38
6. subclone 44
7. subclone 45
8. subclone 50
9. XHindlll/EcoRl
10. subclone 54
172
3.3.5 Transfection of COS-1 cells with the Truncated Rat B-
Lyase cDNA using DEAE-Dextran
COS-1 cells were cultured in Dulbecco’s Modified Eagles Medium, 10% (v/v) 
Australian foetal calf serum, 1% (v/v) gentamycin, 1% (v/v) anti-PPLO at 37°C in an 
atmosphere of 5% CO^. COS-1 cells were subcultured the evening before transfection 
at a ratio of 1:1 so that they would have reached between 65 - 80% confluency the 
following morning. DNA transfection of the COS-1 cell sub-cultures was performed 
as outlined in section 2.8.5.1, using the DEAE-dextran method of transfection. In 
order to obtain sufficient cytosolic protein for enzyme assays, three 75 cm  ^ tissue 
culture flasks (approximately 60 - 80% confluent) were transfected for each of the 
original rat sense cDNA, the truncated rat sense cDNA and a no DNA control. 
Transfected cells were incubated at 37°C, 5% CO^ for 72hr prior to harvesting.
3.3.5.1 Preparation of COS-1 Cell Cytosol
Cytosolic extracts were prepared from the transfected COS-1 cells as outlined in 
section 2.8.7.1. Samples were kept on ice throughout the experiment in order to 
minimise the risk of enzyme inactivation due to protease activity, and were stored at - 
20°C until required.
3.3.5.2 Enzyme Analysis of COS-1 Cell Cytosol
Crude cytosol extracted from COS-1 cells transfected with the original rat sense 
cDNA, the truncated rat sense cDNA and a no DNA control were assayed for GTK 
activity. The specific activities of the samples were calculated using the protein 
concentration values determined by the method of Miller (see section 2.9.1).
Glutamine Transaminase K  Activity
Glutamine transaminase K (GTK) activity was determined as outlined in the method 
of Cooper and Meister (1985; see section 2.9.2). Initial GTK assays using cytosolic
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extracts from the transfected cells showed no or extremely little enzyme activity for 
all cytosol peparations. The assay was repeated using samples previously found to 
possess high levels of GTK activity which again exhibited high levels of GTK 
activity, therefore the assay was still functional. Since the cytosolic samples 
exhibiting high GTK activity had undergone the same cytosol preparation as the 
above, it was unlikely that the problem lay within the preparation of the cytosol. It 
was therefore decided to repeat the transfections using COS-1 cells which were at a 
lower passage number, since the possibility of mutations within the cell line increases 
with increasing passage number.
It was found that the cytosol extracted from COS-1 cells transfected with the cDNA 
encoding the truncated rat 6-lyase did not appear to express increased GTK activity 
compared to the original rat 6-lyase cDNA (fig 3.16). In fact there was a reduction in 
the GTK specific activity observed. Since the aim of the experiment was to increase 
the enzyme activity exhibited by the rat 6-lyase, it was decided not to pursue this 
further. It was quite possible that the differences in enzyme activity observed between 
rat and human 6-lyase are due to differences in levels of expression. The fact that the 
truncated rat 6-lyase when expressed in COS-1 cells had a lower activity than the 
original rat 6-lyase may be due to the amino acid changes found in the truncated rat 
cDNA, one of which changed an arginine residue to a proline residue eight amino 
acids from the stop codon. The changes in amino acids observed in the truncated rat 
cDNA are probably mutations introduced by the thermostable polymerase used to 
generate the truncated cDNA.
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Figure 3.16 - GTK activity (nmol/min/mg) in cytosol extracted from COS-1 cells 
transfected with the original and truncated rat 6-lyase cDNAs. The truncated rat 
antisense cDNA and the no DNA transfections were used as negative controls. All 
results are expressed as the means ± sem of six determinations.
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3.4 STABLE EXPRESSION OF cDNAS CODING FOR RAT AND
HUMAN CYSTEINE CONJUGATE B-LYASE IN THE PIG 
KIDNEY PROXIMAL TUBULE CELL LINE LLC-PKl
The ultimate aim of this project was to develop an in vitro system for the assessment 
of cysteine conjugate metabolism and toxicity. It is well established that the target site 
of nephrotoxicity due to cysteine conjugates is the p3 segment of the proximal tubule 
(Lock and Ishmael, 1979). In order to create an in vitro system which would reflect 
conditions found in vivo, it was necessary to find a cell line which exhibited most of 
the characteristics of the proximal tubule. One such cell line is the pig kidney cell line 
LLC-PKl which was first established in 1958 at Lilly research laboratories, Indiana 
(Hull et al., 1976) and prepared from the kidney of a 171b juvenile Hampshire pig. 
The cell line has been very well characterised (Gstraunthaler et al., 1985; 
Gstraunthaler, 1988; Gstraunthaler et al, 1990) and has been shown to retain in 
tissue culture many of the properties of proximal tubular cells including several 
transport systems and an apical-positive transepithelial potential difference (Mullin et 
al, 1987). Furthermore, the LLC-PKl cell line has been used for several years in the 
study of cysteine conjugate toxicity (Schaeffer & Stevens, 1986; Stevens et al, 1986; 
Chen et al., 1992; Finkelstein et al., 1994; Anthony et al., 1996).
It was therefore decided to attempt to stably incorporate the cDNAs encoding rat and 
human cysteine conjugate 6-lyase isolated by Perry et al, (1993 & 1995) into the 
genome of the LLC-PKl cell line. The expression vector pUSlOOO contained a 
selectable marker, the GPT cassette which would allow clones that had incorporated 
the plasmid into their genome to be selected in media containing xanthine and 
mycophenolic acid.
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The transfection and selection procedures together with some of the GTK assays 
were performed by Dr. Claire Scholfield a former research fellow in this laboratory. 
The subsequent characterisation of the 6-lyase activity in these cell lines and their 
sensitivity to cysteine conjugate toxicity was performed as part of this thesis and is 
reported below.
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3.4.1 DOTAP Transfection of LLC-PKl Cells
LLC-PKl cells were cultured in medium 199 containing 10% (v/v) Australian foetal 
calf serum, 1% (v/v) anti-PPLO and 1% (v/v) gentamycin at 37°C in an atmosphere of 
5% CO2- The evening before transfection the cells were seeded out (section 2.8.2) to a 
density which would allow them to have reached 60 - 80% confluency by the 
following morning (1:1). The cells were transfected as described in section 2.8.5.2 
using lOjAg of DNA for each transfection. Three 75cm^ tissue culture flasks were used 
for each of the human sense cysteine conjugate 6-lyase and the rat sense cysteine 
conjugate 6-lyase. After transfection, the cells were incubated for approximately 
18hrs at 37°C in an atmosphere of 5% CO^ after which the transfection media was 
replaced with fresh medium 199 and the cells allowed to settle overnight. The cells 
were then sub-cultured (section 2.8.2) at a ratio of 1:3 and incubated at 37°C in an 
atmosphere of 5% CO^ overnight.
3.4.2 Selection of Recombinant Clones
The selectable marker present in the expression vector pUS 1000 is the xanthine - 
guanine phophoribosyltransferase or GPT gene. GPT is a bacterial enzyme which 
converts xanthine to XMP, a reaction which does not occur readily in mammalian 
cells. Mulligan and Berg (1981) developed a system whereby they used the GPT 
gene as a selectable marker. Only those cells which have retained the GPT gene will 
be capable of surviving in xanthine rich media containing mycophenolic acid to 
prevent de novo purine synthesis.
After 24hrs in medium 199, the transfected cells were transfered to HAT media, and 
incubated for a period of up to 14 days at 37°C, 5% COj allowing the cells containing 
the GPT gene to form colonies whilst those cells which did not contain the gene died. 
Several changes of media were necessary in order to remove the dead cells from the 
media. The surviving colonies were then picked and each one placed into a well on a
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96 well plate in non-selective media containing 20% (v/v) FCS. Out of approximately 
200 cells that were initially selected, only 14 of those were developed into cell lines, 5 
of those being cell lines expressing the human 6-lyase gene, the remaining cell lines 
expressing the rat 6-lyase gene.
The cell lines were passaged several times before stocks were made and stored in 
liquid nitrogen (see section 2.S.6.2).
3.4.3 Preparation of Cytosol from the Stably Transfected Cell 
Lines
Cytosol from each of the 14 newly established cell lines was prepared as outlined in 
section 2.8.6. The samples were kept on ice throughout the procedure in order to 
minimise the risk of enzyme inactivation due to protease activity, and stored at -20°C 
until required
3.4.4 Enzyme Analysis of the Cell Cytosol Extracted from the
Stably Transfected LLC-PKl Cell Lines.
The crude cytosols from the 14 newly established cell lines were assayed for 
glutamine transaminase K activity. The specific activities of the samples were 
calculated using protein concentrations determined by the method of Miller (see
2.9.1).
3.4.4.1 Glutamine Transaminase K Activity
Glutamine transaminase K activity was determined by the method of Cooper and 
Meister (1985) as outlined in section 2.9.2. Primary screening of the 14 cell lines 
using the glutamine transaminase K assay showed that only seven of the 14 cell lines 
exhibited GTK activity which was significantly higher than that observed for the wild
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type LLC-PKl cells (Dr C. Scholfield, data not shown). Therefore, these seven cell 
lines were selected for further experimentation. As can be seen from figure 3.17 the 
cell line RIJ exhibited a GTK activity which was quite similar to that obtained for the 
cell lines expressing human 6-lyase.
The highest and lowest expressing cell lines for human and rat 6-lyase were then 
choosen for further characterisation. Unfortunately, the higher expressing human 6- 
lyase cell line HS3A developed a bacterial infection and all further attempts to culture 
the remaining HS3A cell line stocks failed, either due to bacterial infection or to the 
fact that the cells would not adhere to the tissue culture flasks. Therefore the cell line, 
HS3C was used for further studies.
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Figure 3.17 - GTK activities (nmol/min/mg) found in cytosolic extracts of the newly 
developed cell lines expressing rat and human renal cysteine conjugate 6-lyase.
1 = untransfected cell line, LLC-PKl; 2 = cell line RIJ ; 3 = cell line RII4B;
4 = cell line R3D; 5 = cell line HS3A ; 6 = cell line HS3C; 7 = cell line HS2A;
8 = cell lineHSII2A
where R = stable transfection of the cDNA encoding rat renal cytosolic cysteine 
conjugate 6-lyase
and H = stable transfection of the cDNA encoding human renal cytosolic cysteine 
conjugate 6-lyase.
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3.4.5 Southern Blot Analysis of DNA Isolated from Stable Cell
Lines
In order to ascertain whether the levels of enzyme activity expressed in the various 
cell lines related to the number of copies of the cDNA which had been integrated into 
the genome of the host cell line LLC-PKl, Southern blot analysis was performed on 
genomic DNA extracted from four selected cell lines from the wild type pig kidney 
cells, LLC-PKl.
30jig of EcoRI digested (2.10.3.1) genomic DNA extracted from the cell lines 
(2.2.10.2) together with 5ng of EcoRI digested plasmid DNA were electrophoresed on
a 1% (w/v) agarose gel alongside X EcoRI/Hindlll DNA markers (2.3.4.2). The DNA
was then depurinated, denatured and transferred onto a nylon membrane (see 2.10.3.2 
& 2.10.3.3). Southern blot analysis was performed as outlined in section 2.10.3 using 
the ECL hybridisation detection procedure and the full length human 6-lyase cDNA 
labelled with the enzyme horseradish peroxidase (see section 2.10.3.4) as the probe. 
Washing conditions of moderate stringency were used (see section 2.10.3.4) before 
the blot was treated with the detection reagent and exposed to X-ray film for 72hr 
(section 2.10.3.4).
The restriction enzyme pattern of the Southern blot (figure 3.18) clearly shows that 
the cDNAs for both rat and human 6-lyase have been stably incorporated into the 
genome of the LLC-PKl cells. Lane 3 - the genomic DNA from the wild type LLC- 
PKl cells shows clearly that there was no detectable levels of 6-lyase DNA present in 
the original cell line. Figure 3.18 also suggests that the difference in enzyme activity 
between the high and low expressing rat 6-lyase cell lines is probably due to the 
number of copies of cDNA integrated into the LLC-PKl cell genome, the same may 
be said for the high and low expressing human 6-lyase cell lines.
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MCID image analysis of the original Southern blot X-ray film taken by Dr Nick Plant 
(data not shown) showed that the ratio of high expressing human 6-lyase DMA : low 
expressing human 6-lyase DMA was 1.7:1, and the ratio of high expressing rat 6-lyase 
DNA to low expressing rat 6-lyase DNA was 1.8:1. The difference in expressed 
enzyme activity however, between high and low rat 6-lyase cDNAs is approximately 
5 fold. A possible reason for this could be that the LLC-PKl cells possess factors 
which limit maximal expression of the enzyme. A similar situation is seen with 
human 6-lyase, there is an 8 fold difference between the level of high and low 
expressing cDNAs, whereas there is only a 6 fold difference in their enzyme activity.
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Figure 3.18 - Southern blot analysis of the cell lines RIJ, RII4B, HS3C and HSII2A 
using the cDNA encoding human cysteine conjugate 6-lyase as the hybridisation 
probe. Genomic and plasmid DNAs were digested with EcoRI prior to analysis. 
Detection of the 6-lyase DNA was achieved using the ECL direct nucleic acid 
labelling and detection system (Amersham).
Lane 1 - Human 6-lyase cDNA clone in the plasmid pUSlOOO.
Lane 2 - Rat 6-lyase cDNA clone in the plasmid pUSlOOO.
Lane 3 - Genomic DNA extracted from LLC-PKl.
Lane 4 - Genomic DNA extracted from HS3C.
Lane 5 - Genomic DNA extracted HSII2A.
Lane 6 - Genomic DNA extracted from RII4B.
Lane 7 - Genomic DNA extracted from RIJ.
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3.5 DISCUSSION
The work presented in this chapter describes the successful expression of rat and 
human renal cytosolic cysteine conjugate 6-lyase when expressed in tissue culture 
cells. Having isolated both the rat and human 6-lyase cDNAs it was then possible to 
express them in tissue culture cells providing an in vitro system which could be used 
to supply large quantities of the crude enzymes. Species differences between rat and 
human 6-lyase were observed and an attempt was made to explain this. Furthermore, 
enzyme activity was also found in the mitochondrial fractions extracted from the 
tissue culture cell systems. Finally, the successful construction of cell lines stably 
expressing rat and human cytosolic cysteine conjugate 6-lyase allowed further 
analysis of the enzymes to be performed.
Perry et al, (1993 & 1995) produced cDNAs encoding rat and human renal cytosolic 
cysteine conjugate 6-lyase. In order to produce large quantities of the enzyme, it was 
necessary to express the cDNAs in a cell system. At the time, one of the better cell 
systems for producing high expression of recombinant proteins was the COS-1 cell 
system used in conjunction with an expression vector possessing an SV40 origin of 
replication. Both the more traditional DEAE-dextran and the newer lipofection based 
DOTAP methods of transfection were performed. It was found that the DEAE- 
dextran method of gene transfer gave higher enzyme activities than the DOTAP 
method, suggesting that it was a more efficient method when used with this particular 
cell line. In fact this is in agreement with Kluxen and LUbbert (1993) who examined 
several different transfection techniques using COS-1 cells. They found that using a 
method very similar to that used in this thesis, for COS-1 cells, DEAE-dextran 
mediated uptake of DNA resulted in higher expression rates than lipofection and 
electroporation. Furthermore, the latter authors left their cells for a period of 72hr as 
opposed to 48hr before harvesting the transfected cells.
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Optimisation of the cytosol preparation did not result in any alterations to the standard 
protocol. My experiments reinforced the fact that the freeze thaw step in the cytosol 
preparation was extremely critical and alteration to the number and method of freeze 
thawing gave rise to lower enzyme activities in the resultant cytosol. The method of 
sonication was vital in the preparation of cytosol, sonication by probe being far too 
extreme a technique.
When the cDNAs for rat and human cytosolic 6-lyase were expressed in COS-1 cells, 
it was clear that there was a difference in their enzyme activity. Although there was 
inter transfection variance which produced different resultant enzyme activities it was 
always clear that the human cysteine conjugate 6-lyase consistently produced higher 
enzyme activities than rat cysteine conjugate 6-lyase at fixed substrate concentrations 
(5mM). It is unlikely that the differences in enzyme activity between the rat and 
human forms of 6-lyase were due to differences in transfection or cytosol preparation 
since they were transfected on the same day, into cells of the same passage number 
which had been sub-cultured the night before, and individual transfections were then 
processed 72hr post transfection under identical conditions. It was more likely that the 
apparent differences in enzyme activity were ‘reaT species differences.
When analysing enzyme activity of mitochondrial fractions prepared from COS-1 
cells transfected with the cDNAs encoding rat and human 6-lyase, it was apparent that 
contrary to previous data (Christopher Lord - final year project) there was in fact 
GTK activity present in this fraction both in the rat and human forms. The 
experiments were repeated many times and the mitochondrial fractions washed with 
large volumes of homogenisation buffer but the enzyme activities remained the same. 
Furthermore the GTK activity observed in these mitochondrial fractions was 
consistently higher for those preparations extracted from cells transfected with the 
sense cDNAs encoding rat and human 6-lyase than for those from the no DNA
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control transfections. Initially it was believed that somehow the cDNAs encoding rat 
and human cytosolic cysteine conjugate 6-lyase was gaining entry to the mitochondria 
and being expressed. It is well documented that both rat (Cooper & Meister (1974); 
Cooper & Meister (1981); Lash et al, (1986); Stevens et al, (1988)) and human 
(Buckberry et al, (1994)) kidney mitochondria possess GTK activity. It is possible 
that it is the endogenous GTK which is producing the observed enzyme activity 
within the mitochondria of the transfected cells. However, this does not explain why 
the GTK activity observed in mitochondrial fractions extracted from COS-1 cells 
transfected with rat and human 6-lyase exhibit higher enzyme activity than 
preparations from the no DNA control transfections. Since these experiments were 
performed, Abraham et al, (1995) have isolated a high molecular weight 
mitochondrial enzyme which they believe is the major cysteine S-conjugate 6-lyase 
of rat kidney mitochondria and is not the same as the cytosolic GTK/6-lyase present 
in rat kidney. Another possible explanation for the increase in GTK activity observed 
in the mitochondrial fractions extracted from COS-1 cells transfected with rat and 
human 6-lyase is that it is an artefact of the mitochondrial preparation.
The kinetics of glutamine transaminase K activity (using phenylalanine as a substrate) 
present in the cytosol of the transfected cells were examined using Hanes-Woolf 
analysis. It was found that on comparison of the Km values for the two enzymes, the 
human 6-lyase had a Km of 0.83 mM and a Vmax of 2118nmol/min/mg of protein, 
whereas the rat 6-lyase had a Km of 0.48mM and a Vmax of 1258 nmol/min/mg of 
protein. Again there are obvious species differences, with the human enzyme having a 
lower affinity for the substrate than the rat enzyme. The human enzyme however, 
does have a higher Vmax than the rat enzyme, but on comparison of enzyme turnover 
rates, the rat enzyme has a slightly higher turnover rate than the human enzyme 
(2620.8 nmol/min/mg/mM for the rat enzyme compared to 2551.8 nmol/min/mg/mM 
for the human enzyme).
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On evaluation of the kinetics of the metabolism of TFEC by cysteine conjugate 6- 
lyase, it was found that again the human enzyme had the higher Vmax (354 
nmol/min/mg) compared to the rat enzyme (90 nmol/min/mg). The human 6-lyase 
enzyme again exhibited a lower affinity for the substrate (Km of 6.5mM) compared to 
the rat enzyme (5.2mM). However, since this assay was only performed once in 
duplicate it may not provide an accurate analysis of the metabolism of TFEC. More 
accurate comparisons between rat and human cysteine conjuagte 6-lyase activity are 
made in chapter 4 using a more sensitive HPLC based method.
Initially it was believed that the differences in enzyme activity between rat and human 
cysteine conjugate 6-lyase were due to the 5’ inverted repeat present in the non­
coding region of the rat 6-lyase cDNA. It was hoped that by removing the 5’ non­
coding region of the rat 6-lyase cDNA increased activity would be observed with the 
expressed enzyme. However, the truncated version of the rat cDNA showed in fact a 
decrease in expressed enzyme activity. There were however several mutations present 
in the truncated rat 6-lyase cDNA, one of which caused a change in amino acids from 
an arginine to a proline residue eight amino acid residues from the end. It is not clear 
that an amino acid change this close to the end of the sequence would have any effect 
on the enzymes activity even though proline residues are known to have an important 
effect on protein folding. However, the possibility may exist that the arginine to 
proline change is crucial for enzyme activity, which is a possibility that requires 
further investigation.
It is likely that the base changes in the truncated rat cDNA sequence were a result of 
the Taq polymerase used to create the cDNA. It is kown that Taq polymerase does not 
possess proof reading ability unlike other thermostable polymerases, hence the 
incorporation of mutations. Another possible explanation for the base changes could 
also be the way in which the cDNA was sequenced. The truncated cDNA was cycle
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sequenced using an automated DNA sequencer. Again, this method is reliant on the 
enzyme Taq polymerase which might have incorporated base changes. Also errors in 
sequences occur when there are several of the same nucleotide present together in a 
sequence giving rise to additional nucleotides being placed in the sequence or the 
masking of the following nucleotide in the sequence. Since there was no increase in 
enzyme activity after truncation of the cDNA, together with the lack of time, this line 
of research was pursued no further.
However, what the data from the truncated clone of the rat 6-lyase did imply was that 
the differences between the rat and human enzymes were indeed species differences 
and not due to differences in expression of the enzyme.
The isolation of the cell lines expressing rat and human cysteine conjugate 6-lyase 
was performed by Dr. Claire Scholfield and proved to be very difficult and indeed the 
highest expressing human 6-lyase cell line HS3A, was eventually lost as a result of 
bacterial contamination. All liquid nitrogen stocks of the line were also contaminated 
indicating that the bacterial infection had probably occurred during the isolation of the 
cell line.
The stable transformant cell lines showed relatively high glutamine transaminase K 
activity, but never as high as that exhibited by the cytosol extracted from the COS-1 
cells transiently transfected with the cDNAs encoding rat and human 6-lyase. This is 
due to the input DNA amplification system present in the COS-1 cells.
Southern blot analysis of the genomic DNA extracted from the 6-lyase expressing cell 
lines showed that the difference in expression between the high and low expressing 
rat and human cell lines was due in part to the number of copies of the cDNAs which 
had been incorporated into the genome of the LLC-PKl cells. Interestingly, in the
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highest rat and human 6-lyase expressing stable cell lines, the enzyme specific 
activity (measured as GTK) similar. This would suggest that either the rat and human 
cDNAs can be transcribed and translated with the same efficiency (and that 
differences seen in the COS-1 transient expression system relate to some other 
reason) or that in the LLC-PKl cells, there are factors which limit the maximal 
expression of the enzyme (e.g. pyridoxal phosphate availability).
Northern blot analysis of the total RNA extracted from the rat and human 6-lyase 
expressing cell lines was attempted to examine the differences in 6-lyase mRNA 
levels between high and low enzyme level cell lines, however the experiments were 
unsuccessful and time did not allow further repeats.
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CHAPTER 4 
STRUCTURE ACTIVITY RELATIONSHIPS OF RAT AND 
HUMAN KIDNEY CYTOSOLIC CYSTEINE CONJUGATE B- 
LYASE / GTK
4 .1  INTRODUCTION
The enzyme cysteine conjugate 6-lyase is present in both rat and man, and metabolises 
the cysteine conjugates of certain halogenated hydrocarbons (Commandeur and 
Vermeulen, 1990). The availability of human kidneys for use in research to examine the 
role of 6-lyase in the bioactivation of halogenated hydrocarbons in man has always been 
a problem. As it becomes more evident from the effects of prolonged exposure of man 
to certain halogenated alkenes that renal cysteine conjugate 6-lyase may indeed play a 
part in the observed nephrotoxicity (Henschler et a l , 1995), it is becoming increasingly 
necessary to find an alternative method of studying this enzyme.
In Chapter 3 the characterisation of cDNAs encoding rat and human 6-lyase and their 
expression in tissue culture cells was discussed. Furthermore, pig LLC-PKl cells had 
been successfully used to produce several cell lines which express rat or human 
cysteine conjugate 6-lyase cDNAs. Of these newly created cell lines, four were chosen 
for closer examination; these were RIJ (high expression of rat 6-lyase); RII4B (low 
expression of rat 6-lyase); HS3C (high expression of human 6-lyase) and HSII2A (low 
expression of human 6-lyase). This chapter will examine the kinetics of the metabolism 
of several cysteine conjugates by cytosolic enzymes isolated from these cell lines, 
together with the cytotoxic effects of these conjugates on the cell lines. The stable cell 
lines expressing the cDNAs for rat and human cysteine conjugate 6-lyase will not only 
be able to provide an unlimited supply of these enzymes to allow their further study, but
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will also provide an efficient and accurate in vitro system for the assessment of 
xenobiotic metabolism and toxicity.
4 .2  OPTIMISATION OF A HPLC-BASED METHOD FOR THE
EVALUATION OF B-LYASE ACTIVITY
The initial optimisation of the HPLC based 6-lyase assay was performed by Mr Richard 
Jones a final year BSc student under my supervision. The method used was that of 
Stijntjes et al (1992; section 2.9.3.2). For all optimisation experiments, 7.5 mM 
tetrafluoroethyl-L-cysteine (TFEC) in O.IM sodium phosphate buffer was used as the 
substrate. All reactions were performed as outlined in section 2.9.3.2 unless otherwise 
stated. After Ihr derivatisation at 65°C followed by centrifugation at 13,000g for 5 min, 
200/d of the resultant supernatant was added to 200/d of the HPLC running buffer 
(54% water, 45% methanol, 1% glacial acetic acid). 90/d of the resultant sample was 
then separated by isocratic gradient reverse phase HPLC (see section 2.9.3.2).
The total run time of each sample was approximately 15 min which left me with very 
little time to prepare more samples or perform any other experiments. The introduction 
of an autosampler therefore left me with more time for sample preparation.
A further improvement to the system was to include a PC-mediated operating system to 
run the HPLC. This solved the problem created by the limited memory of the Spectra- 
physics integrator, allowing up to 48 samples to be analysed and the data recorded and 
manipulated at one time. This improvement was not implemented however until after 
the initial experiments using pyruvate standards had been performed.
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4.2.1 Pyruvate Standard Plots
In order firstly to validate the HPLC-based assay of Stijntjes et al. , data sets of pyruvate 
standards were analysed. Standards ranging in concentration from 0 to 100//M pyruvate 
were analysed, in order to assess the reproducibility of the assay with non-biological 
standards. Figure 4.1 shows that the standard plots obtained were very reproducible 
and were linear over the concentration range investigated.
4.2.2  Optimisation o f Protein Concentration in the 13- 
Lyase Assay.
Before kinetic analysis could be performed, the optimal amount of protein to be used in 
the assay had to be determined. The reaction was performed as outlined in section
2.9.3.2 using 7.5 mM tetrafluoroethyl-L-cysteine (TFEC) as the substrate together with 
cytosol extracted from the cell line, RIJ (high expression of rat 6-lyase). Cytosolic 
protein concentration was determined using the method of Miller (section 2.9.1). The 
protein concentration used in the assay was varied from 0 - 70 //g / assay. Each 
reaction was performed and assayed in triplicate. All reactions were performed in the 
absence and presence of the a-keto acid acceptor, a-KMB.
It can be seen from figure 4.2 that the amount of pyruvate produced increased in a linear 
fashion with increasing protein concentration, although with the higher protein 
concentrations, in the presence of a-KMB there does appear to be slight curvature.
Similar results were obtained when cytosol extracted from the cell line, HS3C (high 
expression of human 6-lyase; data not shown) was used. The presence of a-KMB can 
clearly be seen to increase the amount of pyruvate produced.
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Figure 4.1 - Pyruvate standard plot produced using the HPLC method. All values are 
expressed as mean ± sem; n = 12. r^  = 0.9958.
The standard curve shown above is the result of six experiments performed using 
duplicate samples.
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A concentration of 50/^g of cytosolic protein per reaction was used since this lay on a 
relatively linear part of the plot both in the presence and absence of a-KMB. This 
concentration was a factor of 10 less than that used by Stijntjes et a l , (1992) but equal 
to that used by Andreadou et a l , (1996).
4.2.3 The Effect o f a-KMB on B-Lyase Activity
Cysteine conjugate B-lyase is a PLP-dependent enzyme which is capable of catalysing 
both B-elimination and transamination reactions. The ratio at which these reactions 
occur in vivo is approximately 1:4 B-elimination : transamination. During 
transamination the PLP form of the enzyme is converted to the PMP form which cannot 
subsequently catalyse B-elimination. The presence of the a-keto acid acceptor, a-KMB 
regenerates the PLP form of the enzyme from PMP allowing B-elimination to proceed. 
7« vivo’ there would be many different a-keto acids present in the proximal tubule 
which could convert the inactive PMP form of B-lyase to the active PLP-form.
Initial results (Figure 4.2) suggested that the amount of pyruvate formed during the 
metabolism of cysteine conjugates by rat kidney cytosolic B-lyase extracted from the 
stable cell lines could be significantly increased by the addition a-KMB to the reaction 
mixture. It was therefore decided to examine the effect of the addition of a-KMB with 
time, and whether its addition after the usual 10 min reaction time would have a further 
effect on the amount of product formed. The experiment was performed as outlined in 
section 2.9.3.2 using rat and human kidney cytosolic B-lyase extracted from the cell 
lines RIJ and HS3C (both maintained high expression of the appropriate enzyme) with 
dichlorovinyl-L-cysteine (DCVC) as the substrate. The reaction was allowed to proceed 
for 10 min prior to the addition of 0.2 mM a-KMB and the reaction allowed to proceed 
for a further 10 min.
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It was found that on addition of a-KMB after the initial lOmin reaction followed by a 
further lOmin incubation, both the rat and human enzyme activities increased (Figure 
4.3). When the reactions were allowed to proceed for 20min in the absence of a-KMB, 
the enzyme activity appeared to plateau after lOmin.
Furthermore, when the metabolism of tetrafluoroethyl-L-cysteine (TFEC) by cytosolic 
enzyme extracted from the cell lines RIJ and HS3C was measured in the absence of a- 
KMB, non-linear kinetics plots were obtained (figure 4.4). On closer inspection of the 
enzyme activity data it was clear that kinetics experiments using cytosolic protein 
extracted from the stable cell lines would not provide accurate data in the absence of a- 
KMB. The high and low expressing rat B-lyase are the same enzyme merely expressed 
at different levels in their respective cell lines, they should therefore exhibit the same 
Km value but different values for Vmax. This was not the case in the absence of a- 
KMB. Therefore all subsequent kinetics experiments in this chapter were performed in 
the presence of a-KMB.
196
9 0 . .
! 7 0-.
S  6 0" ■
5
g 5 0 . .
'S
2  4 0 . .
PkV
I
1 0 . .
2 0 3 0 4 0 5 0 6 0 7 00 1 0
Cytosolic Protein (/tg/ml)
Figure 4 .2  - Protein dependence of the B-lyase assay in the presence and absence of 
a-KMB (0.2mM).
The protein dependence of the B-lyase assay was assessed by incubating cytosolic 
protein extracted from RIJ, the high expressing rat kidney cytosolic B-lyase cell line 
with 7.5mM TFEC for 10 min in the presence (■) or absence (#) of a-KMB 
(0.2mM).
Results are expressed as mean ± sem of three determinations.
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Figure 4 . 3 -  The influence of a-KMB addition on the metabolism of dichlorovinyl- 
L-cysteine (DCVC) by rat and human cysteine conjugate B-lyase in extracts from from 
the cell lines RIJ and HS3C respectively.
The influence of a-KMB on B-lyase activity was measured by incubating cytosolic 
protein extracted from the cell lines RIJ (high expressing rat B-lyase) and HS3C (high 
expressing human B-lyase) with 7.5mM DC VC for lOmin after which time, a-KMB
was added and the reaction allowed to proceed for a further 10 min. X represents the
cytosol extracted from HS3C after addition of a-KMB; ▲ represents cytosol extracted 
from HS3C without the addition of a-KMB; ■ represents cytosol extracted from RIJ 
after addition of a-KMB and #  represents cytosol extracted from RIJ without the 
addition of a-KMB. Results are expressed as the mean ± sem of three determinations.
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Figure 4 .4  - Kinetics of TFEC metabolism by cytosolic extracts from pig kidney 
cell lines stably expressing high or low levels of rat cytosolic B-lyase.
A Hanes-Woolf plot of B-lyase activity measured by incubating cytosolic protein 
extracted from RII4B (■), the low expressing rat kidney cytosolic B-lyase cell line and 
RIJ (•), the high expessing rat kidney cytosolic B-lyase cell line with various 
concentrations of TFEC for lOmin. Rate of reaction is expressed as nmol of pyruvate 
formed /min/mg of protein. Results are expressed as the means ± sem, of nine 
determinations.
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4.2 .4  The Effect o f AOAA on B-Lyase Activity
Aminooxyacetic acid (AOAA; Elfana et al, 1986) is an irreversible inhibitor of 
pyridoxal phosphate dependent enzymes such as those which express cysteine 
conjugate B-lyase activity. This experiment was designed to examine the effects of 
AOAA on the cytosolic enzyme extracted from the cell lines, HS3C and RIJ. The 
experiment was performed as outlined in section 2.9.3.2, with the exception that the 
reactions were performed in the presence and absence of AOAA. The substrate used for 
this experiment was DC VC, since this was more readily available at the time.
From figure 4.5 it can be seen that AOAA exerted an inhibitory effect on both the rat 
and human forms of cysteine conjugate B-lyase. However, it would appear that the 
AOAA had less of an inhibitory effect with human B-lyase, at least under these 
experimental conditions (O.IM AOAA).
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Figure 4 .5  - The effects of aminooxyacetic acid (AOAA) on B-lyase activity in 
cytosolic protein extracted from the cell lines RIJ and HS3C.
The effect of AOAA, the PLP-dependent enzyme inhibitor on the metabolism of 
dichlorovinyl-L-cysteine (DC VC) was assessed by incubating 7.5mM DC VC for 
lOminwith cytosol extracted from the cell lines RIJ (rat) and HS3C (human) in the 
presence (b) or absence (a) of 0.1 M AOAA. All values are expressed as the mean ± 
sem of three determinations. The effect of AOAA on the metabolism of DC VC by 
cytosol extracted from the cell line RIJ was seen to be very significant (**, p < 0.01), 
whereas the effect of AOAA on the metabolism of DC VC by cytosol extracted from the 
cell line HS3C was less significant (*, p < 0.05).
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4 .2  ENZYME KINETICS OF HUMAN AND RAT CYSTEINE
CONJUGATE B-LYASE
In order to gain an insight into the metabolism of cysteine conjugates by the enzyme 
cysteine conjugate B-lyase, cytosolic protein extracted from the stable cell lines RIJ and 
HS3C was used in assays with several cysteine conjugates. As detailed in chapter 3, the 
stable cell lines exhibited varying levels of expression of rat and human cysteine 
conjugate B-lyase. In this chapter the kinetics of enzyme activity in cytosolic protein 
extracted from a high and low B-Iyase expressing cell line for the rat and human forms 
of the enzyme were assessed using the cysteine conjugate TFEC. This cysteine 
conjugate has been shown to be rapidly metabolised by both rat and human B-lyase 
extracted from COS-1 cells transiently transfected with the respective cDNAs (Perry et. 
al, 1993 & 1995). Therefore detectable levels of pyruvate should be produced during 
the metabolism of TFEC by cytosol extracted from the cell lines expressing low levels 
of B-lyase. The metabolism of an additional eight cysteine conjugates was assessed 
using cytosol extracted from the cell lines expressing high levels of cysteine conjugate 
B-lyase i.e RIJ (rat) and HS3C (human).
The metabolism of a total of nine different cysteine conjugates by both rat and human 
cysteine conjugate B-lyase was assessed. All reactions were performed as detailed in 
section 2.9.3.2. Kinetic parameters were determined by the computer software Enzpac, 
using the Hanes-Woolf method of analysis. The Km (mM), Vmax (nmol/min/mg of 
protein) and enzyme turnover (nmol/min/mg/mM) are cited as results.
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4.2.1 Enzyme Kinetics o f Rat and Human Cysteine 
Conjugate B-lyase Extracted from Stably
Transfected LLC-PKl Cells
The metabolism of nine different cysteine conjugates was measured by incubating 
various concentrations of cysteine conjugate with cytosolic protein extracted from the 
appropriate cell line, i.e HS3C - human B-lyase or RIJ - rat B-lyase together with
0.2mM a-KMB for 10 min at 37° C (see section 2.8.6.1). The amount of pyruvate 
product formed was measured using the HPLC-based method previously described 
(2.9.3.2) and the enzyme kinetics calculated by a computer package using the Hanes- 
Woolf method of analysis.
Figure 4.6 shows a Hanes-Woolf plot of the data obtained for the metabolism of TFEC 
by cytosolic protein extraced from cell lines with high (RIJ) and low (RII4B) 
expression of rat cysteine conjugate B-lyase. As can be seen from figure 4.6, there is a 
very slight curvature of the kinetic plot when cytosol from the cell line with high 
expression of rat B-lyase (RIJ) was used, and is probably due to the toxic effect of the 
resultant thiol product which may be damaging the enzyme itself at higher substrate 
concentrations. This kinetic plot curvature was not seen with the cytosol extracted from 
the cell line with low expression of rat B-lyase (RII4B) probably due to the rate of 
reaction being slower due to less enzyme being present. A similar effect was seen when 
TFEC is metabolised by human cysteine conjugate B-lyase extracted from cell lines with 
high and low expression of the enzyme (data not shown).
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Figure 4 . 6 -  Kinetics of tetrafluoroethyl-cysteine (TFEC) metabolism pig kidney cell 
lines stably expressing high or low levels of rat cysteine conjugate B-lyase.
A Hanes-Woolf plot of B-lyase activity measured by incubating cytosolic protein 
extracted from RII4B (■), the low expressing rat kidney cytosolic B-lyase cell line and 
RIJ (•), the high expressing rat kidney cytosolic B-lyase cell line with various
concentrations of TFEC and 0.2mM a-KMB for lOmin. Rate of reaction is expressed
as nmol of pyruvate formed /min /mg of protein. Kinetic parameters were determined 
by the computer software, Enzpac using the Hanes-Woolf method of analysis. Results 
are expressed as the means ± sem, of nine determinations.
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Tables 4.1 and 4.2 show the Km (mM), Vmax (nmol/min/mg) and enzyme turnover 
rate (nmol/min/mg/mM) obtained for the metabolism of several cysteine conjugates by 
rat and human cysteine conjugate B-lyase extracted from the stable cell lines. The 
cytosol from cell lines with low expression of rat and human cysteine conjugate B-lyase 
were only used to metabolise TFEC and DC VC (Table 4.1). It was clear that the cytosol 
extracted from cell lines with low expression of rat and human B-lyase exhibited lower 
Vmax values compared to the cytosol extracted from cell lines expressing high levels of 
rat and human cysteine conjugate B-lyase. When the metabolism of DC VC was 
examined, it was found that the Vmax for the cytosol extracted from the high B-lyase 
expressing cell line was in fact slightly lower than that for the low B-lyase expressing 
cell line. This is contrary to what would be expected but may be explained by the fact 
that at higher substrate concentrations the reactive metabolite formed as a result of 
DC VC metabolism is in higher concentrations and it is very likely that the metabolite is 
having a detrimental effect on the enzyme.
It would appear that the fluorinated cysteine conjugates are most rapidly metabolised by 
both rat and human cysteine conjugate B-lyases, with there being little difference 
between the metabolism of TFEC and CTFEC by rat B-lyase (Vmax = 38.1 ± 0.6 
nmol/min/mg and 30.4 ±3.9  nmol/min/mg respectively; see table 4.2).
In the majority of cases, metabolism of cysteine conjugates by human cysteine 
conjugate B-lyase is faster (higher Vmax values) than the respective metabolism by rat 
cysteine conjugate B-lyase (Table 4.2). In the cases where the rate of metabolism of 
cysteine conjugates is similar for both rat and human B-lyases such as for the 
metabolism of PCBC or DCDFEC, it was noted that the Km values were also similar. 
Km may be used as an indication of the affinity that the enzyme has for that particular 
substrate. In the majority of cases, human cysteine conjugate B-lyase would appear to
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have higher Km values than rat B-lyase indicating that the active site of rat B-lyase has a 
greater affinity for its substrates than human cysteine conjugate B-lyase.
The linear alkyl chain cysteine conjugates such as hexyl-, butyl- and ethyl- cysteine are 
poor substrates for both rat and human cysteine conjugate B-lyase in that their rates of 
reaction are extremely slow. Their Km values are quite small indicating that the B-lyase 
enzyme has a good affinity for them. When considering enzyme turnover (otherwise 
known as metabolic clearance) which may be used as an indication of the efficiency of 
catalysis of an enzyme with a particular substrate, it was found that of the more reactive 
substrates (those with higher Vmax values), TFEC when metabolised by rat B-lyase 
produced the highest enzyme turnover rates. Human B-lyase on the other hand, 
produced a high enzyme turnover rate during the metabolism of CTFEC. Considering 
the enzyme turnover rates presented in table 4.2, it is clear that for all substrates except 
the linear alkyl chain sustrates, rat cysteine conjugate B-lyase was more efficient at 
catalysing B-elimination than human cysteine conjugate B-lyase. Table 4.2 shows that 
the linear alkyl chain cysteine conjugates appear to have high enzyme turnover rates 
compared to the unsaturated cysteine conjugates however their reaction rates are very 
low, probably bordering on the limits of detection.
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E x p ressed  E n zym e
Rat Human
Substrate Parameter Low High Low High
TFEC Km 1.5+0.3 1.1+0.05 2.3+0.6 2.8+0.4
Vmax 18.3+1.6 38.1+0.6 18.8+3.0 45.4+4.5
Turnover 12.2 34.6 8.2 16.2
DCVC Km 0.5+0.05 0.5±0.05 0.7+0.1 0.7+0.06
Vmax 7.5+0.3 6.4+0.2 5.2+0.3 11.6+0.5
Turnover 15.0 12.8 7.4 16.6
Table 4 . 1 -  Kinetic parameters found for the metabolism of tetrafluoroethyl-cysteine 
(TFEC) and dichlorovinyl-cysteine (DCVC) by cytosolic extracts from pig kidney cell 
lines stably expressing high or low levels of rat or human cysteine conjugate B-lyase.
Cysteine conjugate B-lyase activity was measured by incubating cytosolic extracts from 
RIJ, the high expressing rat B-lyase cell line; RII4B, the low expressing rat B-lyase cell 
line; HS3C, the high expressing human B-lyase cell line and HSII2A, the low 
expressing human cell line with varying concentrations of the appropriate cysteine 
conjugate and 0.2mM a-KMB for lOmin. Activity is expressed as nmol of pyruvate 
formed / min/ mg of protein. Kinetic parameters were determined by the computer 
software package, Enzpac using the Hanes-Woolf method of analysis. Results are 
expressed as the means ± SD of nine determinations except for enzyme turnover. (Km 
(mM); Vmax (nmol/min/mg); enzyme turnover (nmol/min/mg/mM)).
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I^^^^^Expressed Enzyme
Substrate Parameter Rat Human
TFEC Km 1.1 ±0.05 2.8 ± 0.4
Vmax 38.1 ±0.6 45.4 ± 4.5
Turnover 34.6 16.2
DCVC Km 0.5 ± 0.05 0.7 ± 0.06
Vmax 6.4 ± 0.2 11.6 ±0.5
Turnover 12.8 16.6
CTFEC Km 1.6 ± 0.3 2.6 ± 0.4
Vmax 30.4 ±3.9 46.6 ± 6.5
Turnover 19.0 17.9
DCDFEC Km 1.4 ±0.2 1.4 ±0.2
Vmax 22.1 ±2.4 19.4 ± 1.3
Turnover 15.8 13.9
PCBC Km 0.8 ± 0.2 0.9 ± 0.2
Vmax 8.3 ± 0.9 8.6 ± 0.9
Turnover 10.4 9.6
Table 4 . 2 -  Kinetic parameters found for the metabolism several cysteine conjugates 
by cytosolic extracts from pig kidney cell lines stably expressing high or low levels of 
rat or human cysteine conjugate 6-lyase.
Cysteine conjugate 6-lyase activity was measured by incubating cytosolic protein 
extracted from RIJ, the high expressing rat 6-lyase cell line and HS3C, the high 
expressing human 6-lyase protein with varying concentrations of the appropriate 
cysteine conjugate and 0.2mM a-KMB for lOmin at 37°C. Kinetic parameters were 
determined by the computer software package, Enzpac using the Hanes-Woolf method 
of analysis. Results are expressed as the means ± SD of nine determinations. (Km 
(mM); Vmax (nmol/min/mg); Turnover (nmol/min/mg/mM)).
The cysteine conjugates used were as follows:
Tetrafluoroethyl-cysteine (TEEC); 12-dichlorovinyl-cysteine (DC VC); 2,2-dichloro-1,2,2-
trifluoroethyl-cysteine (CTFEC); 22-didiloro-l,l-difluoroethyl-cysteine (DCDFEC); 
pentadilorobutadienyl-cysteine (PCBC); phenyl-cysteine (PC); hexyl-cysteine (HC); butyl-cystdne 
(BC); ethyl-cysteine (EC) and 4-methoxybenzyl-cysteine (MOBC).
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1 Expressed Enzyme
Substrate Parameter Rat Human
PC Km 0.04 ± 0.003 0.07 ± 0.01
Vmax 2.6 ± 0.06 2.9 ±0.1
Turnover 65 41.4
HC Km 0.06 ± 0.01 0.06 ± 0.01
Vmax 5.3 ± 0.2 5.4 ± 0.2
Turnover 88.3 90.0
BC Km 0.05 ± 0.004 0.02 ± 0.003
Vmax 4.6 ± 0.2 3.4 ±0.1
Turnover 92.0 170.0
EC Km 0.03 ± 0.002 not done
Vmax 4.9 ± 0.02 not done
Turnover 163.3 not done
MOBC Km 0.06 ±0.1 not done
Vmax 1.38 ±0.2 not done
Turnover 23 not done
Table 4 .2  continued.
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4 .4  ANALYSIS OF CYSTEINE CONJUGATE B-LYASE
CYTOTOXICITY USING TRANSFECTED CELL LINES
The work described in section 4.3 demonstrates how the kinetics for rat and human 
cysteine conjugate 6-lyase differ according to substrate. It also describes how the linear 
alkyl chain cysteine conjugates exhibit low Vmax values but relatively high enzyme 
turnover rates. The affinity which the enzymes show for the linear substrates also 
appears to be high compared to those shown for the halogenated conjugates. In order 
to assess whether substrates which were metabolised quickly by cysteine conjugate 6- 
lyase also produced cytotoxicty in the newly established cell lines which expressed rat 
and human cysteine conjugate 6-lyase, cytotoxicity studies were performed. 
Furthermore, it was hoped that the cell lines which stably express cysteine conjugate 6- 
lyase could eventually be used as a primary screening measure for the assessment of 
potentially nephrotoxic haloalkenes or cysteine conjugates.
As mentioned in chapter three, several cell lines were established, all of which 
expressed either rat or human cysteine conjugate 6-lyase at different levels. Again the 
cytotoxic effects of DCVC and TFEC were examined in five cell lines, namely RIJ 
(high expression rat 6-lyase); RII4B (low expression rat 6-lyase); HS3C (high 
expression human 6-lyase); HSII2A (low expression human 6-lyase) and the wild type 
pig kidney cells, LLC-PKl. The cytotoxic effects of the remaining 14 cysteine 
conjugates were examined using the cell lines which exhibited high enzyme expression
i.e HS3C and RIJ, together with the wild type pig kidney cell line LLC-PKl. Cell lines 
were incubated with varying concentrations of the cysteine conjugates (see 2.9.4) for 
24hrs before assessment of cytotoxicity. The method of assessment of cytotoxicity used 
was that of XTT metabolism, the rationale being that cells which had been subjected to 
mitochondrial damage could no longer metabolise XTT. Thus the assay measured gross 
cell survival following toxic insult.
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The experiment was performed as described in section 2.9.4 both in the presence or 
absence of a-KMB.
4.4.1 The Cytotoxic Effects o f TFEC
As can be seen from Figure 4.7a, TFEC was most toxic to the cell line RIJ. At a 
concentration of 0.5mM, approximately 70% of the RIJ cell population was no longer 
viable. The high expressing human 6-lyase cell line appeared to be show some 
resistance to the compound, however LLC-PKl, RII4B and HSII2A cell lines appeared 
to be barely affected by TFEC at concentrations investigated.
When the a-keto acid , a-KMB was included in the culture media, there was a marked 
increase in the toxicity observed (Figure 4.7b). Again a similar trend was observed, 
with the high expressing rat cell line, RIJ showing the greatest effect - only 20% of the 
cell population viable at a concentration of 0.5mM TFEC . The wild type pig kidney cell 
line, LLC-PKl together with the low expressing rat, RII4B and high expressing human 
HS3C appeared to respond similarly to TFEC, with approximately 30% of the cell 
population no longer being viable.
The increase in the toxicity of TFEC when a-KMB was added to the cell media was to 
be expected in view of its effect on enzyme activity and since it is the metabolite of the 
6-elimination reaction which is toxic, not the cysteine conjugate itself.
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Figure 4 .7  a - The cytotoxic effects of tetrafluoroethyl-cysteine (TFEC) on several 
transfected pig kidney cell lines.
The cell lines LLC-PKl (♦; wild type pig kidney), RIJ (■; high expression of rat 
cysteine conjugate B-lyase), HS3C (A; high expression of human cysteine conjugate 13- 
lyase), RII4B (• ;  low expression of rat cysteine conjugate B-lyase) and HSII2A (*; low 
expression of human cysteine conjugate B-lyase), were incubated with varying 
concentrations of TFEC for 24hr at 37° C, 5% CO .^ Cell viability was assessed using 
the XTT-based cytotoxicity test (section 2.9.4). Results are expressed as the means ± 
sem of four determinations.
2 1 2
100
9 0 - -
80 ■ ■
6 0 - -
5 0 - -
U
^ 3 0  +
2 0 - -
1 0 - -
0.50.2 0.3 0.40.10
TFEC (mM)
Figure 4 .7b  - The cytotoxic effects of tetrafluoroethyl-cysteine (TFEC) in the 
presence of 0.2mM a-KMB on several transfected pig kidney cell lines.
The cell lines LLC-PKl (♦; wild type pig kidney), RIJ (■; high expression of rat 
cysteine conjugate 6-lyase), HS3C (A; high expression of human cysteine conjugate 6- 
lyase), RII4B (• ; low expression of rat cysteine conjugate 6-lyase) and HSII2A (^; low 
expression of human cysteine conjugate 6-lyase), were incubated with varying 
concentrations of TFEC and 0.2mM a-KMB for 24hr at 37° C, 5% CO .^ Cell viability 
was assessed using the XTT-based cytotoxicity test (section 2.9.4). Results are 
expressed as the means ± sem of four determinations.
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4.4 .2  The Cytotoxic Effects of DCVC
Figure 4.8a shows that DCVC was more toxic to the cell line LLC-PKl,than TFEC. 
Again, the cell line which appeared to be most affected by DCVC was RIJ the cell line 
which expressed high levels of rat cysteine conjugate 6-lyase. At 0.5mM DCVC, only 
25% of the RIJ cells remained viable, there being a steady decline in cell viability as 
concentrations of DCVC increased. The cell line expressing low levels of rat 6-lyase 
(RII4B) appeared to show a negligible decrease in cell viability below 0.2mM DCVC. 
The decline in cell viability seemed to increase more rapidly above 0.2mM DCVC, until 
only 65% of the RII4B cells remained viable at 0.5mM DCVC.
The cell line expressing high levels of human 6-lyase (HS3C) appeared to be 
unaffected at less than 0.2mM DCVC, above which the cells began to show signs of 
toxicity, giving rise to a sharp decrease in cell viability. At 0.5mM DCVC, only 55% of 
the HS3C cells remained viable. HSII2A - the cell line expressing low levels of human 
6-lyase, on the other hand showed minimal signs of toxicity. The percentage of viable 
cells slowly decreased with increasing concentration of DCVC until at 0.5mM DCVC, 
80% of the cells were still functional.
The presence of 0.2 mM a-KMB appeared to enhance the cytotoxic effect of DCVC 
(Figure 4.8b), apart from the wild type pig kidney cell line, LLC-PKl which appeared 
unaffected by its addition. The cell line expressing high levels of rat 6-lyase (RIJ) once 
again appeared to exhibit the greatest cytotoxic effect as a result of DCVC exposure. 
There was a sharp decline in cell viability observed with increasing concentrations of 
DCVC. At O.lmM DCVC approximately 80% of the cells were no longer viable, after 
this point the graph plateaued and any increase in DCVC concentration did not appear to 
produce a further decrease in cell viability. The cell line expressing low levels of rat 6- 
lyase (RII4B) showed a steady decrease in cell viability until 0.5mM DCVC, at which 
point only 47% of the cells remained viable.
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HS3C, the cell line expressing high levels of human cysteine conjugate 6-lyase, 
showed a more marked cytotoxic effect in the presence of 0.2 mM a-KMB than in its 
absence. At 0.5mM DCVC only 32% of the HS3C cells remained viable. Again, the 
cell line expressing low levels of human cysteine conjugate 6-lyase (HSII2A) showed 
the least cytotoxic effect, with 60% of the cells remaining viable at 0.5mM DCVC.
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Figure  4.8a - The cytotoxic effects of dichlorovinyl-cysteine (DCVC) on several 
transfected pig kidney cell lines.
The cell lines LLC-PKl (♦; wild type pig kidney), RIJ (■; high expression of rat 
cysteine conjugate B-lyase), HS3C (A; high expression of human cysteine conjugate B- 
lyase), RII4B (• ; low expression of rat cysteine conjugate B-lyase) and HSII2A (^; low 
expression of human cysteine conjugate B-lyase), were incubated with varying 
concentrations of DCVC for 24hr at 37“ C, 5% CO .^ Cell viability was assessed using 
the XTT-based cytotoxicity test (section2.9.4). Results are expressed as the means ± 
sem of four determinations.
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Figure 4.8b - The cytotoxic effects of dichlorovinyl-cysteine (DCVC) in the 
presence of 0.2mM a-KMB on several transfected pig kidney cell lines.
The cell lines LLC-PKl (♦; wild type pig kidney), RIJ (■; high expression of rat 
cysteine conjugate B-lyase), HS3C (A; high expression of human cysteine conjugate B- 
lyase), RII4B (• ; low expression of rat cysteine conjugate B-lyase) and HSII2A (*; low 
expression of human cysteine conjugate B-lyase), were incubated with varying 
concentrations of DCVC and 0.2mM a-KMB for 24hr at 37“ C, 5% CO .^ Cell viability 
was assessed using the XTT-based cytotoxicity test (section 2.9.4). Results are 
expressed as the means ± sem of four determinations.
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4.4.3 The Cytotoxic Effects of CTFEC.
As can be seen from figure 4.9a, CTFEC appeared to exhibit the greatest cytotoxicity 
with the cell line expressing high levels of rat cysteine conjugate 6-lyase, RIJ. A steady 
decline in cell viability was observed with increasing concentration of CTFEC and at 
0.5mM CTFEC only 30% of the RIJ cells still remained viable. The wild type cell line 
LLC-PKl also appeared to be susceptible to CTFEC and there was a steady decrease in 
cell viability with increasing concentration of CTFEC. At 0.5mM CTFEC, 42% of the 
LLC-PKl cells were no longer viable. The cell line expressing high levels of human 
cysteine conjugate 6-lyase, HS3C appeared to exhibit a similar trend to that observed 
with the LLC-PKl cells. At 0.5mM CTFEC, approximately 55% of the HS3C cells 
were still viable.
The addition of 0.2mM a-KMB again produced a distinct increase in cytotoxicity with 
all the cell lines used (Figure 4.9b). The addition of the a-KMB appeared to increase 
the toxicity normally observed with CTFEC in the wild type pig kidney cells, LLC- 
PKl. The cells appeared to lose viability very dramatically as the concentration of 
CTFEC increased to 0. ImM, after which their viability continued to decrease but to a 
much lesser extent. The cell line expressing high levels of rat cysteine conjugate 6- 
lyase, RIJ once again demonstrated the greatest toxic insult. There was a sharp 
decrease in cell viability below 0.2mM CTFEC which then levelled out. At 0.2mM 
CTFEC, only approximately 23% of the cells remained viable. HS3C, the cell line 
expressing high levels of human cysteine conjugate 6-lyase showed a marked increase 
in the cytotoxic effect of CTFEC in the presence of 0.2mM a-KMB compared to in its 
absence (Figure 4.9b). The cell viability appeared to decrease sharply with increasing 
CTFEC concentration up to 0.2mM CTFEC, where 55% of the HS3C cells were no 
longer viable. At 0.5mM CTFEC, only 30% of the HS3C cells remained viable, which 
was close to that observed for the RIJ cell line.
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Figure 4.9a - The cytotoxic effects of chlorotrifluoroethyl-cysteine (CTFEC) on 
several transfected pig kidney cell lines.
The cell lines LLC-PKl (♦; wild type pig kidney), RIJ (■; high expression of rat 
cysteine conjugate 6-lyase) and HS3C (A; high expression of human cysteine conjugate 
6-lyase), were incubated with varying concentrations of CTFEC for 24hr at 37° C, 5% 
CO .^ Cell viability was assessed using the XTT-based cytotoxicity test (section 2.9.4). 
Results are expressed as the means ± sem of four determinations.
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Figure 4.9b - The Cytotoxic Effects of Chlorotrifluoroethyl-cysteine (CTFEC) in 
the presence of 0.2mM a-KMB on several transfected pig kidney cell lines.
The cell lines LLC-PKl (♦; wild type pig kidney), RIJ (■; high expression of rat 
cysteine conjugate 6-lyase) and HS3C (A; high expression of human cysteine conjugate 
6-lyase), were incubated with varying concentrations of CTFEC and 0.2mM a-KMB 
for 24hr at 37° C, 5% CO .^ Cell viability was assessed using the XTT-based 
cytotoxicity test (section 2.9.4). Results are expressed as the means ± sem of four 
determinations.
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4.4 .4  The Cytotoxic Effects o f DCDFEC
Figure 4,10a shows the cytotoxic effects observed when the cell lines LLC-PKl, RIJ 
and HS3C were challenged with increasing concentrations of DCDFEC. It can be seen 
that the DCDFEC appeared to have a similar effect on all three cell types. The wild type 
pig kidney cell line, LLC-PKl and the cell line expressing high levels of rat cysteine 
conjugate 6-lyase exhibited very similar cytotoxic effects. A steady decrease in cell 
viability was observed for both cell types as DCDFEC concentrations increased to 
0.5mM DCDFEC at which point both cell lines were approximately 65% viable. The 
cell line expressing high levels of human cysteine conjugate 6-lyase (HS3C) exhibited a 
trend similar to that observed for the LLC-PKl and RIJ cell lines, however at 0.5mM 
DCDFEC, approximately 78% of the cells remained viable.
In the presence of 0.2mM a-KMB (Figure 4.10b), the cytotoxicity observed with all 
three cell lines was greater than that observed in the absence of a-KMB. At a 
concentration of 0.5mM DCDFEC, the wild type pig kidney cells, LLC-PKl exhibited 
only 45% cell viability. The cell line expressing high levels of rat cysteine conjugate 6- 
lyase - RIJ, showed a steady increase in cytotoxicity as concentrations of DCDFEC 
increased. At 0.2mM DCDFEC approximately 51% of the cells remained viable. The 
cytotoxic effect further increased until at 0.5mM DCDFEC, approximately 78% of the 
RIJ cells were no longer viable. The cell line expressing high levels of human cysteine 
conjugate 6-lyase - HS3C, also showed a steady increase in toxicity with increasing 
DCDFEC concentration. At 0.5mM DCDFEC, only 35% of the cells remained viable.
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Figure 4 .10a - The cytotoxic effects of dichlorodifluoroethyl-cysteine (DCDFEC) 
on several transfected pig kidney cell lines.
The cell lines LLC-PKl (♦; wild type pig kidney), RIJ (■; high expression of rat 
cysteine conjugate 6-lyase) and HS3C (A; high expression of human cysteine conjugate 
6-lyase), were incubated with varying concentrations of DCDFEC for 24hr at 37° C, 
5% CO .^ Cell viability was assessed using the XTT-based cytotoxicity test (section 
2.9.4). Results are expressed as the means ± sem of four determinations.
2 2 2
100
.1
U
0.50.40.1 0.2 0.30
DCDFEC (mM)
Figure 4 .10b - The cytotoxic effects of dichlorodifluoroethyl-cysteine (DCDFEC) in 
the presence of 0.2mM a-KMB on several pig kidney cell lines.
The cell lines LLC-PKl (♦; wild type pig kidney), RIJ (■; high expression of rat 
cysteine conjugate B-lyase) and HS3C (A; high expression of human cysteine conjugate 
B-lyase), were incubated with varying concentrations of DCDFEC and 0.2mM a-KMB 
for 24hr at 37° C, 5% CO .^ Cell viability was assessed using the XTT-based 
cytotoxicity test (section 2.9.4). Results are expressed as the means ± sem of four 
determinations.
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4.4.5  The Cytotoxic Effects o f PCBC
Figure 4.11a shows the cytotoxic effect which the cysteine conjugate 
pentachlorobutadienyl-cysteine (PCBC) had on cell lines LLC-PKl, HS3C and RIJ. 
The wild type pig kidney cells, LLC-PKl showed a very clear, sharp response to the 
addition of PCBC. At a concentration of 0.2mM approximately 80% of the LLC-PKl 
cells were no longer viable. The cell lines expressing high levels of rat cysteine 
conjugate B-lyase (RIJ) and human cysteine conjugate B-lyase (HS3C) also exhibited a 
definite cytotoxic response as a result of exposure to PCBC, but the response curve 
was less steep than that observed for the LLC-PKl cells. Again, at 0.5mM PCBC only 
20% of the total cell number, for both cell types, remained viable.
The presence of 0.2mM a-KMB (figure 4.11b), appeared to enhance the cytotoxicity 
observed with all three cell types. Again, at 0.5 mM PCBC only 20% of all three cell 
lines used remained viable. The greatest cytotoxic response observed was with the 
LLC-PKl cells, which at a concentration of 0. ImM PCBC only 30% remained viable. 
The cell line expressing high levels of human cysteine conjugate B-lyase - HS3C, 
exhibited a greater toxic response in the presence of a-KMB than in its absence. At a 
concentration of 0.2mM PCBC only 40% of the HS3C cells remained viable. At 
O.SmM PCBC 80% of the HS3C cells were no longer viable. The cell line expressing 
high levels of rat cysteine conjugate B-lyase (RIJ) also showed an increased toxic effect 
in the presence of a-KMB but not as clear an increase as that observed for the human 
cell line(HS3C).
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Figure 4 .11a - The cytotoxic effects of pentachlorobutadienyl-cysteine (PCBC) on 
several transfected pig kidney cell lines.
The cell lines LLC-PKl (♦; wild type pig kidney), RIJ (■; high expression of rat 
cysteine conjugate B-lyase) and HS3C (A; high expression of human cysteine conjugate 
B-lyase), were incubated with varying concentrations of PCBC for 24hr at 37° C, 5% 
CO .^ Cell viability was assessed using the XTT-based cytotoxicity test (section 2.9.4). 
Results are expressed as the means ± sem of four determinations.
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Figure 4 .11b - The cytotoxic effects of pentachlorobutadienyl-cysteine (PCBC) in 
the presence of 0.2mM a-KMB on several transfected pig kidney cell lines.
The cell lines LLC-PKl (♦; wild type pig kidney), RIJ (■; high expressing rat cysteine 
conjugate B-lyase) and HS3C (A; high expression of human cysteine conjugate B- 
lyase), were incubated with varying concentrations of PCBC and 0.2mM a-KMB for 
24hrat 37° C, 5% CO .^ Cell viability was assessed using the XTT-based cytotoxicity 
test (section 2.9.4). Results are expressed as the means ± sem of four determinations.
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4.4.6  The Cytotoxic Effect o f Methoxy benzyl-L- 
cysteine
As can be seen from Figure 4.12, methoxybenzyl-L-cysteine had no toxic effect on any 
of the cell lines used, and the addition of a-KMB did not alter this lack of response. 
This result was not unexpected sinee methoxy benzyl-L-cysteine was very insoluble 
and kinetic studies showed that it was not a good substrate for human or rat cysteine 
conjugate B-lyase (see section 4.3).
4.4.7  Other Cysteine Conjugates Tested for Cytotoxicity.
Several other cysteine conjugates were also tested for toxicity using the cell lines, LLC- 
PKl, HS3C and RIJ. These conjugates were:
Methyl-L-cysteine Ethyl-L-cysteine
Butyl-L-eysteine Hexyl-L-cysteine
Phenyl-L-cysteine Benzyl-L-cysteine
Methylbenzyl-L-cysteine T rityl-L-cysteine
Carboxymethyl -L-cysteine Carbamyl -L-cysteine
However, they all exhibited similar effects to that observed for methoxybenzyl-L- 
cysteine, i.e. no apparent eytotoxicity at the concentrations used within the experiment. 
All of the above compounds were extremely difficult to dissolve in the tissue culture 
medium. For this reason, together with the lack of sufficient compound, no further 
experiments were performed using higher concentrations of these cysteine conjugates.
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Figure 4 . 1 2 -  The cytotoxic effects of methoxybenzyl - L - cysteine (MOBC) in the 
presence of 0.2mM a- KMB on several transfected pig kidney cell lines.
The cell lines LLC-PKl (♦; wild type pig kidney), RIJ (■; high expression of rat 
cysteine conjugate 6-lyase) and HS3C (A; high expression of human cysteine conjugate 
6-lyase), were incubated with varying concentrations of PCBC and 0,2mM a-KMB for 
24hr at 37° C, 5% CO2. Cell viability was assessed using the XTT-based cytotoxicity 
test (section 2.9.4). Results are expressed as the means ± sem of four determinations.
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Table 4.3 shows the IC50 values (mM) obtained when the cell lines RIJ ( high level 
expression of rat cysteine conjuagte 6-lyase), HS3C (high level expression of human 
cysteine conjugate 6-lyase) and LLC-PKl (wild type pig kidney cells) were treated with 
five of the cysteine conjugates successfully used in the cytotoxicity experiment. It can 
be seen that DCVC and PCBC appear to be the most toxic cysteine conjugates 
especially to the wild type pig kidney cells LLC-PKl. It was also noted that the cell line 
expressing high levels of rat cysteine conjugate 6-lyase (RIJ) showed a greater 
cytotoxic response to the cysteine conjugates than the cell line expressing high levels of 
human cysteine conjugate 6-lyase, although some exceptions to this general conclusion 
did exist.
The cell lines expressing low levels of human and rat cysteine conjugate 6-lyase 
exhibited IC50 values greater than 0.5mM in the absence of 0.2mM a-KMB. In the 
presence of a-KMB, however, the cell line expressing low levels of rat 6-lyase 
exhibited an IC50 of 0.41 mM when cells were exposed to DCVC. The cell line with 
low expression of human 6-lyase exhibited IC50 values greater than 0.5mM under 
these experimental conditions both in the presence and absence of a-KMB.
IC50 values could not be obtained for the remaining cysteine conjugates under the 
experimental conditions used for this thesis.
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Cysteine
Conjugate
IC50 (mM) in the 
presence of 0.2mM a -  
KMB
IC50 (mM) in the 
absence of 0.2mM a -  
KMB
Control
(LLC-
PKl)
Rat
(RIJ)
Human
(HS3C)
Control
(LLC-
PKl )
Rat
(RIJ)
Human
(HS3C)
TFEC >0.50 0.13 >0.50 >0.50 0.34 >0.50
DCVC 0.16 0.05 0.18 0.18 0.20 >0.50
DCDFEC 0.39 0.20 0.35 >0.50 >0.50 >0.50
CTFEC 0.40 0.09 0.19 >0.50 0.37 0.50
PCBC 0.09 0.30 0.18 0.11 0.33 0.31
Table 4 .3  - IC50 values obtained for various cysteine conjugates when exposed to 
LLC-PKl cells stably transfected with the cDNAs encoding rat or human cysteine 
conjugate 6-lyase, both in the absence and presence of a-KMB.
IC50 values were determined using the XTT method of evaluating cell viability. LLC- 
PKl cells stably incorporating the cDNA encoding rat renal cysteine conjugate 6-lyase 
(Rat) and human renal cysteine conjugate 6-lyase (Human) were exposed to several 
different cysteine conjugates.
The following cysteine conjugates were also used for toxicity testing, however at the 
concentrations used in these experiments, their IC50 values were determined to be 
greater than O.SmM:
4-methoxybenzyl-L-cysteine; 4-methylbenzyl-L-cysteine; benzyl-L-cysteine; phenyl-L- 
cysteine; methyl-L-cysteine; ethyl-L-cysteine; butyl-L-cysteine; hexyl-L-cysteine; trityl- 
L-cysteine; carboxymethyl-L-cysteine and carbamyl-L-cysteine.
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4 .5  DISCUSSION
Cysteine conjugate 6-lyase is known to metabolise the cysteine conjugates derived from 
halogenated alkene compounds, such as trichloroethylene. The resulting metabolites 
have been shown to be nephrotoxic in rodents (Dekant et a l , 1994; Lock, 1988), and 
possibly both nephrotoxic and neurotoxic in man (Mutti et a l, 1992). Over the years 
many attempts have been made to isolate and characterise the pure kidney 6-lyase 
enzyme, both in man and rat. However, human kidney is not that easily obtained, most 
available kidneys being used for transplantation. Rat kidneys, although more readily 
available, still present the problem of successful isolation of large quantities of the 
kidney enzyme.
The development of an ‘m vitro' system, which responded to cysteine conjugates as ‘in 
vivo ’ would be a valuable addition to research in this area. The production of rat and 
human 6-lyase producing cell lines would give rise to an endless supply of both 
enzymes, as well as presenting a method for ‘in vitro' screening of potentially toxic 
cysteine conjugates.
The work presented in this chapter demonstrates the use of rat and human cysteine 
conjugate 6-lyase cDNAs stably incorporated into the genome of the pig kidney cell line 
LLC-PKl as both an ‘in vitro' screening method for the assessment of cysteine 
conjugate toxicity and a plentiful source of both forms of the 6-lyase enzyme. Several 
kinetics studies have been performed using cysteine conjugate 6-lyase isolated from rat 
and human kidney (Jakoby et al, 1984; Lash et a l, 1990; McCarthy et a l, 1994). 
However, due to the lack of availability and the difficulty in isolation of the enzymes, a 
complete kinetics study using several cysteine conjugates for both the rat and human 
enzymes has never been performed until now.
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Cysteine conjugate 6-lyase activity was assessed using the method of Stijntjes et al., 
(1992) which proved to be sensitive and accurate. The only problem which arose from 
this method was that the fluorescent agent OPD appeared to react with the metal 
components of the autosampler producing a dark brown residue which eventually 
blocked the analytical column together with the guard column. This caused several 
delays in the work as the precise nature of the problem was not discovered until later.
From the 6-lyase reactions performed in this chapter it is quite clear that the a-keto acid, 
a-KMB stimulated renal cysteine conjugate 6-lyase activity both in the rat and human 
forms of the enzyme and that its presence is necessary when evaluating 6-lyase activity 
in the stable cell lines. These results are in agreement with Elfarra et a l, (1986) who 
found that a-KMB stimulated both cytosolic and mitochondrial forms of rat renal 
cysteine conjugate 6-lyase activity. They proposed that 6-lyase activity in kidney cells is 
determined by the ratio of PLP (pyridoxal phosphate)/PMP (pyridoxamine) forms of 
the enzyme and that a-KMB promotes the regeneration of the PLP form of the enzyme, 
hence increasing the metabolism and toxicity of the enzyme.
It was noted throughout the experiments that the kinetics of certain cysteine conjugates 
produced non-linear Hanes-Woolf plots. In the presence of a-KMB this “non-linearity” 
did not occur to such an extent. Commandeur et al, (1991) observed a similar effect 
when studying the kinetics of rat cysteine conjugate 6-lyase using DCVC as a 
substrate. They suggested that there was more than one enzyme involved in 6- 
elimination, since their data produced “non-linear” Eadie-Hofstee plots.
A possible explanation for this phenomenon could be the fact that there are two 
reactions occurring at the same time, one being the 6-elimination reaction and the other 
being a transamination reaction. During transamination the PLP state of the 6-lyase 
enzyme is converted to the PMP state which does not catalyse the 6-elimination
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reaction, hence as the reaction proceeds, more and more enzyme is being inactivated. 
The presence of an a-keto acid, such as a-KMB, regenerates the PLP form of the 
enzyme and hence this effect is not observed in the presence of a-KMB in most cases. 
Another possible explanation is that at high concentration of cysteine conjugate, the 
reactive intermediate formed during 6-elimination is present at sufficiently high 
concentrations to damage the 6-lyase enzyme itself, i.e. the cysteine conjugates are 
acting as suicide substrates for the 6-lyase enyzme. In agreement with Commandeur et 
al. , (1991) it is also possible that another form of 6-lyase such as a mitochondrial form 
can catalyse 6-elimination, which would give rise to non-linear kinetic plots since the 
activity observed would be the result of the action of two separate enzymes which may 
have different enzyme turnover rates.
Overall, the kinetics obtained from the experiments presented in this thesis compare 
well with those obtained by other researchers using enzymes isolated from rat and 
human kidneys. The most commonly used cysteine conjugate appears to be DCVC, 
which is often used in cytotoxicity studies. Researchers have obtained Km values of 
0.33mM (Yamuchi etal, 1993), 0.1 ImM (Jakoby eta l, 1984) and 0.26 mM (Stevens 
et al. , 1986) when DCVC was used as the substrate for rat renal cysteine conjugate 6- 
lyase. In this thesis a Km of 0.49mM was obtained for the metabolism of DCVC by rat 
cysteine conjugate 6-lyase in the presence of a-KMB. In the Hanes-Woolf analysis of 
enzyme kinetic data. Km is given directly by the negative of the intercept of the plot 
with the x-axis. As can be seen from figure 4.6, the Hanes-Woolf plot is slightly 
curved and the regression line gives a Km value which is probably a little greater than 
the true Km. Lock et al. , (1996) obtained a Km of 0.58 ± 0.1 mM for the metabolism 
of DCVC by bovine renal cysteine conjugate 6-lyase, which again is similar to that 
obtained using the rat form of the enzyme. McCarthy et a l, (1994) performed kinetic 
analysis of the metabolism of DCVC by human cysteine conjugate 6-lyase. They 
obtained a Km of 5.9mM compared to a Km of 0.67mM obtained in this thesis. A
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possible explanation for the different values obtained by McCarthy et al., (1994)may 
be that they used human kidney cortex cytosolic preparations as the source of 6-lyase, 
these fractions were kept at -70° for 3 months, by which time there could possibly have 
been substantial loss of enzyme activity or degradation of the enzyme. All kinetics in 
this thesis, were examined using freshly isolated cytosol as the source of 6-lyase. 
Furthermore, McCarthy etal,(1994) used kidney cytosol preparations which were not 
further purified, therefore the kinetics observed would not be strictly accurate, since 
there would be various other protein factors present which could interfere with the 6- 
lyase reaction. Exogenous enzymes such as transaminases would be present in kidney 
preparations which could also metabolised the cysteine conjugates giving products other 
than pyruvate. The enzymes used in this thesis were extracted from LLC-PKl cells 
which stably expressed either the rat or human form of cysteine conjugate 6-lyase. 
Although there would also be other transaminases and inhibitory factors present in these 
cytosolic preparations, they will probably be present to a lesser extent than in kidney 
preparations. Buckberry etal, (1990) suggested that more than one isoform of human 
cytosolic 6-lyase exists,which again may explain the differences in Km values obtained 
in work from this thesis and that performed by McCarthy et a l , ( 1994).
TFEC appeared to be good substrate for cysteine conjugate 6-lyase, both for the rat and 
human form of the enzyme, producing high enzyme activities compared to the other 
cysteine conjugates examined. Previous enzyme kinetic studies of the metabolism of 
TFEC by rat renal cysteine conjugate 6-lyase gave Km values of 3.22mM (Stijntjes et 
a l, 1992) and 1.4mM (McCarthy et a l , 1994). A Km of l.OSmM was obtained for the 
metabolism of TFEC by rat renal cysteine conjugate 6-lyase in this thesis. McCarthy et 
al, (1994) performed kinetic analysis on the metabolism of TFEC by human kidney 
cysteine conjugate 6-lyase. They obtained a Km of 6.5mM compared to a Km of 
2.8mM obtained in this thesis. Again the difference in Km observed between these two 
studies may be explained by the existence of more than one isoform of human cysteine
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conjugate 6-lyase (Buckberry et a l, 1990). Another possible explanation for the 
apparent differences in Km may also be due to sex differences, as Damerud et a l , 
(1991) noted that DCVC toxicity in mouse kidney was both age- and sex-dependent. 
They saw that at low doses of DCVC, the female kidney was most susceptible whilst at 
high doses of DCVC the male kidney was most affected. In adult mice it was seen that 
the female kidney exhibited higher 6-lyase activity than the male. It is quite possible that 
sex and age differences in cysteine conjugate toxicity also apply to other species 
including humans.
The cysteine conjugate CTFEC appeared to be the next best substrate for both rat and 
human cysteine conjugate 6-lyase, with a Km of 1.62mM for the rat enzyme and 
2.63mM for the human enzyme. The kinetics of TFEC and CTFEC are almost identical, 
the only difference in their chemical structure being that CTFEC has one of the fluorine 
atoms substituted with a chlorine atom. The Km obtained for rat 6-lyase correlates 
well with those found by Stijntjes et a l, (1992) - 1.78± 0.47 mM and Lash et a l , 
(1986) - 1.78 ± 0.17 mM. No previous kinetic analysis has been performed for the 
metabolism of CTFEC by human cysteine conjugate 6-lyase, therefore we have no 
information to make a comparison.
The metabolism of the cysteine conjugate DCDFEC by rat kidney cysteine conjugate 6- 
lyase has also been described previously. Stijntjes e ta l, (1992) obtained a Km of 2.58 
± 0.44mM compared to a Km of 1.36mM obtained in this thesis.
No previous kinetic analysis had been performed with the other cysteine conjugates 
used in this thesis. The kinetic analysis performed here has shown that the substrates 
with the lower Km values also exhibit slower reaction rates. Andreadou et a l, (1996) 
attempted to perform kinetic analysis on several of these less active substrates, but since
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they were using rat renal cytosol the enzyme activities which they obtained were too 
low to produce accurate kinetic information.
On comparing enzyme turnover or metabolic clearance, (Vmax/ Km 
(nmol/min/mg/mM)) it was found that hexyl-L-cysteine, butyl-L-cysteine, and ethyl-L- 
cysteine appeared to be good substrates. However, when the cytotoxicity tests for these 
substrates are taken into consideration, under the experimental conditions used, they do 
not appear to produce any cytotoxicty. When considering enzyme turnover rates, the 
catalytic efficiency of rat renal cysteine conjugate 6-lyase decreased in the order of ; 
TFEC > CTFEC > DCDFEC > DCVC > PCBC.
For human cysteine conjugate 6-lyase the catalytic efficiency decreased in the order of : 
CTFEC > DCVC > TFEC > DCDFEC> PCBC.
Boogaard et a l , (1989) discovered a similar trend using the cysteine conjugates TFEC, 
CTFEC, DCDFEC and DBDFEC, in the presence of rat cysteine conjugate 6-lyase. 
Unfortunately, no similar experiments have been performed for the human 6-lyase 
enzyme so no comparison could be made.
The cytotoxicity tests performed using the wild type pig kidney cell line, LLC-PKl, 
and the cell lines expressing high levels of rat (RIJ) and human (HS3C) kidney 
cysteine conjugate 6-lyase demonstrated results not unlike those obtained with kidney 
homogenates Hn vitro’. The cytotoxicity tests confirmed that the addition of a-KMB 
did in fact increase the cytotoxic effect of the cysteine conjugates used.
It is well recorded that DCVC and PCBC have quite dramatic toxic effects on wild type 
pig kidney cells (Stevens e ta l , 1986; Mertens et a l , 1990). Here we observed similar 
trends, with DCVC for example, the wild type pig kidney cells appeared to respond at
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low substrate concentrations to conjugate exposure both in the presence and absence of 
a-KMB and a similar effect was observed with PCBC. Furthermore, with regards to 
PCBC cytotoxicity, this cysteine conjugate proved to be more toxic to the wild type pig 
kidney cells (LLC-PKl) than to the cell lines expressing rat and human cytosolic 
cysteine conjugate 6-lyase. This result was quite unexpected, since it is assumed that 
the reactive intermediate formed during 6-elimination of cysteine conjugates is very 
toxic, hence it would be expected that the greater the concentration of 6-lyase, the 
greater the toxic effect observed. One explanation for this occurrence could be that 
PCBC is metabolised to a lesser extent, if at all by the cytosolic form of 6-lyase, being 
metabolised to a greater extent by a mitochondrial form of the enzyme. The cell lines 
which have had the cDNAs for rat and human cytosolic 6-lyase stably incorporated into 
their genome probably metabolise the cysteine conjugate before it can reach its target 
site (the mitochondria), hence they appear to show a more reduced toxic effect 
compared to the LLC-PKl cells.
A similar effect is seen with the cysteine conjugate DCVC, which is also known to have 
a similar mechanism of toxicity to PCBC. However, in the presence of a-KMB, cell 
lines expressing rat cytosolic cysteine conjugate 6-lyase exhibit a toxic response greater 
than that observed for the pig kidney cell line LLC-PKl.
Cytotoxic effects were also observed with CTFEC, DCDFEC and TFEC, however in 
these cases, the LLC-PKl cells did not demonstrate cytotoxic effects to the same extent 
as that observed with PCBC and DCVC. A possible explanation for the differences in 
cytotoxicity observed between the above cysteine conjugates compared to PCBC and 
DCVC may be that compounds which encourage high enzyme turnover rates are 
metabolised faster than those which encourage slower enzyme turnover rates, hence 
their rapid metabolism by the cytosolic 6-lyase enzyme ensures that the cysteine 
conjugate does not reach the mitochondria in order to be processed by mitochondrial
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enzymes. PCBC produced the slowest enzyme turnover rate of all the cytotoxic cysteine 
conjugates examined, allowing more of the cysteine conjugate to reach and be 
metabolised by the mitochondrial enzymes. Rat cytosolic cysteine conjugate 6-lyase 
appeared to have very slow metabolic clearance of DCVC, and cytotoxicity studies 
showed that DCVC was in fact toxic to the cell line expressing rat cytosolic 6-lyase, 
particularly in the presence of a-KMB. Human cysteine conjugate 6-lyase on the other 
hand, appeared to have a relatively high metabolic clearance of DCVC, hence a lesser 
degree of cytotoxicity was observed in the cell line (HS3C).
Furthermore, the intermediate formed during metabolism of CTFEC, DCDFEC and 
TFEC, is a thionoacyl fluoride, whereas PCBC and DCVC both form thioketenes 
which are very toxic. Again the mechanism of metabolism of cysteine conjugate may 
provide an explanation for the toxic effects observed for DCVC and PCBC. None of 
the other eleven cysteine conjugates exhibited any toxic effect under the experimental 
concentrations used in this study, both in the presence or absence of a-KMB.
Of those cysteine conjugates which proved to be cytotoxic, when comparing IC50 
values, the order of their toxicity appears to be as follows:
For rat cytosolic cysteine conjugate 6-lyase in the presence of a-KMB:
DCVC > CTFEC > TFEC > DCDFEC > PCBC
Rat cysteine conjugate 6-lyase in the absence of a-KMB:
DCVC > PCBC > TFEC > CTFEC > DCDFEC
Human cysteine conjugate 6-lyase in the presence of a-KMB:
PCBC > DCVC > CTFEC > DCDFEC > TFEC
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Human cysteine conjugate 6-lyase in the absence of a-KMB:
PCBC > CTFEC > DCVC > DCDFEC ^ TFEC
Again the results found for rat 6-lyase agree with those found by Boogard et a l , (1989) 
who discovered that the ‘m vivo’ cytotoxicity of some of the above mentioned cysteine 
conjugates when dosed to rats decreased as follows : TFEC % CTFEC > DCDFEC 
The cytotoxicity results would imply that the toxicity of PCBC is unaffected by the 
addition of a-KMB, whereas the other cysteine conjugates all exhibit increased toxic 
effects in its presence. This would suggest that the mechanism of PCBC toxicity is 
somewhat different to that of the other cysteine conjugates or perhaps that PCBC is 
processed by a mitochondrial enzyme which does not also catalyse transamination 
reactions. With the human 6-lyase it would appear that even with the addition of a- 
KMB the order of toxicity remains unchanged, even though there is a definite increase 
in toxicity when a-KMB is added. Also it is worth noting that unlike the rat 6-lyase, 
the human 6-lyase exhibits such toxicity when exposed to PCBC, that even the 
inclusion of a-KMB does not sufficiently increase the toxic effects of the other cysteine 
conjugates to make them more toxic.
The results obtained for the cytotoxicity tests also suggest that even though TFEC 
proved to be an extremely good substrate as far as the kinetic data was concerned, in 
actual fact its cytotoxic effect, especially with human 6-lyase was not that great. From 
the results shown in this chapter it may also be proposed that those cysteine conjugates 
which would appear to be good substrates according to enzyme turnover data do not 
necessarily produce the greatest toxic effect. Both PCBC and DCVC appear to be 
extremely toxic to LLC-PKl cells, yet their effect on the transfected cells needed higher 
concentrations of the substrate before a similar effect was seen. The mechanisms of 
action of DCVC and PCBC are thought to be very similar in that they both induce a 
reduction in intra-cellular calcium levels. Vamvakas et a l , (1989) stated that PCBC and
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DCVC are very toxic to mitochondria and that renal cells are highly metabolically active 
with mitochondrial function closely coupled to oxidative metabolism. It is therefore 
possible that the effects of DCVC and PCBC observed with LLC-PKl cells is a result 
of mitochondrial dysfunction. The stably transfected cell lines contain large quantities of 
cytosolic 6-lyase allowing them to metabolise cysteine conjugates rapidly before they 
can reach the mitochondria and hence they produce a lower cytotoxic effect than the 
LLC-PKl cells.
In order for ‘m vitro’ test systems to be useful, it is essential that they reflect accurately 
the ‘m vivo’ toxicity. All of the cysteine conjugates which induced a toxic response in 
this cell culture system are also known to induce toxicity ‘m vivo’ (Boogard et a l , 
1989; Commandeur er al, 1987; Bonhaus er a/., 1981; Bimer gr a/., 1993), however 
less is known about the effects of these compounds in human kidney.
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CHAPTER 5
FINAL DISCUSSION
5 .1  INTRODUCTION
For many years xenobiotics such as halogenated alkenes have been linked to toxicity, in 
particular nephrotoxicity, in biological systems and have received much attention. 
During metabolism, the body converts such xenobiotics and drugs to their 
corresponding mercapturic acids via glutathione conjugation. Generally the 
mercapturates which are now more water soluble than the parent compounds are 
excreted by the kidney in urine. Thus, glutathione conjugation and mercapturic acid 
formation is considered a major pathway for the detoxification and disposal of 
xenobiotics and drugs. Mercapturates however, can be further metabolised by N- 
deacetylation to the cysteine-S-conjugates of the original compound which 
subsequently act as substrates for the enzyme cysteine conjugate 6-lyase. This enzyme 
is found in many parts of the body, however in this thesis we have concentrated on a 
form found primarily in the kidney, although it has also been isolated from rat brain 
(Alberati-Giani etal., 1995). In rat and human kidney this enzyme activity is expressed 
by a particular form of 6-lyase known as glutamine transaminase K/ kynurenine 
aminotransferase (GTK / KAT; EC 2.6.1.64) and is responsible for the catalysis of a 6- 
elimination reaction which converts the cysteine conjugate to its corresponding thiol 
together with the formation of ammonia and pyruvate.
In rats, exposure to xenobiotics has resulted in the production of thiols which are toxic 
to the P3 segment of the kidney proximal tubule (Lock & Ishmael, 1979; Dilley et al, 
1974). In man, exposure to the dry cleaning solvent perchloroethylene has resulted in 
proximal tubular damage (Mutti et al, 1992). Exposure of man to trichloroethylene 
appears to result in chronic tubular damage leading to renal cell cancer (Henschler et al.
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1995; Brüning et al, 1996), although there still appears to be some disagreement 
amongst researchers over this point. However, exposure of man to trichloroethylene 
has produced neurotoxicity and neurodegeneration (Buxton & Hayward, 1967; 
Schaumberg, 1992). Furthermore, human kidney samples (in vitro) have shown the 
ability to metabolise cysteine conjugates such as dichlorovinyl-L-cysteine (Blagbrough 
et al, 1990; Buckberry et al, 1990; Buckberry et al, 1994; McCarthy et al, 1994). 
Bemauer et al, (1996) have also shown that exposure of human volunteers to 
trichloroethylene for a period of 6hr results in the presence of mercapturic acids in 
urine, suggesting that the metabolites from trichloroethylene metabolism are also 
formed in humans after conjugation with glutathione.
Recently, rat kidney cysteine conjugate 6-lyase / GTK has been shown to possess 
kynurenine aminotransferase activity (Mosca etal, 1994) and also to be identical to the 
brain form of 6-lyase/GTK/KAT (Alberati-Giani et al.,, 1995). Kynurenine 
aminotransferase being the enzyme responsible for the production of kynurenic acid 
from the tryptophan metabolite, kynurenine. It has been suggested that KAT activity 
plays a role in neurotransmission via modulation of the NMDA receptor (Stone, 1993).
Many researchers have studied the structure and function of rat and human cysteine 
conjugate 6-lyase (Buckbery et al, 1990 & 1994; Lash et al, 1990; Stevens & Wallin, 
1990; Stijntjes etal, 1993; McCarthy et al, 1994) in order to understand further the 
toxicity of cysteine conjugates and to ascertain whether or not exposure to such 
compounds would result in toxicity for man. In order to gain a better understanding of 
the effects of halogenated alkene bioactivation by cysteine conjugate 6-lyase/GTK/KAT 
the cDNAs encoding rat and human cysteine conjugate 6-lyase were isolated (Perry et 
al, 1993 & 1995).
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This thesis reports the subsequent transient expression of these cDNAs in the COS-1 
cell system, providing large quantities of rat and human cysteine conjugate 6-lyase 
which could be then used for characterisation and kinetic studies of the enzyme. 
Furthermore, the creation of cell lines which stably express rat and human kidney 
cytosolic cysteine conjugate 6-lyase provided a permanent long term supply of both 
enzymes allowing comparative kinetic and toxicity studies to be performed using 
several cysteine S-conjugates.
5 .2  CONCLUDING DISCUSSION
Chapter 3 presents the transient transfection of COS-1 cells using the rat and human 
kidney cytosolic cysteine conjugate 6-lyase cDNAs isolated by Perry et al., (1993 & 
1995). Transient transfection of COS-1 cells with rat and human cysteine conjugate 6- 
lyase resulted in a significant increase in cytosolic GTK and 6-lyase activities compared 
to the anti-sense and no DNA control cells. The pyridoxal phosphate dependent enzyme 
inhibitor, AGAA inhibited this activity. Although there was some inter-transfection 
variance, the ratio of human : rat enzyme activity remained the same throughout. The 
differences in transfection could be explained by differences in transfection efficiency 
due to factors such as the stage of confluency and growth conditions of the cells, the 
DMSO shock which is particularly harsh and the length of time the transfection was 
incubated for before being harvested.
It was also noted that the level of cytosolic GTK and 6-lyase activity from those cells 
which had been transfected with the human 6-lyase cDNA was higher than that 
obtained using cytosol from cells transfected with the cDNA encoding rat cytosolic 
cysteine conjugate 6-lyase. There are two possible explanations for this occurrence; 
either there is a greater level of expression of the human cysteine conjugate 6-lyase
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cDNA than the rat in COS-1 cells or the human cysteine conjugate 6-lyase is a more 
active enzyme than the rat cysteine conjugate 6-lyase.
Closer examination of the cDNA for rat cysteine conjugate 6-lyase provided evidence 
that the lower levels of expression may be due to the presence of a 5’ inverted repeat in 
the rat cDNA. It was believed that the inverted repeat results in secondary mRNA 
folding, slowing ribosomal progression and hence modulating enzyme expression. If 
this is a correct assumption, then removal of the 5’ inverted repeat would theoretically 
increase the level of expression of rat cytosolic cysteine conjugate 6-lyase in the COS-1 
cell system.
Removal of the rat 5’ inverted repeat by the creation of a truncated rat 6-lyase cDNA did 
not appear to show any signs of increased enzyme activity, suggesting that the 
difference in enzyme activity between rat and human cysteine conjugate 6-lyase was 
due to something other than the inverted repeat, and probably representative of a 
difference in the structure of the enzyme active site, since there is a 10% difference in 
sequence homology around the pyridoxal phosphate site of the enzymes.
Once it was ascertained that the full length cDNAs isolated by Perry et a l, (1993 & 
1995) were functional when expressed in COS-1 cells, the cDNAs were then stably 
incorporated into the genome of LLC-PKl, a proximal tubular derived cell line. The 
cell lines were then used to study further the enzyme kinetics of rat and human cysteine 
conjugate 6-lyase, together with providing a method of assessing the cytotoxic effect of 
cysteine conjugates. Again, it was clear from enzyme assays that human cytosolic 
cysteine conjugate 6-lyase possessed greater GTK and 6-lyase activity than rat cytosolic 
cysteine conjugate 6-lyase, although this appeared to be dependent on the cysteine 
conjugate used. Southern blot analysis of genomic DNA extracted from the cell lines 
RIJ and HS3C (cell lines expressing high levels of rat and human cysteine conjugate 6-
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lyase respectively) showed that there was little or no difference in the levels of DNA, 
therefore it would appear that the expression of both rat and human cysteine conjugate 
6-lyase in the cell lines was equivalent. Unfortunately all attempts at Northern blot 
analysis failed, so it could not be established whether there was a difference in mRNA 
levels between the cell lines expressing rat and human cysteine conjugate 6-lyase. 
Kinetic analysis of the metabolism of various cysteine conjugates by both rat and 
human 6-lyase showed that in general the human enzyme possessed the greater activity, 
however it often possessed lower substrate specificitites (higher Km values) and 
metabolic clearance rates than the rat enzyme. There was no correlation however 
between metabolic clearance rates and the extent of the cytotoxicity observed.
Preliminary computer aided molecular modelling (performed for me by Dr David 
Lewis, University of Surrey, data not shown) of the interaction between several 
cysteine conjugates and the putative active site of rat and human cysteine conjugate 6- 
lyase (by homology with aspartate aminotransferase) would suggest that the species 
differences in enzyme activity observed in this thesis are due to subtle differences in the 
structures of the enzyme active site. The active site of human cysteine conjugate 6- 
lyase appears to be smaller and possibly less accessible than the active site for rat 6- 
lyase. Furthermore, fluorine containing cysteine conjugates appear to be able to 
hydrogen bond with the glutamine residue at position 325 of human cysteine conjugate 
6-lyase. This cannot occur with the rat cysteine conjugate 6-lyase, since it does not 
possess this residue at position 325. The result is the formation of an enzyme-substrate 
complex which is more stable than that formed in the rat enzyme. This, together with 
the fact that fluorine containing conjugates appear to be better substrates for 6-lyase 
enzymes, in particular the human form, may help explain the difference in enzyme 
activity between the rat and human cysteine conjugate 6-lyase.
245
The cysteine conjugate DCDFEC, possesses chlorine atoms on the terminal carbon 
atom of the halogenated group in place of the fluorine atoms of TFEC and CTFEC. 
Chlorine is not as electronegative as fluorine and hence DCDFEC cannot form 
hydrogen bonds with the surrounding glutamine residues. Since the ability of 
fluorinated cysteine conjugates to form hydrogen bonds only occurs in human cysteine 
conjugate 6-lyase, it may help explain why human cysteine conjugate 6-lyase has a 
faster reaction rate than rat 6-lyase for fluorinated conjugates. On comparison with rat 
cysteine conjugate 6-lyase, the metabolism of DCDFEC is almost identical to that for 
the human enzyme, both having the same affinity for DCDFEC. This evidence again 
would suggest that the presence of certain amino acids in the wall of the enzyme active 
site is partially responsible for the differences in enzyme activity observed between rat 
and human cysteine conjugate 6-lyase.
The size of the enzyme active sites may also contribute toward the differences between 
the two forms of 6-lyase, rat 6-lyase has a larger, more open active site than human 6- 
lyase which would allow quicker metabolic clearance, however, it would also allow 
other molecules to interfere with the reaction, hence slowing down the reaction rate of 
rat cysteine conjugate 6-lyase.
Another question raised in this thesis, is the presence of a mitochondrial form of 
cysteine conjugate 6-lyase. In the initial work performed using transient transfection of 
the COS-1 cells, it was clear that mitochondria isolated from preparations of COS-1 
cells transfected with either rat or human cytosolic cysteine conjugate 6-lyase possessed 
GTK activity. It was believed that the GTK activity observed in the mitochondrial 
fractions could possibly be due to an artefact of the mitochondrial preparation. Due to 
the small quantities of mitochondria that were available, together with the limited 
availability of cysteine conjugates it was not possible to perform cysteine conjugate 6- 
lyase assays using mitochondrial fractions extracted from transfected COS-1 cells.
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Therefore, it was not possible to ascertain whether or not the mitochondrial fractions 
also possessed a separate (non-GTK) 6-lyase activity and their comparison to the 
cytosolic forms.
Again, using the stable cell lines it was not possible to obtain enough mitochondria or 
cysteine conjugate to perform 6-lyase assays. Furthermore, mitochondria were not 
isolated from the stable cell lines since it was believed that the mitochondrial GTK 
activity observed in the COS-1 cell isolates was probably an artefact of the 
mitochondrial preparation. However, cytotoxicity studies performed using the stable 
cell lines to assess the effects of various cysteine conjugates, showed that two cysteine 
conjugates, namely DCVC and PCBC produced an unexpected result. It was expected 
that those cell lines which possessed an increased amount of cytosolic cysteine 
conjugate 6-lyase would show increased cytotoxicity to cysteine conjugates when 
compared to the wild type, LLC-PKl cells. In the case of PCBC and to some extent 
DCVC this did not appear to be so. The LLC-PKl cells exhibited a toxic response to 
PCBC and DCVC at low substrate concentrations, whereas the cell lines RIJ (high 
expression of rat cytosolic cysteine conjugate 6-lyase) and HS3C (high expression of 
human cytosolic cysteine conjugate 6-lyase) exhibited a lesser toxic response at lower 
concentrations of cysteine conjugate, eventually reaching the same level of toxic 
response as the LLC-PKl cells at higher concentrations of cysteine conjugate. In the 
case of DCVC, the addition of the a-KMB increased the toxic effect observed with the 
cell lines RIJ and HS3C sufficiently that they exhibited greater cytotoxicity than the 
wild type LLC-PKl cells. It was also noted that the addition of a-KMB to the wild type 
LLC-PKl cells in the presence of both DCVC and PCBC had no effect on the resultant 
cytotoxicity, suggesting the involvement of a non-PLP dependent enzyme.
Many researchers have suggested that a mitochondrial form of cysteine conjugate 6- 
lyase exists, although opinions on its function and location in the mitochondrion tend to
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differ (Cooper and Meister, 1974; Dohn and Anders, 1982; Cooper, 1988; Stevens et 
ai, 1988). In 1986, Lash et al, (a) reported that the outer membrane of rat kidney 
mitochondria contained glutamine transaminase K/ 6-lyase activity. However, Stevens 
et a l , (1988) reported that there was GTK/6-lyase activity present in the mitochondrial 
matrix of rat kidney mitochondria. Isolation of the mitochondrial form of rat kidney 
cysteine conjugate 6-lyase by various groups (Cooper, 1978 and Stevens et a l , 1988) 
suggested that there were subtle differences in substrate affinity between the 
mitochondrial and cytosolic form of the enzymes. Stevens et a l , (1988) noted that the 
cysteine conjugate DCVC could act as a substrate for both the cytosolic and 
mitochondrial forms of cysteine conjugate 6-lyase.
Kidney mitochondria are known to be a toxicological target for the cysteine conjugate 
DCVC (Lash et a l , 1986) and there is much evidence that the mitochondrial form of 
cysteine conjugate 6-lyase can also catalyse the elimination of an unstable thiol (Dekant 
et a l , 1987; 1988a & 1988b).
More recently, Abraham and Cooper (1991) have isolated a higher molecular weight 
enzyme which is present in both the cytosol and mitochondria of rat kidneys which 
possesses weak transaminase activity but substantial DCVC-lyase activity together with 
activity towards leukotiiene E4 (Abraham et a l , 1995a). It does not however, appear to 
have any obvious relationship to glutamine transaminase K and is not located in the 
brain (Cooper et al, 1993). Since it does possess a DCVC-lyase activity, Abraham et 
a l, (1995) suggest that the mitochondrial form of the high molecular weight lyase may 
contribute to the nephrotoxicity observed with DCVC and similar cysteine conjugates. 
It is quite possible that the cytotoxic effects observed with DCVC and LLC-PKl cells 
in this study were due to the metabolism of DCVC by the high molecular weight 
mitochondrial enzyme. Abraham eta l, (1995a) suggest that the mitochondrial form of 
the high molecular weight 6-lyase is a major cysteine conjugate 6-lyase in rat kidney
248
and suggest two possible mechanisms by which DCVC and other such compounds 
may be toxic.
The results presented within chapter four would tend to agree with the data presented 
by Abraham etal. , (1995b) in that toxicity observed with DCVC is probably due to its 
metabolism by the high molecular weight mitochondrial form of 6-lyase together with 
the usual cytosolic form. Furthermore, since the high molecular weight mitochondrial 
DCVC-lyase possesses little transaminase activity, the a-keto acid, a-KMB would have 
little or no effect on its activity, which is confirmed by the cytotoxicity assays 
performed in Chapter 4 of this thesis using the cysteine conjugates DCVC and PCBC. 
It would also follow that PCBC which appears to have a similar mechanism of 
bioactivation as DCVC (Jones et al. , 1988; Groves et al. , 1991) forming a thioketene as 
the reactive intermediate, may also act as a substrate for the high molecular weight 
mitochondrial 6-lyase. The other cysteine conjugates used in this thesis contained 
fluorine atoms, and it is possible that fluorine-containing molecules are metabolised in a 
slightly different way to chlorine containing compounds forming different types of 
reactive intermediates.
In 1995, Gaskin et al, reported that both aspartate and alanine aminotransferase 
isolated from pig heart also exhibited C-S lyase activity when reacted with several 
cysteine conjugates. It was noted that the cysteine conjugate DCVC appeared to be a 
good substrate for both enzymes. Both aspartate and alanine aminotransferase are 
present at high levels in the kidney (Miles, 1985) as well as the heart, liver and lung, 
aspartate aminotransferase having both a cytosolic and a mitochondrial isoform. It is 
also quite possible that one of these enzymes contributes to the cytotoxicity observed 
with DCVC in LLC-PKl cells compared to the RIJ or HS3C cells. However, since 
both aspartate and alanine aminotransferase are pyridoxal 5’-phosphate-dependent 
enzymes it would have been expected that the addition of a-KMB would have increased
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the cytotoxic effect observed. In fact, Kato et al (1996), have shown that certain 
cysteine conjugates such as DCVC and TFEC, inactivate cytosolic aspartate 
aminotransferase and alanine aminotransferase. Abraham and Cooper (1996), have 
also reported that another enzyme exists in rat renal cytosol which possesses glutamine 
transaminase K, 6-lyase and kynurenine aminotransferase activities and shares 90% 
sequence homology with GTK/6-lyase/KAT.
5 .3  CONCLUSIONS AND FUTURE WORK
The original aim of this thesis was to assess and compare the structure / activity 
relationship of rat and human cysteine conjugate 6-lyase and the construction of cell 
lines expressing rat and human cytosolic cysteine conjugate 6-lyase for use as a means 
of in vitro assessment of cysteine conjugate toxicity. It would appear that although 
there is little other literature available to allow a comparison of the results obtained in 
this thesis for human cytosolic cysteine conjugate 6-lyase to be made, it would seem 
that what data there is agrees at least in part with the results obtained here.
The full length rat and human cDNAs have been expressed both transiently and stably, 
and kinetic analysis and cytotoxicity tests have been performed using a large panel of 
cysteine conjugates. Kinetic analysis of rat and human cysteine conjugate 6-lyase 
confirms that fluorinated alkenes would appear to be metabolised at a faster rate than 
chlorinated alkenes, however, chlorinated alkenes appear to be more cytotoxic. In the 
majority of cases, human cysteine conjugate 6-lyase metabolises cysteine conjugates 
faster than rat cysteine conjugates, this is probably due to the differences in amino acid 
structure around the enzyme active site. This could be confirmed by site-directed
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mutagenesis of the rat and human cDNAs, which would enable the identification of the 
amino acid residues responsible for enzyme catalysis. X-ray crystallography studies 
could also be performed since the stable cell lines provide an inexhaustable supply of 
enzyme for crystallisation. Furthermore, the availability of large quantities of relatively 
pure 6-lyase protein will allow the production of specific antibodies which could be 
used to assess the amounts of 6-lyase present in rat and human kidney and brain via 
immunohistochemichal studies. The availability of antibodies specific for rat and human 
cysteine conjugate 6-lyase would also allow Western blot analysis to be perfomed, in 
order to assess whether the differences in enzyme activity between rat and human 
cysteine conjugate 6-lyase is due to there being more human 6-lyase protein being 
produced in the cell line compared to rat 6-lyase. Although Northern blot analysis of the 
levels of 6-lyase message present in the cell lines was unsuccessful, it would be 
worthwhile, given more time, to establish a quantitative RT-PCR assay which would 
be capable of detecting low levels of message.
The establishment of cell lines which stably express varying levels of rat and human 
cysteine conjugate 6-lyase form the basis of a sensitive model for the study of cysteine 
conjugate toxicity. They will also provide a means of assessing the mechanisms 
involved in cysteine conjugate toxicity, for example the effects of cysteine conjugate 
metabolism on cellular processes such as respiration, signalling or apoptosis / necrosis 
could be studied. Furthermore, the cell lines provide a system whereby the metabolism 
of cysteine conjugates may be assessed using proton NMR.
It would also be interesting to study the metabolism of conjugates such as DCVC and 
PCBC, which this study has suggested are possibly metabolised via a different 
mechanism to the other conjugates evaluated in this thesis, namely via a heavy 
molecular weight mitochondrial form of lyase which possesses poor levels of 
transaminase activity (Abraham et al. , 1995).
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The stable cell lines expressing human cytosolic cysteine conjugate 6-lyase will also 
enable us to gain a further insight into why nephrotoxicity in humans does not appear to 
be as obvious and accepted as it is in rats. However, more recently there has been 
acknowledgement that cysteine conjugates do produce nephrotoxicity in man 
(Henschler et al. , 1995; Tofigueras et al. , 1997), although it appears not to be an accute 
effect, and renal tumours develop some time after exposure (Henschler et al, 1995).
From the results presented within this thesis, together with more recent work 
performed by other research groups, it is becoming increasingly clearer that many 
enzymes within the body possess C-S lyase activity, the result of whose action appears 
to produce nephrotoxicity in both rats and humans. It would appear that the renal 
cytosolic cysteine conjugate 6-lyase enzymes examined in this thesis are merely the tip 
of the iceberg, and that it is indeed a field which deserves further research.
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APPENDIX:
BUFFERS, SOLUTIONS AND MEDIA
Ammediol Buffer (0.2M):
10.51g 2-amino-2-methyl-1,3-propanediol-HCl
add 80ml distilled water
adjust to pH 9.0 with concentrated HCl
Make up to 100ml with distilled water and sterilise by autoclaving.
Ampicillin Stock Solution:
lOOmg/ml ampicillin in distilled water, filter sterilise.
Store at -20°C and use at 50//g/ml in growth media when selecting ampicillin resistant 
bacteria.
Chloroform /  isoamyl alcohol (24:1):
24ml chloroform 
1ml isoamyl alcohol
Chloroquine (40mM):
40mM chloroquine in PBS ( Ca^  ^and Mg^  ^free)
CIAP (5x) Buffer:
250mM Tris-HCl,pH 9.0 
5mM MgCl^
0.5mM ZnCl^
5mM spermidine
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2x Cracking Buffer:
2ml 5M NaOH 
2.5ml 10% (w/v) SDS 
lOg sucrose
make up to 50ml with distilled water (store at 4°C)
DEAE-Dextran (lOmg/ml):
O.lg DEAE-Dextran
10ml PBS (Ca^  ^, Mg^ "" free), sterilise by autoclaving
Denhardt’s Solution (50x):
lOg Bovine Serum Albumen fraction V
lOg Ficoll 400,00
lOg Polyvinyl Pyrrolidone 40,000
Make up to 11 with distilled water, stir vigorously for Ihr and sterilise by autoclaving. 
DEPC-Treated Water:
0.1% (v/v) DEPC ( diethyl pyrocarbonate; 1ml) in 11 of distilled water 
Stir for Ihr at 37°C then autoclave.
DNA Denaturing Solution:
20gNaOH(0.5M)
87.66g NaCl (1.5M)
Make up to 11 with distilled water and autoclave to sterilise
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DNA Neutralising Solution:
60.5gTris-HCl(0.5M)
87,66g NaCl (1.5M)
pH to 7.5 and make up to 11 with distilled water, autoclave to sterilise.
0.5M EDTA:
186.1g EDTA 
20g NaOH pellets
pH to 8.0 and make up to 11 with distilled water.
GTK Reagent:
500//1, IM Ammediol (2-amino-2-methyl-1,3-propanediol HCl)
250/^1, lOOmM L-Phenylalanine (4.13mg/250/<l)
125/<1, lOOmM a-KMB (2.125mg/125/<l)
Keep on ice an use shortly after preparation.
Hybridisation /  Prehybridisation Solution:
20ml SSPE
20ml Denhardt’s (50x)
1.0ml 20% (w/v) SDS
2ml Herring Sperm DNA
Add to 200ml sterile distilled water
O.IM IPTG:
0.24g IPTG in 10ml distilled water - store at -20°C 
Use 5ml/l of agar to give a final concentration of 0.5mM.
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LB-agar:
15g Agar / Il LB medium, autoclave to sterilise and allow to cool to approx. 58°C before 
pouring.
LB (Luria-Bertaini) Medium:
lOg Tryptone 
lOgNaCl 
5g Yeast Extract
Make up to 11 with distilled water and autoclave to sterilise.
PBS for Transfections:
Dissolve 1 Dulbecco ‘A’ tablet in 100ml of distilled water 
Autoclave to sterilise.
Phenol /  Chloroform (1:1):
50ml Phenol pH8.0 
50ml Chloroform
Restriction Enzyme Reaction Buffers (Ix Concentrate):
Buffer A:
6mM Tris-HCl pH7.5 
6mM MgClj 
6mM NaCl 
ImMDTT
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Buffer B:
6mMTris HCl pH 7.5 
6mM MgClj 
50mMNaCl 
ImMDTT
Buffer D:
6mM Tris-HCl pH 7.9 
6mM MgClj 
150mM NaCl 
ImMDTT
Buffer J:
lOmM Tris-HCl pH 7.5 
7mMMgCl^
50mMKCl
ImMDTT
Buffer M :
6mM Tris-HCl pH 7.5 
6mM MgClj 
50mM NaCl 
ImMDTT
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Buffer H:
90mMTris-HCl pH 7.5 
lOmM MgClj 
SOmMNaCl
REact 4 (R4):
20mMTris-HClpH7.4 
5mM MgClj 
SOmMNaCl
RNA Dye:
4% (w/v) Bromophenol blue 
4% (w/v) xylene cyanol 
lOmMEDTA (pH8.0)
50% (v/v) Glyeerol
RNA Electrophoresis Buffer (lOx):
400mMMOPS 
lOOmM sodium acetate 
lOmMEDTA
Make up in DEPC treated water.
Sequencing Gel (6%  (w/v) polyacrylamide):
15ml 30% (w/v) acrylamide (Alternatively use a ready made gel such
11.25ml 2% (w/v) bisacrylamide as Scottlabs Easi gel)
31.5g urea 
7.5ml lOxTBE
Make up to 75ml with distilled water, heat to 37° C to dissolve urea, place on ice to cool.
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Sequencing Gel Fixing Solution:
10% (v/v) methanol 
10% (v/v) acetic acid 
Made up in distilled water
SOC media (TA vector Kit);
20g Tryptone 
5g Yeast Extract 
0.6g NaCl 
3.6g Glucose 
0.95g MgCl,
0.19g KCl 
1.2gMgSO^
Make up to 11 with distilled water, autoclave to sterilise.
O.IM Sodium Phosphate Buffer:
O.IM Na^HPO^ (a; 14. Ig) in 11 of distilled water 
O.IM NaH2P0 ^.2H20 (b; 15.6g) in 11 of distilled water 
Adjust the pH of solution a to 7.4 by adding solution b.
20 X SSC - Saline-sodium Citrate:
3MNaCl
0.3M Sodium Citrate pH 7.0
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20 X SSPE:
174g NaCl
27.6g NaH2P04.H20 
7.4g EDTA
Add 800ml distilled water and adjust to pH 7.7, Make up to 11 with distilled water and 
autoclave to sterilise
10 X TAE Electrophoresis Buffer:
400mM Tris Acetate 
20mMEDTA,pH8.3
Make up in distilled water, dilute to Ix before use.
10 X TBE Tris-borate EDTA:
108gTris-HCl 
55g Boric acid 
40ml 0.5M EDTA, pH 8.0
Make up to 11 with distilled water and autoclave to sterilise.
Tris-EDTA (TE): 
lOmM Tris-HCl, pH 8.0 
ImMEDTA
Make up in distilled water, autoclave to sterilise.
Wizard mini/Maxi Preparation Solutions:
Cell Lysis Solution:
0.2MNaOH 
1% (w/v) SDS
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Column Wash Buffer:
200itiMNaCl
20mM Tris-HCl pH 7.5
SmMEDTA
Before use, add 125ml of the wash buffer to 170ml of 95% (v/v) ethanol.
Neutralising Solution:
1.32M Potassium Acetate, pH 4.8
Resuspension Solution:
50mM Tris-HCl pH7.5 
lOmMEDTA 
100/fg/ml RNase A
X-Gal:
40mg/ml of dimethylformamide (DMF)
Prepare fresh and add to 11 of agar (58°C) to give a final concentration of 40/<g/ml.
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